
<html lang="en"     class="pb-page"  data-request-id="572383c6-21b6-4dac-8e61-a5741e39bc5b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b02153;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-10"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery and Optimization of Glucose Uptake Inhibitors" /></meta><meta name="dc.Creator" content="Kevin G.  Liu" /></meta><meta name="dc.Creator" content="Ji-In  Kim" /></meta><meta name="dc.Creator" content="Kellen  Olszewski" /></meta><meta name="dc.Creator" content="Anthony M.  Barsotti" /></meta><meta name="dc.Creator" content="Koi  Morris" /></meta><meta name="dc.Creator" content="Christophe  Lamarque" /></meta><meta name="dc.Creator" content="Xuemei  Yu" /></meta><meta name="dc.Creator" content="Jack  Gaffney" /></meta><meta name="dc.Creator" content="Xiao-Jiang  Feng" /></meta><meta name="dc.Creator" content="Jeegar P.  Patel" /></meta><meta name="dc.Creator" content="Masha V.  Poyurovsky" /></meta><meta name="dc.Description" content="Aerobic glycolysis, originally identified by Warburg as a hallmark of cancer, has recently been implicated in immune cell activation and growth. Glucose, the starting material for glycolysis, is tr..." /></meta><meta name="Description" content="Aerobic glycolysis, originally identified by Warburg as a hallmark of cancer, has recently been implicated in immune cell activation and growth. Glucose, the starting material for glycolysis, is tr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 13, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02153" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02153" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02153" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02153" /></link>
        
    
    

<title>Discovery and Optimization of Glucose Uptake Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02153" /></meta><meta property="og:title" content="Discovery and Optimization of Glucose Uptake Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0016.jpeg" /></meta><meta property="og:description" content="Aerobic glycolysis, originally identified by Warburg as a hallmark of cancer, has recently been implicated in immune cell activation and growth. Glucose, the starting material for glycolysis, is transported through the cellular membrane by a family of glucose transporters (GLUTs). Therefore, targeting glucose transporters to regulate aerobic glycolysis is an attractive approach to identify potential therapeutic agents for cancers and autoimmune diseases. Herein, we describe the discovery and optimization of a class of potent, orally bioavailable inhibitors of glucose transporters, targeting both GLUT1 and GLUT3." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02153"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02153">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02153&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02153&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02153&amp;href=/doi/10.1021/acs.jmedchem.9b02153" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5201-5211</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b02135" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00021" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Optimization of Glucose Uptake Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Kevin G. Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin G. Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#94fff1e2fdfabaf8fde1d4fff5f0f9fbfabaf7fbf9"><span class="__cf_email__" data-cfemail="0f646a7966612163667a4f646e6b626061216c6062">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+G.++Liu">Kevin G. Liu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1562-6201" title="Orcid link">http://orcid.org/0000-0003-1562-6201</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ji-In Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ji-In Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ji-In++Kim">Ji-In Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kellen Olszewski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kellen Olszewski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kellen++Olszewski">Kellen Olszewski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anthony M. Barsotti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anthony M. Barsotti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+M.++Barsotti">Anthony M. Barsotti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Koi Morris</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Koi Morris</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Koi++Morris">Koi Morris</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christophe Lamarque</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christophe Lamarque</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Lamarque">Christophe Lamarque</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xuemei Yu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xuemei Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xuemei++Yu">Xuemei Yu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jack Gaffney</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jack Gaffney</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jack++Gaffney">Jack Gaffney</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiao-Jiang Feng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiao-Jiang Feng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Jiang++Feng">Xiao-Jiang Feng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeegar P. Patel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeegar P. Patel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeegar+P.++Patel">Jeegar P. Patel</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Masha V. Poyurovsky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Masha V. Poyurovsky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kadmon Corporation, LLC., 450 East 29th Street, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Masha+V.++Poyurovsky">Masha V. Poyurovsky</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02153&amp;href=/doi/10.1021%2Facs.jmedchem.9b02153" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5201–5211</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 13, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 December 2019</li><li><span class="item_label"><b>Published</b> online</span>13 April 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 May 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02153</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5201%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKevin%2BG.%2BLiu%252C%2BJi-In%2BKim%252C%2BKellen%2BOlszewski%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D10%26contentID%3Dacs.jmedchem.9b02153%26title%3DDiscovery%2Band%2BOptimization%2Bof%2BGlucose%2BUptake%2BInhibitors%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5211%26publicationDate%3DMay%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02153"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1771</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02153" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Optimization of Glucose Uptake Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;G. Liu&quot;},{&quot;first_name&quot;:&quot;Ji-In&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Kellen&quot;,&quot;last_name&quot;:&quot;Olszewski&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;M. Barsotti&quot;},{&quot;first_name&quot;:&quot;Koi&quot;,&quot;last_name&quot;:&quot;Morris&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Lamarque&quot;},{&quot;first_name&quot;:&quot;Xuemei&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Jack&quot;,&quot;last_name&quot;:&quot;Gaffney&quot;},{&quot;first_name&quot;:&quot;Xiao-Jiang&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Jeegar&quot;,&quot;last_name&quot;:&quot;P. Patel&quot;},{&quot;first_name&quot;:&quot;Masha&quot;,&quot;last_name&quot;:&quot;V. Poyurovsky&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;5201-5211&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02153&quot;},&quot;abstract&quot;:&quot;Aerobic glycolysis, originally identified by Warburg as a hallmark of cancer, has recently been implicated in immune cell activation and growth. Glucose, the starting material for glycolysis, is transported through the cellular membrane by a family of glucose transporters (GLUTs). Therefore, targeting glucose transporters to regulate aerobic glycolysis is an attractive approach to identify potential therapeutic agents for cancers and autoimmune diseases. Herein, we describe the discovery and optimization of a class of potent, orally bioavailable inhibitors of glucose transporters, targeting both GLUT1 and GLUT3.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02153&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02153" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02153&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02153" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02153&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02153" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02153&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02153&amp;href=/doi/10.1021/acs.jmedchem.9b02153" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02153" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02153" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02153%26sid%3Dliteratum%253Aachs%26pmid%3D32282207%26genre%3Darticle%26aulast%3DLiu%26date%3D2020%26atitle%3DDiscovery%2Band%2BOptimization%2Bof%2BGlucose%2BUptake%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D10%26spage%3D5201%26epage%3D5211%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/jmcmar.2020.63.issue-10/20200528/jmcmar.2020.63.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Aerobic glycolysis, originally identified by Warburg as a hallmark of cancer, has recently been implicated in immune cell activation and growth. Glucose, the starting material for glycolysis, is transported through the cellular membrane by a family of glucose transporters (GLUTs). Therefore, targeting glucose transporters to regulate aerobic glycolysis is an attractive approach to identify potential therapeutic agents for cancers and autoimmune diseases. Herein, we describe the discovery and optimization of a class of potent, orally bioavailable inhibitors of glucose transporters, targeting both GLUT1 and GLUT3.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glucose is the most abundant energy source for cells in human tissues. Under aerobic conditions, cells normally metabolize glucose into pyruvate in the cytosol, which is oxidized in the tricarboxylic acid (TCA) cycle to drive oxidative phosphorylation (OXPHOS) in the mitochondria. When oxygen is lacking, a condition called hypoxia, cells are forced to switch to anaerobic glycolysis where the aerobic glycolysis product pyruvate is instead converted to lactate. Glycolysis is significantly less efficient than the OXPHOS pathway, producing an order of magnitude less ATP per glucose. Despite this, both cultured cancer cells and tumors typically ferment glucose to lactate at a high rate, even in the presence of abundant oxygen. This altered metabolism phenomenon, known as the Warburg effect,<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> is a hallmark of cancer cells. This phenomenon has been exploited for cancer imaging and diagnosis with the PET ligand [<sup>18</sup>F]fluoro-2-deoxyglucose (<sup>18</sup>F-FDG), a metabolically stable glucose analogue. There is still considerable academic debate about the nature of the survival benefit aerobic glycolysis phenomenon provides for cancer and other rapidly proliferating cells. It is, however, undisputed that elevation in the rate of glycolysis and increased glucose uptake<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> are associated with tumor growth and present interesting targets for potential therapeutic intervention.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a></div><div class="NLM_p">Elevated rates of glucose consumption and glycolysis were recently implicated in immune cell activation and growth. Immunometabolism,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> an emerging field studying the interplay between the immune system and metabolism, has attracted considerable attention both for understanding the phenomenon and searching for new treatments for autoimmune diseases. Upon activation, naïve CD4<sup>+</sup> T cells rapidly grow, proliferate, and differentiate into functional subsets including T helper (Th) cells such as effector Th1, Th2, and Th17 cells, which drive the immune response, and Foxp3<sup>+</sup> regulatory T (Treg) cells, which suppress the immune activity. Unlike their precursor naïve CD4<sup>+</sup> T cells, which rely predominantly on OXPHOS, effector CD4<sup>+</sup> T cells primarily rely on aerobic glycolysis for their metabolic needs and immune functions.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a></div><div class="NLM_p">Glucose transporters (GLUTs) constitute a family of proteins that facilitate the transport of glucose across cellular membranes. To date, 14 human GLUT members (GLUT1–14) have been identified.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> GLUTs have 12 transmembrane domains, and several crystal structures including human GLUT1 and GLUT3 have been obtained.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> Given that glucose transport is one of the rate-limiting steps in glucose metabolism, GLUTs, especially GLUT1, are overexpressed in cancer and activated immune cells to meet their glucose demands and have become an interesting therapeutic target for cancers and autoimmune diseases.<a onclick="showRef(event, 'ref9 ref10 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref14 ref15 ref16">(9,10,14−16)</a></div><div class="NLM_p">A number of GLUT (mainly GLUT1) inhibitors have been reported. Representative GLUT inhibitors are summarized in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>. Compounds <b>1</b>–<b>3</b><a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> have limited potency (in the μM to mM range) and have been reported to have additional activity independent of GLUT inhibition. Compound <b>4</b> of peptidic nature and its analogue have been reported as GLUT inhibitors and co-crystallized with hGLUT1.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Compounds <b>5</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and <b>6</b> (BAY-876),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> reported by Siebeneicher and co-workers at Bayer, represent two classes of GLUT1 subtype selective inhibitors. Compound <b>6</b> was reported to be a potent and orally bioavailable GLUT1 selective inhibitor. Very recently, Waldmann et al. disclosed a potent GLUT1/2/3 inhibitor <b>7</b> (Glutor) and its ability to suppress the growth of a number of cancer cell lines. However, no pharmacokinetic or <i>in vivo</i> functional data associated with this compound was disclosed.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0001.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Known GLUT Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As part of our research efforts in metabolomics, we were interested in studying the inhibition of glucose uptake and its potential therapeutic indications. While a number of above-mentioned compounds have been tested in cell-based assays, little or no <i>in vivo</i> functional data is available. This is due in part to their poor pharmacokinetic properties, which limit the ability to fully interrogate the potential therapeutic utility of GLUT inhibitors. In order to assess the clinical potential of GLUT targeting, we set out to generate GLUT inhibitors with optimized safety and PK profiles. To avoid possible compensatory mechanisms from GLUT3 following GLUT1 inhibition, we additionally aimed to generate compounds targeting both isoforms.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Dihydrofuropyrimidine and Dihydropyranopyrimidine Derivatives</h3><div class="NLM_p">To identify novel glucose uptake inhibitors, we screened Kadmon’s compound collection utilizing a high-throughput cell-based phenotypic assay. In this assay, HT-1080 colorectal cancer cells were treated with 10 μM oligomycin to inhibit ATP synthase, blocking mitochondria-derived ATP production through oxidative phosphorylation and rendering the cells dependent on glycolytic ATP production. Glycolytically derived ATP production was measured with the Cell Titer-Glo assay kit (Promega). HT-1080 cells express both GLUT1 and GLUT3 transporters, so the inhibitory activity of our compounds in these cells is referred to broadly as “GLUT” inhibition. Because simply inhibiting ATP production cannot be linked to inhibition of glucose uptake directly, we confirmed inhibition of glucose transport, but not other targets such as downstream glycolysis enzymes, by also measuring direct glucose uptake, lactate secretion, glutamine consumption, and metabolomic profiling of treated cells. The results from the above-mentioned experiments supported the direct blockade of glucose transport mechanisms and were further reinforced by the <i>in vivo</i> glucose tolerance and imaging experiments (Olszewski et al., manuscript in preparation). GLUT subtype activity was measured using cell lines that specifically express the GLUT isoforms, e.g., GLUT1 (DLD1); GLUT3 (DLD1-<i>SLC2A1</i><sup>–/–</sup>). We initially utilized the GLUT assay in HT1080 cells to identify hits and lead chemical series. As the project progressed, we relied primarily on more informative GLUT1 and GLUT3 subtype assays for lead optimization.</div><div class="NLM_p">Our screening efforts led to the identification of compound <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) as a potent GLUT inhibitor (IC<sub>50</sub> = 150 nM). To elucidate the molecular mechanism of GLUT inhibition, we compared the activity of compound <b>8</b> in a GLUT1 inhibition assay to cytochalasin B at varying glucose concentrations. Cytochalasin B has been extensively characterized as a glucose competitive inhibitor of GLUT1, which functions by binding in the glucose pocket in the central cavity of the transporter.<a onclick="showRef(event, 'ref20 ref24'); return false;" href="javascript:void(0);" class="ref ref20 ref24">(20,24)</a> We observed that both cytochalasin B and compound <b>8</b> exhibited a similar level of competition with glucose, with the GLUT1 IC<sub>50</sub> for compound <b>8</b> shifting from 268 nM at 10 mM glucose to 33 nM in the presence of 0.37 mM glucose (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_001.pdf" class="ext-link">Table S1</a>). These data suggested that the molecular mechanism of the inhibition of glucose import by our compounds was through direct competition for the glucose binding pocket of GLUT1.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Screening hit and optimization strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>8</b> is competitive with glucose. GLUT1 IC<sub>50</sub> values for cytochalasin B and compound <b>8</b> at different glucose concentrations. The graph shows the calculated IC<sub>50</sub> values ± the 95% confidence interval.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While being a potent hit as a starting point, this compound was characterized by suboptimal physicochemical properties, such as poor aqueous solubility (3.36 μM, 0.01 μM, 0.03 μM at pH 2.0, pH 4.5, and pH 6.8, respectively), high protein binding (>99.9%), and poor permeability (Caco-2 <i>P</i><sub>app</sub> 2.0 × 10<sup>–6</sup> cm/s). To follow up on compound <b>8</b>, we studied the SAR (structure–activity relationship) and carried out optimization in three regions of the molecule: phenylpyrazole region I, phenoxylacetamide II, and quinazoline core III (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). For region I, we replaced phenylpyrazole with a variety of groups such as small monocyclic rings, fused rings, and those that are structurally similar to phenylpyrazole. Disappointingly, all of the replacements resulted in either a complete loss or a dramatic reduction of GLUT inhibitory activity. Phenylpyrazole was strongly preferred in this region. It is worth mentioning that the high preference for phenylpyrazole in this region was maintained with concomitant changes to other portions of the molecules.</div><div class="NLM_p">Aiming to improve the physicochemical properties and to enhance drug-like properties, we undertook further optimization of region II. We first removed the phenyl ring in order to reduce the total number of aromatic rings<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> or replace the phenyl ring with a saturated ring system in order to reduce sp<sup>2</sup> and to increase sp<sup>3</sup> hybridization characteristics of the molecule aiming to improve the physicochemical property<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> as well as to potentially improve the potency by incorporating moieties similar to the glucose ring.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Unfortunately, these efforts were not successful as the phenyl group was shown to be required for GLUT activity. Replacement of the phenyl ring by heterocycles also led to inactivity. We then kept the phenyl group but replaced the amide moiety with nonamide groups such as acyclic amine or ether, lactams, heterocycles, or heteroaryls with the hope that these groups can avoid the potential metabolic liability of the amide group. Once again, these replacements resulted in significantly reduced potency (>5 μM).</div><div class="NLM_p">Upon further optimization, we found that the quinazoline core (region III) tolerated modifications without loss of GLUT activity. Although replacement of the quinazoline core with a pyrimidine or substituted pyrimidines resulted in a dramatic loss of activity, fusing the pyrimidine ring with a variety of heterocycles provided alternatives to the quinazoline ring which retained potency. Some of the explored heterocycle-fused pyrimidine cores are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Select Heterocycle-Fused Pyrimidine Cores<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0011.gif" alt="" id="GRAPHIC-d7e437-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0012.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least two determinations.</p></div></div><div></div></div><div class="NLM_p">While most of the compounds with heterocycle-fused pyrimidine cores (<b>9a</b>–<b>m</b>) are expected to have improved physical properties over quinazoline derivative <b>8</b> by simply having reduced cLogP with the introduction of additional heteroatoms, compounds <b>9c</b> and <b>9l</b> were more interesting to us due to their increased sp<sup>3</sup> hybridization feature contributed by the dihydrofurano and tetrahydropyrido groups, respectively. The increased sp<sup>3</sup> content was expected to translate into less molecular flatness and enhanced water solubility.</div><div class="NLM_p">Select SAR of dihydrofuropyrimidine and dihydropyranopyrimidine derivatives is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The data clearly shows that the amide N–H is required for both GLUT1 and GLUT3 activity as <i>N</i>,<i>N</i>-disubstituted amides (<b>10e</b> and <b>10f</b>) are either significantly less active or inactive. The most potent dihydrofuropyrimidine derivative identified, <b>10g</b>, displayed an IC<sub>50</sub> of 37 nM and 12 nM against GLUT1 and GLUT3, respectively. BAY-876 (<b>6</b>) was also tested in our assays and was shown to be a potent GLUT1 selective inhibitor as reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of Dihydrofuranyl and Dihydropyranyl Derivatives<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0013.gif" alt="" id="GRAPHIC-d7e509-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">GLUT1 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">GLUT3 IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>Pr</td><td class="colsep0 rowsep0" align="char" char=".">447</td><td class="colsep0 rowsep0" align="char" char=".">298</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>Pr</td><td class="colsep0 rowsep0" align="char" char=".">666</td><td class="colsep0 rowsep0" align="char" char=".">238</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="char" char=".">289</td><td class="colsep0 rowsep0" align="char" char=".">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>Bu</td><td class="colsep0 rowsep0" align="char" char=".">179</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>Pe</td><td class="colsep0 rowsep0" align="char" char=".">102</td><td class="colsep0 rowsep0" align="char" char=".">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">1828</td><td class="colsep0 rowsep0" align="char" char=".">686</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10f</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>4</sub>–</td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>4</sub>–</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">1414</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>t</i>Pe</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">565</td><td class="colsep0 rowsep0" align="char" char=".">160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">885</td><td class="colsep0 rowsep0" align="char" char=".">325</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-Pe</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>t</i>Bu</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">50 (2<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a>)</td><td class="colsep0 rowsep0" align="char" char=".">4809 (1670<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a>)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least two determinations.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Reported data in ref <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>.</p></div></div></div><div class="NLM_p">The SAR of 6-membered ring dihydropyranopyrimidine derivatives, in general, was consistent with that of their 5-membered ring dihydrofuropyrimidine analogues. Two of the most potent compounds identified are <b>11a</b> and <b>11b</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">The <i>in vitro</i> ADME and <i>in vivo</i> PK profiles of <b>10g</b> and <b>11a</b> are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Compound <b>10g</b> was characterized by very poor water solubility at pH 6.8 and pH 4.5 while it was more soluble at lower pH (2.0) due to its basicity. Compound <b>10g</b> was also characterized by a relatively low mouse liver microsomal stability (29 min), modestly high protein binding (<i>f</i><sub>u</sub> = 3%), and good plasma stability. The 6-membered ring dihydropyranopyrimidine derivative <b>11a</b> was more soluble, displaying solubility of 32 μM, 0.75 μM, and 0.19 μM at pH 2.0, pH 4.5, and pH 6.8, respectively. The increased solubility of <b>11a</b> is presumably due to the higher degree of flexibility of dihydropyranyl and 3-pentyl groups present in <b>11a</b> as compared to their corresponding groups in <b>10g</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. ADME and PK Profile of <b>10g</b> and <b>11a</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>10g</b></th><th class="colsep0 rowsep0" align="center"><b>11a</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">solubility @ pH 2.0/4.5/6.8 (μM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5.9/0.08/0.03</td><td class="colsep0 rowsep0" align="left">32/0.75/0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">mLM stability (<i>t</i><sub>1/2</sub>, min)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">mPPB (%)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">97.0</td><td class="colsep0 rowsep0" align="left">99.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">mouse plasma stability<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">>95%</td><td class="colsep0 rowsep0" align="left">>95%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="7" align="left">mouse PK<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0">oral <i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">1233</td><td class="colsep0 rowsep0" align="left">1870</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">oral AUC (ng/mL)</td><td class="colsep0 rowsep0" align="left">3299</td><td class="colsep0 rowsep0" align="left">5982</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">34.0</td><td class="colsep0 rowsep0" align="left">23.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><i>V</i><sub>dss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">1.42</td><td class="colsep0 rowsep0" align="left">0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.94</td><td class="colsep0 rowsep0" align="left">0.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">B/P<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">0.10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The <i>in vitro</i> ADME data are the average values of at least two determinations; The <i>in vivo</i> PK parameters are average values from three animals.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Solubility was determined in PBS buffer solutions.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Mouse liver microsomal <i>t</i><sub>1/2</sub>: 2 μM substrate, 0.5 mg/mL pooled liver microsomes, 1 mM NAPDH, 37 °C.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Mouse plasma protein binding.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Percentage of compound remaining after 18 h.</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">iv dose 10 mg/kg, vehicle 10% DMSO/40% PEG400/50% water; po dose 30 mg/kg, vehicle 0.5% methylcellulose/0.25% Tween-80 in water.</p></div><div class="footnote" id="t3fn7"><sup><sup>g</sup></sup><p class="last">Compound brain and plasma exposure ratio measured at 2 h following oral administration.</p></div></div></div><div class="NLM_p">In the <i>in vivo</i> mouse PK studies, both <b>10g</b> and <b>11a</b> were orally bioavailable. The relatively low oral bioavailability (22% and 28% for <b>10g</b> and <b>11a</b>, respectively) may be due in part to their relatively high intrinsic clearance and poor water solubility. Both compounds are characterized by a modest volume of distribution (1.42 and 0.63 L/kg for <b>10g</b> and <b>11a</b>, respectively). The lower volume of distribution of <b>11a</b> may have been due to its higher plasma protein binding that helped confine the drug in the plasma.</div><div class="NLM_p">Unlike other organs, the brain is uniquely dependent on glucose for survival and function. To avoid potential toxicities associated with the blockade of neuronal glucose uptake, we aimed to keep compound brain exposure levels to a minimum. Similar to Lipinski’s landmark rule of 5 (Ro5) for drug oral bioavailability,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> desirable physicochemical properties for brain penetration have been extensively studied using successful CNS drugs and drug candidates.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31">(28−31)</a> The GLUT inhibitors like <b>10g</b> and <b>11a</b> fall well outside of the CNS preferred range as they are characterized by a high molecular weight (∼500 Da), high <i>t</i>PSA (>100 Å<sup>2</sup>), and high number of hydrogen bond donors (HBDs, 3) and therefore were not expected to exhibit significant brain penetration. As predicted, <b>10g</b> and <b>11a</b> were found to be only modestly brain penetrant with measured <i>in vivo</i> brain and plasma ratios of 0.15 and 0.10, respectively.</div><div class="NLM_p last">While being potent and orally bioavailable, <b>10g</b> and <b>11a</b> still possessed some undesirable physical properties such as poor water solubility. We, therefore, focused our efforts on other classes of compounds with improved physicochemical properties.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Tetrahydropyridopyrimidine Derivatives</h3><div class="NLM_p">To identify compounds with improved aqueous solubility, we turned our attention to the tetrahydropyridopyrimidine derivatives represented by <b>9l</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The p<i>K</i><sub>a</sub> value of the piperidinyl nitrogen of <b>9l</b> is expected to be ∼10. Under a physiological pH (7.4), it should be mostly protonated, increasing the overall compound aqueous solubility.</div><div class="NLM_p">The SAR of select tetrahydropyridopyrimidine derivatives is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Several substituents including H, Me, Et, and <i>i</i>Pr on the piperidinyl nitrogen (R<sub>1</sub>) and a number of groups on the amide nitrogen were explored. In general, compounds of this class are dual GLUT1 and GLUT3 inhibitors. Relatively bulkier amide groups (R<sub>2</sub>) such as <i>t</i>Pe and <i>t</i>Bu (e.g., <b>12e</b>, <b>12f</b>, <b>12j</b>, <b>12p</b>) tended to be associated with increased GLUT1 and GLUT3 activity and retained glucose competitive MOA (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_001.pdf" class="ext-link">Table S1</a>), while relatively smaller groups such as <i>i</i>Pr (<b>9l</b>, <b>12g</b>, <b>12k</b>, <b>12m</b>) provided compounds with reduced GLUT1 potency. Among these analogues, <b>12p</b> displayed an overall more favorable pharmacological and pharmaceutical profile. The ADME and pharmacokinetic data of <b>12p</b> are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of Tetrahydropyridopyrimidine Derivatives<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0014.gif" alt="" id="GRAPHIC-d7e1262-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">GLUT1 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">GLUT3 IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9l</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">1266</td><td class="colsep0 rowsep0" align="left">867</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"><i>i</i>Bu</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">846</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"><i>c</i>Bu</td><td class="colsep0 rowsep0" align="left">763</td><td class="colsep0 rowsep0" align="left">566</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"><i>c</i>Pe</td><td class="colsep0 rowsep0" align="left">559</td><td class="colsep0 rowsep0" align="left">391</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-Pe</td><td class="colsep0 rowsep0" align="left">789</td><td class="colsep0 rowsep0" align="left">584</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"><i>t</i>Bu</td><td class="colsep0 rowsep0" align="left">359</td><td class="colsep0 rowsep0" align="left">368</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"><i>t</i>Pe</td><td class="colsep0 rowsep0" align="left">342</td><td class="colsep0 rowsep0" align="left">391</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">1458</td><td class="colsep0 rowsep0" align="left">365</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>Pe</td><td class="colsep0 rowsep0" align="left">459</td><td class="colsep0 rowsep0" align="left">138</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-Pe</td><td class="colsep0 rowsep0" align="left">441</td><td class="colsep0 rowsep0" align="left">121</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>t</i>Bu</td><td class="colsep0 rowsep0" align="left">220</td><td class="colsep0 rowsep0" align="left">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12k</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">1578</td><td class="colsep0 rowsep0" align="left">846</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12l</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left"><i>t</i>Bu</td><td class="colsep0 rowsep0" align="left">552</td><td class="colsep0 rowsep0" align="left">482</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12m</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">2711</td><td class="colsep0 rowsep0" align="left">619</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12n</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left"><i>i</i>Bu</td><td class="colsep0 rowsep0" align="left">1890</td><td class="colsep0 rowsep0" align="left">802</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12o</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left"><i>c</i>Pe</td><td class="colsep0 rowsep0" align="left">1112</td><td class="colsep0 rowsep0" align="left">548</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12p</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left"><i>t</i>Bu</td><td class="colsep0 rowsep0" align="left">326</td><td class="colsep0 rowsep0" align="left">412</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least two determinations.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. ADME and PK Profile of <b>12p</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility @ pH 2.0/4.5/6.8 (μM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" colspan="2" align="left">256/189/47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LM stability (<i>t</i><sub>1/2</sub>, min)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" colspan="2" align="left">76 (mouse), 64 (rat)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mPPB (%)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" colspan="2" align="left">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse plasma stability<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" colspan="2" align="left">>95%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 <i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" colspan="2" align="left">A-B 7.1/B-A 12.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PK<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0">rat</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral <i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">1418</td><td class="colsep0 rowsep0">399</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral AUC (ng/mL)</td><td class="colsep0 rowsep0" align="left">7745</td><td class="colsep0 rowsep0">2267</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">40.6</td><td class="colsep0 rowsep0">44.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>dss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">3.00</td><td class="colsep0 rowsep0">4.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">1.68</td><td class="colsep0 rowsep0">1.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B/P<a class="ref internalNav" href="#t5fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">0.07</td><td class="colsep0 rowsep0"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">The <i>in vitro</i> ADME data are average values of at least two determinations. The <i>in vivo</i> PK parameters are average values from three animals.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Solubility was determined in PBS buffer solutions.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Mouse and rat liver microsomal <i>t</i><sub>1/2</sub>: 2 μM substrate, 0.5 mg/mL pooled liver microsomes, 1 mM NAPDH, 37 °C.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Mouse plasma protein binding.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Percentage of compound remaining after 18 h.</p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last">Apparent permeability coefficients (<i>P</i><sub>app</sub>) of test compounds at 5 μM across Caco-2 cell monolayers: apical to basolateral (A-B) and basolateral to apical (B-A).</p></div><div class="footnote" id="t5fn7"><sup><sup>g</sup></sup><p class="last">iv dose 10 mg/kg, vehicle 10% DMSO/40% PEG400/50% water; po dose 30 mg/kg, vehicle 0.5% methylcellulose/0.25% Tween-80 in water.</p></div><div class="footnote" id="t5fn8"><sup><sup>h</sup></sup><p class="last">Compound brain and plasma exposure ratio measured at 2 h following oral administration.</p></div></div></div><div class="NLM_p">As expected, <b>12p</b> had dramatically increased water solubility (256 μM, 189 μM, and 47 μM at pH 2.0, 4.5, and 6.8, respectively) over dihydrofuropyrimidine or dihydropyranopyrimidine derivatives (e.g., <b>10g</b> and <b>11a</b>). This compound was also characterized by overall favorable ADME properties including good liver microsomal stability in the mouse (<i>t</i><sub>1/2</sub> 76 min) and rat (<i>t</i><sub>1/2</sub> 64 min), low protein binding (83%, mouse), good plasma stability, and good permeability (<i>P</i><sub>app</sub> A-B 7.1 × 10<sup>–6</sup> cm/s). In the mouse pharmacokinetic studies, <b>12p</b> displayed high oral bioavailability (61%), good plasma exposure levels (AUC 7745 ng/mL @ 30 mg/kg, po), and low brain penetration (B/P = 0.07). However, in the rat, <b>12p</b> displayed a less favorable pharmacokinetic profile, which was characterized by a low plasma exposure level (<i>C</i><sub>max</sub> 399 ng/mL) and low oral bioavailability (20%). Relatively low rat plasma exposure for <b>12p</b> necessitated further optimization in order to identify compounds with improved PK across multiple species.</div><div class="NLM_p">Incorporation of a basic group to a molecule can, in general, help its water solubility, yet higher basicity may decrease its permeability as the positively charged form of the molecule resulted from protonation under physiological conditions tends to interact with negatively charged lipid membranes, thereby hindering its permeability.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The charged form also has reduced lipophilicity and thus limits its passive diffusion ability across the gut wall. We, therefore, tried to modulate the basicity of the piperidinyl nitrogen with the hope that this kind of fine-tuning can help enhance oral bioavailability while maintaining favorable physiochemical properties.</div><div class="NLM_p">Compound <b>13a</b>, a fluorinated analogue of <b>12p</b>, was then synthesized (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Fluorine has been extensively used in drug design to influence compound p<i>K</i><sub>a</sub>, conformation, potency, and membrane permeability.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> A fluorine atom at the β-position of an amine can reduce the p<i>K</i><sub>a</sub> value by ∼1.5 units. We postulated that the reduced basicity would translate into rat PK improvement. Indeed, as we expected, <b>13a</b> did display improved rat PK parameters (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>) including plasma exposure levels (<i>C</i><sub>max</sub> 1875 ng/mL), clearance (23.5 mL/min/kg), and oral bioavailability (31%) over <b>12p</b> (<i>C</i><sub>max</sub> 399 ng/mL, clearance 44.3 mL/min/kg, oral <i>F</i> 20%). Minimal food effect was observed in the dog following oral administration at 10 mg/kg with 31% and 43% oral bioavailability, when fed and fasted, respectively. Compound <b>13a</b> showed a robust linear rat PK profile up to 300 mg/kg dose. Unfortunately, there were also signs of toxicity at high doses in both the mouse and the rat. While the cause of observed toxicity was not fully elucidated, brain penetration of <b>13a</b> was found to be 0.15 (brain/plasma ratio). This level of brain penetration was not optimal for this target and may have at least partially contributed to the observed toxicity.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Additional Tetrahydropyridopyrimidine Derivatives<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0015.gif" alt="" id="GRAPHIC-d7e1980-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center" char=".">GLUT1 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">GLUT3 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="/">Caco-2 ER<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">B/P<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="char" char=".">105</td><td class="colsep0 rowsep0" align="char" char=".">232</td><td class="colsep0 rowsep0" align="char" char="/">7.33/6.23</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">211</td><td class="colsep0 rowsep0" align="char" char="/">11.97/4.52</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14c</b></td><td class="colsep0 rowsep0" align="char" char=".">140</td><td class="colsep0 rowsep0" align="char" char=".">548</td><td class="colsep0 rowsep0" align="char" char="/">10.52/5.60</td><td class="colsep0 rowsep0" align="char" char=".">0.062</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="char" char=".">259</td><td class="colsep0 rowsep0" align="char" char=".">287</td><td class="colsep0 rowsep0" align="char" char="/">4.58/6.09</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="char" char=".">242</td><td class="colsep0 rowsep0" align="char" char=".">179</td><td class="colsep0 rowsep0" align="char" char="/">11.19/4.33</td><td class="colsep0 rowsep0" align="char" char=".">0.050</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15c</b></td><td class="colsep0 rowsep0" align="char" char=".">914</td><td class="colsep0 rowsep0" align="char" char=".">238</td><td class="colsep0 rowsep0" align="char" char="/">13.20/3.97</td><td class="colsep0 rowsep0" align="char" char=".">0.046</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="char" char=".">1048</td><td class="colsep0 rowsep0" align="char" char=".">392</td><td class="colsep0 rowsep0" align="char" char="/">7.11/4.83</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="char" char=".">161</td><td class="colsep0 rowsep0" align="char" char=".">155</td><td class="colsep0 rowsep0" align="char" char="/">4.25/3.53</td><td class="colsep0 rowsep0" align="char" char=".">0.073</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="char" char=".">143</td><td class="colsep0 rowsep0" align="char" char=".">175</td><td class="colsep0 rowsep0" align="char" char="/">12.26/3.01</td><td class="colsep0 rowsep0" align="char" char=".">0.062</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="char" char=".">128</td><td class="colsep0 rowsep0" align="char" char=".">275</td><td class="colsep0 rowsep0" align="char" char="/">7.20/2.94</td><td class="colsep0 rowsep0" align="char" char=".">0.064</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Efflux ratio calculated by <i>P</i><sub>app(B-A)</sub>/<i>P</i><sub>app(A-B)</sub>.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Compound brain and plasma exposure ratio at 1 h following oral administration at 100 mg/kg in CD–1 mice.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. ADME and PK Profile of <b>13a</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility @ pH 2.0/4.5/6.8 (μM)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">305/212/1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LM stability (<i>t</i><sub>1/2</sub>, min)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">100 (mouse), 60 (rat)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mPPB (%)<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse plasma stability<a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">>95%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">rat PK<a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral <i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">1875</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral AUC (ng/mL)</td><td class="colsep0 rowsep0" align="left">6720</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">23.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>dss</sub>(L/kg)</td><td class="colsep0 rowsep0" align="left">2.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">1.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">31</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">The <i>in vitro</i> ADME data are average values of at least two determinations; The <i>in vivo</i> PK parameters are average values from three animals.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Solubility was determined in PBS buffer solutions.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">Mouse and rat liver microsomal <i>t</i><sub>1/2</sub>: 2 μM substrate, 0.5 mg/mL pooled liver microsomes, 1 mM NAPDH, 37 °C.</p></div><div class="footnote" id="t7fn4"><sup><sup>d</sup></sup><p class="last">Mouse plasma protein binding.</p></div><div class="footnote" id="t7fn5"><sup><sup>e</sup></sup><p class="last">Percentage of compound remaining after 18 h.</p></div><div class="footnote" id="t7fn6"><sup><sup>f</sup></sup><p class="last">iv dose 10 mg/kg, vehicle 10% DMSO/40% PEG400/50% water; po dose 30 mg/kg, vehicle 0.5% methylcellulose/0.25% Tween-80 in water.</p></div></div></div><div class="NLM_p">Both passive diffusion and transporter-mediated processes are major mechanisms for brain permeability.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The brain penetration of the GLUT inhibitors reported here is likely mainly driven by passive diffusion due to their relatively high lipophilicity and lack of active transporter-recognized moieties. Several approaches were explored to lower brain penetration, such as incorporating a carboxylic acid group or significantly increasing the hydrophilicity of the molecule with the hope that the carboxylate (formed <i>in vivo</i>) or the increased molecular polarity would reduce their ability to get into the brain through the passive diffusion mechanism. However, in line with the above-described SAR exploration, compounds generated through these changes either totally lost GLUT activity or were not orally bioavailable.</div><div class="NLM_p">Xenobiotics are either blocked from entering the brain by tight junctions between brain vascular endothelial cells (BVECs) of the BBB or are rapidly pumped out from the BVECs by ATP-dependent transporter proteins such as P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP). Compounds designed to act as substrates for these efflux transporters in order to lower brain penetration have been reported.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> We tried to adopt this approach by designing and identifying compounds with efflux properties as measured by the <i>in vitro</i> Caco-2 assay. Caco-2 cells express efflux transporters and have been widely used as a model of the intestinal or brain barrier.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">We then designed and synthesized a number of compounds aiming to marginally increase the polarity of the molecule to facilitate efflux and to slightly reduce the basicity of piperidinyl nitrogen to help rat PK (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). For the amide region, smaller and less hydrophobic groups including <i>i</i>Pr and 1-methylcyclopropyl were introduced. For the piperidinyl group, slightly electron-withdrawing groups were chosen to reduce the basicity of the nitrogen either through hyperconjugation (e.g., cyclopropyl group, <b>14</b>) or through inductive effect (e.g., methoxyethyl, <b>18</b>). With the exception of <b>15c</b> and <b>16c</b>, these compounds maintained good GLUT1 and GLUT3 activity, and when tested, <b>14c</b> and <b>15b</b> maintained glucose competitive MOA, suggesting that the binding site was retained by all of the compounds across our SAR efforts (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_001.pdf" class="ext-link">Table S1</a>). The efflux ratios of these compounds were in the range of approximately 1 to 4. As a result, compounds with reduced brain penetration were identified. For example, <b>14c</b>, <b>15b</b>, <b>15c</b>, <b>18a</b>, and <b>19a</b> all displayed a brain/plasma ratio below 0.07. The B/P ratios were plotted against the Caco-2 efflux ratio values (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) in order to see their relationship. These data indicated that a small degree of correlation between brain penetration and the Caco-2 efflux ratio exists for the compounds examined.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of brain and plasma exposure ratio (B/P) at 1 h following oral administration at 100 mg/kg in CD-1 mice versus Caco-2 efflux ratio.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Most of the compounds in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> displayed high plasma exposure levels in mice following oral administration (data not shown). A single 100 mg/kg dose of compounds <b>14c</b>, <b>15b</b>, and <b>17a</b> was well-tolerated without obvious adverse effects. Compound <b>15b</b> was chosen to be further profiled due to its overall favorable properties. The profile of <b>15b</b> is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>. While being very soluble at a lower pH (>200 μM at pH 2.0 and pH 4.5), <b>15b</b> displayed a much lower solubility at pH 6.8 (1.4 μM). The compound is characterized by modest to good liver microsomal and plasma stability across all species. In PK studies, <b>15b</b> showed good oral bioavailability in both the mouse (45.4%) and rat (49.4%) at 30 mg/kg dose. A linear PK was observed in rats up to 300 mg/kg without obvious adverse effects. In the dog PK study at 10 mg/kg orally, <b>15b</b> displayed a modest food effect with a 19% (fed) and a 29% (fasted) oral bioavailability. It is worth noting that the PK studies were typically done with methylcellulose/Tween-80 standard formulation for the compounds. A number of other commonly used oral formulations, e.g., cyclodextrins, were explored, and it was found that 2-hydroxypropyl-β-cyclodextrin significantly enhanced oral bioavailability and plasma exposure levels of <b>15b</b>. However, with this PK-enhanced formulation, a mild and transient toxicity was observed following oral administration of <b>15b</b> at a 100 mg/kg dose in mice.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. ADME and PK Profile of <b>15b</b><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility @ pH 2.0/4.5/6.8 (μM)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" colspan="2" align="left">291/256/1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LM stability (<i>t</i><sub>1/2</sub>, min)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" colspan="2" align="left">70 (m), 63 (r), 58 (d), 116 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB (%)<a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" colspan="2" align="left">79.8 (m), 98.9 (r), 99.0 (d), 99.3 (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse plasma stability<a class="ref internalNav" href="#t8fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" colspan="2" align="left">>95%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PK<a class="ref internalNav" href="#t8fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0">rat</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral <i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">2525</td><td class="colsep0 rowsep0">1675</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral AUC (ng/mL)</td><td class="colsep0 rowsep0" align="left">5890</td><td class="colsep0 rowsep0">6813</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>dss</sub>(L/kg)</td><td class="colsep0 rowsep0" align="left">1.70</td><td class="colsep0 rowsep0">4.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.785</td><td class="colsep0 rowsep0">2.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">45.4</td><td class="colsep0 rowsep0">49.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B/P<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.05</td><td class="colsep0 rowsep0"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">The <i>in vitro</i> ADME data are the average values of at least two determinations; the <i>in vivo</i> PK parameters are the average values from three animals.</p></div><div class="footnote" id="t8fn2"><sup><sup>b</sup></sup><p class="last">Solubility was determined in PBS buffer solutions.</p></div><div class="footnote" id="t8fn3"><sup><sup>c</sup></sup><p class="last">Mouse, rat, dog, and human liver microsomal <i>t</i><sub>1/2</sub>: 2 μM substrate, 0.5 mg/mL pooled liver microsomes, 1 mM NAPDH, 37 °C.</p></div><div class="footnote" id="t8fn4"><sup><sup>d</sup></sup><p class="last">Mouse, rat, dog, and human plasma protein binding.</p></div><div class="footnote" id="t8fn5"><sup><sup>e</sup></sup><p class="last">Percentage of the compound remaining after 18 h.</p></div><div class="footnote" id="t8fn6"><sup><sup>f</sup></sup><p class="last">iv dose 10 mg/kg, vehicle 10% DMSO/40% PEG400/50% water; po dose 30 mg/kg, vehicle 0.5% methylcellulose/0.25% Tween-80 in water.</p></div></div></div><div class="NLM_p">Safety profiling of <b>15b</b> showed low potential for QT prolongation with an estimated IC<sub>50</sub> greater than 10 μM in the manual patch clamp hERG channel assay. It also had no appreciable activity when tested at 10 μM in a safety screening panel that included 31 receptors, ion channels, and transporters.</div><div class="NLM_p last">When dosed orally, a number of compounds including <b>8</b>, <b>10g</b>, and <b>15b</b> showed <i>in vivo</i> efficacy in tumor xenograft models as well as models of autoimmune conditions at doses devoid of overt toxicity (data not shown). These data further support the notion that pharmacological blockade of glucose transport <i>in vivo</i> may have therapeutic benefits across multiple disease areas and will be presented elsewhere.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of boronic esters <b>23</b> and THP protected 4-aminophenylpyrazole <b>26</b> is depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. These are necessary intermediates for the synthesis of the final compounds. The chloroacetamides <b>21</b> were easily synthesized from amines <b>20</b> and 2-chloroacetyl chloride. Alkylation of 3-bromophenol with <b>21</b> followed by Pd-mediated coupling with bis(pinacolato)diboron afforded boronic esters <b>23</b>. Alternatively, boronic esters <b>23</b> were prepared by direct alkylation of 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol with <b>21</b>. THP protected 4-aminophenylpyrazole <b>26</b> was synthesized in two steps from readily available <b>24</b>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Boronic Esters and THP Protected 4-Aminophenylpyrazole Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-chloroacetyl chloride, Na<sub>2</sub>CO<sub>3</sub>, water, rt, 1 h; (b) 3-bromophenol, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h; (c) 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi-1,3,2-dioxaborolane, Pd(dppf)Cl<sub>2</sub>, AcOK, dioxane, 85 °C, 16 h; (d) 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h; (e) DHP, <i>p</i>-TsOH, DCM, 20 °C, 4 h; (f) 4-bromoaniline, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/water, 100 °C, 16 h.</p></p></figure><div class="NLM_p">The synthesis of <b>8</b>, <b>9a</b>–<b>f</b>, and <b>9h</b>–<b>k</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) was accomplished by starting with fused 1,4-dichloropyrimidines <b>27</b> (with the fused ring designated as W) that are either commercially or synthetically available. Nucleophilic substitution with 4-(1<i>H</i>-pyrazol-4-yl) aniline<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> exclusively or predominantly occurred at the 4-position of the pyrimidine ring to provide free pyrazole <b>28</b>. The free pyrazole <b>28</b> successfully went through Suzuki coupling with <b>23</b> in a microwave reactor at 180 °C for 2 h to provide the final compounds in good yields. Alternatively, free pyrazole <b>28</b> was protected with Boc or THP protecting groups (<b>29</b> and <b>30</b>), and Suzuki coupling was then carried out under more conventional reaction conditions (e.g., 100 °C, overnight). These synthetic routes, in general, worked well for the synthesis of the majority of the final compounds with a few exceptions including <b>9g</b>. Attempts to synthesize the dichloropyrimidine <b>27</b> core of <b>9g</b> failed due to its stability issue. Compound <b>9g</b> was then synthesized through a different and slightly lengthier route that is depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>8</b>, <b>9a</b>–<b>f</b>, and <b>9h</b>–<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-(1<i>H</i>-pyrazol-4-yl) aniline, <i>i</i>Pr<sub>2</sub>NEt, DMF, 90–110 °C, 3 h; (b) <b>23</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 9:1 dioxane/water, Na<sub>2</sub>CO<sub>3</sub>, microwave, 180 °C, 2 h; (c) Boc<sub>2</sub>O, DMAP, TEA, DCM, 50 °C, 1.5 h; (d) <b>26</b>, <i>i</i>Pr<sub>2</sub>NEt, <i>n</i>-BuOH, 90−110 °C, 16 h; (e) Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/water, 100 °C, 16 h; (f) HCl in dioxane or TFA/DCM, rt, 2 h.</p></p></figure><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>9g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3-methoxybenzoyl chloride, TEA, DCM, rt, 16 h; (b) NH<sub>3</sub>, MeOH, rt, 16 h; (c) NaOH, <i>i</i>PrOH, 90 °C, 3 h; (d) POCl<sub>3</sub>, <i>i</i>Pr<sub>2</sub>NEt, 80 °C, 14 h; (e) 4-bromoaniline, THF, 60 °C, 16 h; (f) BBr<sub>3</sub>, 35 °C, 16 h; (g) methyl 2-bromoacetate, K<sub>2</sub>CO<sub>3</sub>, DMF, 40 °C, 1 h; (h) <b>25</b>, Pd(dppf)Cl<sub>2</sub>, dioxane/water, 100 °C, 16 h; (i) LiOH, THF/water, 15 °C, 16 h; (j) HCl in dioxane, 15 °C, 1 h.</p></p></figure><div class="NLM_p">One general synthesis of the tetrahydropyridopyrimidine derivatives is depicted in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. This synthetic route allows efficient derivatization of the piperidinyl nitrogen. The synthesis started with commercially available Boc protected 1,4-dichloropyrimidine <b>44</b> followed by aromatic nucleophilic substitution, Suzuki coupling, and deprotection to provide free piperidine <b>47</b>, which was then derivatized through alkylation, reductive amination, or acylation.</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthesis of Tetrahydropyridopyrimidine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>26</b>, <i>i</i>Pr<sub>2</sub>NEt, <i>n</i>-BuOH, 100 °C, 16 h; (b) <b>23</b>, Pd(dppf)Cl<sub>2</sub>, dioxane/water, 100 °C, 16 h; (c) HCl/dioxane/water, rt, 15 h; (d) aldehyde, NaBH<sub>3</sub>CN, HOAc, MeOH, rt, 16 h; (e) R’Br, DMF, rt, 16 h.</p></p></figure><div class="NLM_p">Another general synthesis of the tetrahydropyridopyrimidine derivatives is depicted in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. This general synthesis allows efficient modification of the amide region of the molecule. The synthesis started with double Michael addition of amine <b>48</b> to ethyl acrylate affording <b>49</b>, followed by intramolecular Claisen condensation of <b>49</b>, providing <b>50</b>. Subsequent cyclization with urea followed by chlorination provided substituted piperidine-fused 1,4-dichloropyrimidine <b>52</b>, which further underwent Suzuki coupling followed by deprotection to provide the final compounds.</div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Second General Synthesis of Tetrahydropyridopyrimidine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ethyl acrylate, EtOH, rt, 72 h; (b) LiHMDS, THF, rt, 2 h; (c) urea, NaOMe, MeOH, 80 °C, 16 h; (d) POCl<sub>3</sub>, <i>i</i>Pr<sub>2</sub>NEt, 90 °C, 16 h; (e) <b>26</b>, <i>i</i>Pr<sub>2</sub>NEt, <i>n</i>-BuOH, 100 °C, 16 h; (f) <b>23</b>, Pd(dppf)Cl<sub>2</sub>, dioxane/water, 100 °C, 16 h; (g) HCl/dioxane/water, rt, 15 h.</p></p></figure><div class="NLM_p">Both versions of the general synthesis depicted in <a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a> and <a class="ref internalNav" href="#sch5" aria-label="5">5</a> worked well to introduce variations in different regions of the molecule and were used to prepare gram quantities of material. However, these synthetic sequences are not ideal for the synthesis of large quantities of GLP or GMP grade material, due to some undesirable or low-yielding steps such as the Pd-mediated coupling and the reductive amination. For individual compounds, a more efficient synthesis was then developed. In <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>, a scale-up synthesis of <b>15b</b> is presented, and it represents another general synthesis of this class of compounds. The key feature of this efficient convergent synthesis is that the amide moiety was preinstalled in amidine <b>58</b>, and the tetrahydropyridopyrimidine core was synthesized via a [3+3] cyclization. This robust synthesis allows less effort for purification of intermediates and has been used for greater than 100 g scales.</div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>15b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-chloroacetyl chloride, TEA, DCM, −5 to 20 °C, 2 h, 72%; (b) 3-cyanophenol, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 10 to 80 °C, 24 h, 64%; (c) (i) AcCl, EtOH, 0 to 20 °C, 12 h; (ii) NH<sub>3</sub>, EtOH, 20 to 25 °C, 11 h; (d) ethyl acrylate, EtOH, 20 °C, 72 h, 72%; (e) LiHMDS, THF, 20 °C, 2 h, 98%; (f) 58, NaOMe, 80 °C, 9 h, 60%; (g) SOCl<sub>2</sub>, DMF, 0 to 20 °C, 9.5 h, 52%; (h) 4-(1<i>H</i> pyrazol-4-yl) aniline, NMP, 145 °C, 5 h, 51%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a class of potent and orally bioavailable inhibitors of glucose transport, targeting GLUT1/3, has been identified. SAR and optimization were carried out to improve the ADME, PK, and the brain penetration profiles. Compound <b>15b</b> was identified with good GLUT1/3 potency, low brain penetration, and favorable ADME and PK profiles across several different species and can serve as a valuable tool molecule to study GLUT functions <i>in vivo</i>.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General</h3><div class="NLM_p">All solvents and reagents were obtained commercially and used as received. <sup>1</sup>H NMR spectra were recorded on a Bruker instrument (300, 400, or 500 MHz) in the cited deuterated solvents. Chemical shifts are given in ppm, and coupling constants are in hertz. All final compounds were purified by flash chromatography using 220–400 mesh silica gel or reverse-phase HPLC with CH<sub>3</sub>CN/water as the solvents. Thin-layer chromatography was done on silica gel 60 F-254 (0.25 mm thickness) plates. Visualization was accomplished with UV light and/or 10% phosphomolybdic acid in ethanol. LC–MS experiments were done on a Shimadzu LCMS-2020 system. Compound purity was determined by an LC–MS or HPLC with 230 and 254 nm wavelengths. All final compounds reported here have purity ≥95%. All animal experiments performed in the manuscript were conducted in compliance with institutional guidelines. All efforts were made to minimize animal suffering and to reduce the number of animals.</div><div id="sec-15524-F6A78886" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Synthesis of 2-(3-(4-((4-(1<i>H</i>-Pyrazol-4-yl)phenyl)amino)-6-cyclobutyl-5,6,7,8-tetrahydropyrido[4,3-<i>d</i>]pyrimidin-2-yl)phenoxy)-<i>N</i>-(1-methylcyclopropyl)acetamide (<b>15b</b>)</h4><div id="sec5_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Step 1: 2-Chloro-<i>N</i>-(1-methylcyclopropyl)acetamide (<b>56</b>)</h5><div class="NLM_p last">To a mixture of 1-methylcyclopropan-1-amine hydrochloride <b>55</b> (200.0 g, 1.86 mol) and triethylamine (564.4 g, 5.58 mol) in DCM (1.0 L) was added 2-chloroacetyl chloride (220.6 g, 1.95 mol) dropwise at −10 °C. The reaction mixture was then warmed to 20 °C and stirred at 20 °C for 12 h, poured into water, and washed with HCl (1.0 M, 4.0 L). The organic layer was dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum to give the title compound (198.0 g, 72%) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.42 (s, 1H), 3.93 (s, 2H), 1.27 (s, 3H), 0.62–0.53 (m, 4H). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>6</sub>H<sub>10</sub>ClNO [M + H<sup>+</sup>], 148.0524; found, 148.0529.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> Step 2: 2-(3-Cyanophenoxy)-<i>N</i>-(1-methylcyclopropyl)acetamide (<b>57</b>)</h5><div class="NLM_p last">To a mixture of 3-hydroxybenzonitrile (152.0 g, 1.28 mol) and K<sub>2</sub>CO<sub>3</sub> (352.8 g, 2.55 mol) in CH<sub>3</sub>CN (2.0 L) was added <b>56</b> (198.3 g, 1.34 mol) in portions. The mixture was stirred at 80 °C for 10 h, concentrated, and extracted with EtOAc (2.0 L × 3). The combined organic phases were dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a crude black solid. The crude product was triturated with EtOAc and MTBE/EtOAc to give the title compound as a brown solid (105 g). The mother liquor was concentrated and purified by chromatography to provide an additional crop of the title compound (84.0 g). Total yield: 189 g, 64%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.43 (m, 1H), 7.31 (m, 1H), 7.19–7.16 (m, 2H), 6.82 (s, 1H), 4.43 (s, 2H), 1.41 (s, 3H), 0.81–0.68 (m, 4H). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub> [M + H<sup>+</sup>], 231.1128; found, 231.1132.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Step 3: 2-(3-Carbamimidoylphenoxy)-<i>N</i>-(1-methylcyclopropyl)acetamide (<b>58</b>)</h5><div class="NLM_p last">To a mixture of <b>57</b> (189.0 g, 0.821 mol) in EtOH (1.0 L) was added acetyl chloride (773.2 g, 9.85 mol) dropwise at 0 °C. The mixture was stirred at 20 °C for 12 h and was concentrated and was then stirred with NH<sub>3</sub> in EtOH (2 L) for 10 h. The mixture was concentrated to provide a residue, which was triturated with EtOH (300 mL) to afford the title compound (242.0 g) as a yellow solid. The crude material was used directly in the next step reaction without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.33 (b, 3H), 8.46 (s, 1H), 7.53 (t, <i>J</i> = 8.0 Hz, 1H), 7.45–7.43 (m, 2H), 7.30–7.28 (m, 1H), 4.53 (s, 2H), 1.28 (s, 3H), 0.66–0.64 (m, 2H), 0.56–0.53 (m, 2H). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub> [M + H<sup>+</sup>], 248.1394; found, 248.1395.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> Step 4: Diethyl 3,3′-(cyclobutylazanediyl)dipropionate (<b>60</b>)</h5><div class="NLM_p last">A mixture of cyclobutanamine <b>59</b> (300.0 g, 4.22 mol) and ethyl acrylate (1.24 kg, 12.39 mol) in EtOH (900 mL) was stirred at 30 °C for 72 h. The reaction mixture was concentrated under vacuum. The residue was purified by flash chromatography (SiO2, petroleum ether/ethyl acetate = 1:0 to 1:2) to give the title compound (823.0 g, 71.9%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.03 (q, 4H), 2.99–2.96 (m, 1 H) 2.66 (t, <i>J</i> = 7.2 Hz, 4H), 2.32 (t, <i>J</i> = 7.6 Hz, 4H), 1.95–1.91 (m, 2H), 1.77–1.74 (m, 2H), 1.53–1.48 (m, 2H), 1.17 (t, <i>J</i> = 7.2 Hz, 6H). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>25</sub>NO<sub>4</sub> [M + H<sup>+</sup>], 272.1856; found, 272.1863.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Step 5: Ethyl 1-cyclobutyl-4-oxopiperidine-3-carboxylate (<b>61</b>)</h5><div class="NLM_p last">To LiHMDS in THF (1.0 M, 1.11 L) was added a solution of <b>60</b> (200.0 g, 0.727 mol) in THF (400 mL) under a N<sub>2</sub> atmosphere. The mixture was stirred at 20 °C for 2 h, quenched with saturated NH<sub>4</sub>Cl (2.00 L), and extracted with ethyl acetate (2.00 L × 2). The combined organic phases were dried with Na<sub>2</sub>SO<sub>4</sub> and concentrated <i>in vacuo</i> to provide the title compound (163.0 g, 98.2%) as a brown oil which was used directly in the next step reaction without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 4.21–4.09 (m, 2H), 3.53–3.50 (m, 1H), 2.90–2.69 (m, 4H), 2.48–2.30 (m, 3H), 2.00–1.98 (m, 2H), 1.83–1.77 (m, 2H), 1.65–1.61 (m, 2H), 1.24–1.17 (m, 3H). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>19</sub>NO<sub>3</sub> [M + H<sup>+</sup>], 226.1438; found, 226.1437.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Step 6: 2-(3-(6-Cyclobutyl-4-oxo-3,4,5,6,7,8-hexahydropyrido[4,3-<i>d</i>]pyrimidin-2-yl)phenoxy)-<i>N</i>-(1-methylcyclopropyl)acetamide (<b>62</b>)</h5><div class="NLM_p last">To a mixture of <b>61</b> (163.0 g, 0.724 mol) and <b>58</b> (119.3 g, 0.482 mol) in MeOH (1.6 L) was added NaOMe (104.2 g, 1.93 mol). The mixture was stirred at 80 °C for 9 h and was concentrated under reduced pressure. The residue was diluted with H<sub>2</sub>O (2.0 L) and neutralized with HCl. The mixture was filtrated, and the cake was dried <i>in vacuo</i> to provide the title compound (118.7 g, 60.1%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.58 (s, 1H), 8.33 (s, 1H), 7.68 (d, <i>J</i> = 8.0 Hz, 1H), 7.64 (s, 1H), 7.41 (t, <i>J</i> = 8.0, 1H), 7.14 (dd, <i>J</i> = 8.0, and 1.6 Hz, 1H), 4.47 (s, 2H), 3.16 (s, 2H), 2.89–2.70 (m, 1H), 2.66–2.64 (m, 2H), 2.55–2.54 (m, 2H), 2.06–2.05 (m, 2H), 1.86–1.83 (m, 2H), 1.69–1.67 (m, 2H), 1.29 (s, 3H), 0.67–0.64 (m, 2H), 0.64–0.55 (m, 2H). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub> [M + H<sup>+</sup>], 409.2234; found, 409.2250.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Step 7: 2-(3-(4-Chloro-6-cyclobutyl-5,6,7,8-tetrahydropyrido[4,3-<i>d</i>]pyrimidin-2-yl)phenoxy)-<i>N</i>-(1-methylcyclopropyl)acetamide (<b>63</b>)</h5><div class="NLM_p last">A mixture of <b>62</b> (116.0 g, 0.284 mol) was dissolved in DMF (1.50 L) and was cooled to 0 °C. To the mixture was added SOCl<sub>2</sub> (50.7 g, 0.426 mol). The resulting mixture was stirred at 0 °C for 30 min followed by 20 °C for 9 h. The mixture was filtrated, and the solid collected was washed with cold saturated sodium bicarbonate solution (1.0 L) and water. The solid was redissolved in dichloromethane, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to afford the title compound (70.0 g, 57.7% yield) as a brown solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.07 (d, <i>J</i> = 8.4 Hz, 1H), 7.98 (d, <i>J</i> = 2.4 Hz, 1H), 7.40 (t, <i>J</i> = 8.0 Hz, 1H), 7.00 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 6.91 (s, 1H), 4.51 (s, 2H), 3.53 (s, 2H), 3.07–3.02 (m, 3H), 2.73 (t, <i>J</i> = 6.0 Hz, 2H), 2.19–2.17 (m, 2H), 2.02–1.96 (m, 2H), 1.81–1.74 (m, 2H), 1.43 (s, 3H), 0.84–0.81 (m, 2H), 0.72–0.68 (m, 2H). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>27</sub>ClN<sub>4</sub>O<sub>2</sub> [M + H<sup>+</sup>], 427.1895; found, 427.1897.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Step 8: 2-(3-(4-((4-(1<i>H</i>-Pyrazol-4-yl)phenyl)amino)-6-cyclobutyl-5,6,7,8-tetrahydropyrido[4,3-<i>d</i>]pyrimidin-2-yl)phenoxy)-<i>N</i>-(1-methylcyclopropyl)acetamide (<b>15b</b>)</h5><div class="NLM_p last">A mixture of <b>63</b> (145.0 g, 0.340 mol), 4-(1<i>H</i>-pyrazol-4-yl)aniline (54.1 g, 0.340 mol), and <i>N</i>-methyl-2-pyrrolidone (580 mL) was stirred at 145 °C for 5 h, diluted with CH<sub>3</sub>CN (1.50 L), and filtered. The filter cake was dissolved with concentrated HCl (500 mL) and MeOH (3 L). The resulting solution was concentrated to give a crude material, which was purified by prep-HPLC to give the title compound as a yellow HCl salt solid (102.2 g, 51.4%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.12 (s, 2H), 7.88 (d, <i>J</i> = 8.0 Hz, 1H), 7.83 (m, 1H), 7.73 (m, 4H), 7.49 (t, <i>J</i> = 8.0 Hz, 1H), 7.26 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 4.52 (s, 2H), 4.38 (s, 2H), 4.08–3.99 (m, 1H), 3.64 (s, 2H), 3.36 (t, <i>J</i> = 5.2 Hz, 2H), 2.54–2.50 (m, 4H), 2.02–1.95 (m, 2H), 1.35 (s, 3H), 0.72 (m, 2H), 0.62 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.24, 159.75, 158.39, 157.19, 156.52, 137.15, 136.65, 131.10, 130.20, 129.36, 125.61, 123.64, 121.41, 121.22, 118.38, 114.33, 105.66, 67.42, 58.56, 45.05, 44.47, 28.63, 27.23, 25.40, 25.35, 23.03, 14.01. HRMS: <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>35</sub>N<sub>7</sub>O<sub>2</sub> [M + H<sup>+</sup>], 550.2925; found, 550.2912.</div></div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> GLUT, GLUT1, and GLUT3 Assays</h4><div class="NLM_p last">GLUT1 and GLUT3 assays were performed using a modified version of the pairwise assay described by Siebeneicher et al.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Briefly, GLUT1-dependent DLD1 wild-type and GLUT3-dependent DLD1-<i>SLC2A1</i><sup>–/–</sup> (Horizon Discovery) were maintained in RPMI 1640 cell culture medium containing 10% fetal bovine serum, 1% penicillin–streptomycin, and 10 mM HEPES in a humidified incubator with 5% CO<sub>2</sub> at 37 °C. The day before the assay, the cells were seeded in 90 μL of this medium in 96-well plates at a density of 50 000 cells/well and allowed to attach overnight. The day of the assay, 10 μL of the culture medium containing GLUT inhibitors and oligomycin was added to each well to a final concentration of 10 μM oligomycin and 0.06% DMSO. The plates were returned to the incubator for 90 min, and then ATP levels were determined using the CellTiter-Glo Luminescent Cell Viability Assay (Promega). For the GLUT HT-1080 assay, the procedure was the same except the cells were seeded at 40 000 cells/well.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Glucose Competition Assay</h4><div class="NLM_p last">The assay was performed according to the standard GLUT1 (DLD-1) assay protocol, except that the cells were washed once in 100 μL of PBS prior to the addition of media containing the test compounds, oligomycin (10 μM), and glucose at either 10, 3.33, 1.11, or 0.37 mM concentrations.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.9b02153" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b02153?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02153</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Details of the synthetic procedures and analytical data for intermediates and final compounds <b>9a</b>–<b>m</b>, <b>10a</b>–<b>i</b>, <b>11a</b>, <b>11b</b>, <b>12a</b>–<b>p</b>, <b>13a</b>, <b>14b</b>, <b>14c</b>, <b>15a</b>, <b>15c</b>, <b>16c</b>, <b>17a</b>, <b>18a</b>, <b>19a</b>; GLUT1 IC<sub>50</sub> values (nM) in the presence of varying glucose concentrations; eurofins safety panel screen of <b>15b</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_001.pdf">jm9b02153_si_001.pdf (1.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_002.csv">jm9b02153_si_002.csv (4.44 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b02153" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin G. Liu</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1562-6201" title="Orcid link">http://orcid.org/0000-0003-1562-6201</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#274c42514e49094b4e52674c46434a48490944484a"><span class="__cf_email__" data-cfemail="b3d8d6c5dadd9ddfdac6f3d8d2d7dedcdd9dd0dcde">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ji-In Kim</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kellen Olszewski</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony M. Barsotti</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span>; 
    <span>Present Address:
                        A.M.B.: Inzen Therapeutics, Inc., 430 East 29th Street, New York, NY 10016, USA</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koi Morris</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Lamarque</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuemei Yu</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jack Gaffney</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Jiang Feng</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeegar P. Patel</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masha V. Poyurovsky</span> - <span class="hlFld-Affiliation affiliation">Kadmon Corporation, LLC., 450 East 29th Street, New
York, New York 10016, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Professor Joshua D. Rabinowitz of Princeton University for his valuable insights and suggestions and Yong Li, Yafeng Cao, Binglin Wang, Xian Xiao, and others involved at WuXi AppTec (Wuhan) for their synthetic support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">adsorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">Ac</td><td class="NLM_def"><p class="first last">acetyl</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">Da</td><td class="NLM_def"><p class="first last">Dalton</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DHP</td><td class="NLM_def"><p class="first last">3,4-dihydropyran</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-(dimethylamino)pyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">GLUT</td><td class="NLM_def"><p class="first last">glucose transporters</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">inhibitory concentration at half maximal effect</p></td></tr><tr><td class="NLM_term"><sup>18</sup>F-FDG</td><td class="NLM_def"><p class="first last">[<sup>18</sup>F]fluoro-2-deoxyglucose</p></td></tr><tr><td class="NLM_term">fu</td><td class="NLM_def"><p class="first last">unbound fraction</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LM</td><td class="NLM_def"><p class="first last">liver microsomes</p></td></tr><tr><td class="NLM_term">LiHMDS</td><td class="NLM_def"><p class="first last">lithium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">mM</td><td class="NLM_def"><p class="first last">millimolar</p></td></tr><tr><td class="NLM_term">μM</td><td class="NLM_def"><p class="first last">micromolar</p></td></tr><tr><td class="NLM_term">OXPHOS</td><td class="NLM_def"><p class="first last">oxidative phosphorylation</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">Pd(dppf)Cl2</td><td class="NLM_def"><p class="first last">[1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II)</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">oral administration</p></td></tr><tr><td class="NLM_term">Ro5</td><td class="NLM_def"><p class="first last">rule of five (Lipinski)</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TCA</td><td class="NLM_def"><p class="first last">tricarboxylic acid</p></td></tr><tr><td class="NLM_term">Th</td><td class="NLM_def"><p class="first last">T helper</p></td></tr><tr><td class="NLM_term">THP</td><td class="NLM_def"><p class="first last">2-tetrahydropyranyl</p></td></tr><tr><td class="NLM_term"><i>p</i>-TsOH</td><td class="NLM_def"><p class="first last"><i>p</i>-Toluenesulfonic acid</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>dss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warburg, O.</span></span> <span> </span><span class="NLM_article-title">ÜBer Den Stoffwechsel Der Carcinomzelle</span>. <i>Naturwissenschaften</i> <span class="NLM_year" style="font-weight: bold;">1924</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1131</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1007/BF01504608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1007%2FBF01504608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADyaB2MXosFSk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1924&pages=1131-1137&author=O.+Warburg&title=%C3%9CBer+Den+Stoffwechsel+Der+Carcinomzelle&doi=10.1007%2FBF01504608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of carcinoma cells</span></div><div class="casAuthors">Warburg, O.</div><div class="citationInfo"><span class="NLM_cas:title">Naturwissenschaften</span>
        (<span class="NLM_cas:date">1924</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1131-7</span>CODEN:
                <span class="NLM_cas:coden">NATWAY</span>;
        ISSN:<span class="NLM_cas:issn">0028-1042</span>.
    </div><div class="casAbstract">Review.  Cf. C. A. 18, 2036.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVz66JIWvuLrVg90H21EOLACvtfcHk0liXC3getKlVFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaB2MXosFSk&md5=337ec5943b458b1ea0c68bd27c1ac109</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2FBF01504608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01504608%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3D%25C3%259CBer%2520Den%2520Stoffwechsel%2520Der%2520Carcinomzelle%26jtitle%3DNaturwissenschaften%26date%3D1924%26volume%3D12%26spage%3D1131%26epage%3D1137%26doi%3D10.1007%2FBF01504608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warburg, O.</span></span> <span> </span><span class="NLM_article-title">On the Origin of Cancer Cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1126/science.123.3191.309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1126%2Fscience.123.3191.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=13298683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1956&pages=309-314&author=O.+Warburg&title=On+the+Origin+of+Cancer+Cells&doi=10.1126%2Fscience.123.3191.309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">On the origin of cancer cells</span></div><div class="casAuthors">WARBURG O</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3191</span>),
    <span class="NLM_cas:pages">309-14</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsp1coYpQW669lAbTj9rGfW6udTcc2eZFTMcX4Ypt7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D&md5=860d5ce9456831968fcc897b37d6d9c2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.123.3191.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.123.3191.309%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DOn%2520the%2520Origin%2520of%2520Cancer%2520Cells%26jtitle%3DScience%26date%3D1956%26volume%3D123%26spage%3D309%26epage%3D314%26doi%3D10.1126%2Fscience.123.3191.309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greulich, K. O.</span></span> <span> </span><span class="NLM_article-title">Genes of Glycolysis Are Ubiquitously Overexpressed in 24 Cancer Classes</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1014</span>– <span class="NLM_lpage">1020</span>, <span class="refDoi"> DOI: 10.1016/j.ygeno.2004.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.ygeno.2004.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=15533718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlykt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=1014-1020&author=B.+Altenbergauthor=K.+O.+Greulich&title=Genes+of+Glycolysis+Are+Ubiquitously+Overexpressed+in+24+Cancer+Classes&doi=10.1016%2Fj.ygeno.2004.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes</span></div><div class="casAuthors">Altenberg, B.; Greulich, K. O.</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1014-1020</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Using NIH's public database dbEST for expression of genes and ESTs, genes of the glycolysis pathway have been found to be overexpressed in a set of 24 cancers representing more than 70% of human cancer cases worldwide.  Genes can be classified as those that are almost ubiquitously overexpressed, particularly glyceraldehyde-3-phosphate dehydrogenase, enolase 1, and also pyruvate kinase, and those that are overexpressed in less than 50% of the investigated cancers.  Cancers can be classified as those with overexpression of the majority of the glycolysis genes, particularly lymph node, prostate, and brain cancer, in which essentially all glycolysis genes are overexpressed, and those with only sporadic overexpression, particularly cancers of the cartilage or bone marrow.  This classification may be useful when cancer therapies aimed at the Warburg effect are designed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXdbCc2JC3I7Vg90H21EOLACvtfcHk0ljOY42HG4xLHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlykt78%253D&md5=6b9515a2e3a4781acc4960f92f31ad4f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ygeno.2004.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygeno.2004.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DAltenberg%26aufirst%3DB.%26aulast%3DGreulich%26aufirst%3DK.%2BO.%26atitle%3DGenes%2520of%2520Glycolysis%2520Are%2520Ubiquitously%2520Overexpressed%2520in%252024%2520Cancer%2520Classes%26jtitle%3DGenomics%26date%3D2004%26volume%3D84%26spage%3D1014%26epage%3D1020%26doi%3D10.1016%2Fj.ygeno.2004.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Upadhyay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandpal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivekanandan, P.</span></span> <span> </span><span class="NLM_article-title">The Warburg Effect: Insights from the Past Decade</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2012.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.pharmthera.2012.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=23159371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKqt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2013&pages=318-330&author=M.+Upadhyayauthor=J.+Samalauthor=M.+Kandpalauthor=O.+V.+Singhauthor=P.+Vivekanandan&title=The+Warburg+Effect%3A+Insights+from+the+Past+Decade&doi=10.1016%2Fj.pharmthera.2012.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Warburg effect: Insights from the past decade</span></div><div class="casAuthors">Upadhyay, Mohita; Samal, Jasmine; Kandpal, Manish; Singh, Om Vir; Vivekanandan, Perumal</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">318-330</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Several decades ago, Otto Warburg discovered that cancer cells produce energy predominantly by glycolysis; a phenomenon now termed "Warburg effect".  Warburg linked mitochondrial respiratory defects in cancer cells to aerobic glycolysis; this theory of his gradually lost its importance with the lack of conclusive evidence confirming the presence of mitochondrial defects in cancer cells.  Scientists began to believe that this altered mechanism of energy prodn. in cancer cells was more of an effect than the cause.  More than 50 years later, the clin. use of FDG-PET imaging in the diagnosis and monitoring of cancers rekindled the interest of the scientific community in Warburg's hypothesis.  In the last ten years considerable progress in the field has advanced our understanding of the Warburg effect.  However, it still remains unclear if the Warburg effect plays a causal role in cancers or it is an epiphenomenon in tumorigenesis.  In this review we aim to discuss the mol. mechanisms assocd. with the Warburg effect with emphasis on recent advances in the field including the role of epigenetic changes, miRNAs and post-translational modification of proteins.  In addn., we also discuss emerging therapeutic strategies that target the dependence of cancer cells on altered energy processing through aerobic glycolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKDpFSBEDbr7Vg90H21EOLACvtfcHk0ljOY42HG4xLHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKqt7nP&md5=f0f2c0c0f81cb19b9a9ea75feec4b5f6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DUpadhyay%26aufirst%3DM.%26aulast%3DSamal%26aufirst%3DJ.%26aulast%3DKandpal%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DO.%2BV.%26aulast%3DVivekanandan%26aufirst%3DP.%26atitle%3DThe%2520Warburg%2520Effect%253A%2520Insights%2520from%2520the%2520Past%2520Decade%26jtitle%3DPharmacol.%2520Ther.%26date%3D2013%26volume%3D137%26spage%3D318%26epage%3D330%26doi%3D10.1016%2Fj.pharmthera.2012.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzivassiliou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2007.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.cmet.2007.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=18177721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFSnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=11-20&author=R.+J.+DeBerardinisauthor=J.+J.+Lumauthor=G.+Hatzivassiliouauthor=C.+B.+Thompson&title=The+Biology+of+Cancer%3A+Metabolic+Reprogramming+Fuels+Cell+Growth+and+Proliferation&doi=10.1016%2Fj.cmet.2007.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of cancer: metabolic reprogramming fuels cell growth and proliferation</span></div><div class="casAuthors">DeBerardinis, Ralph J.; Lum, Julian J.; Hatzivassiliou, Georgia; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-20</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Cell proliferation requires nutrients, energy and biosynthetic activity to duplicate all macromol. components during each passage through the cell cycle.  It is therefore not surprising that metabolic activities in proliferating cells are fundamentally different from those of nonproliferating cells.  This review examines the idea that several core fluxes, including aerobic glycolysis, de novo lipid biosynthesis, and glutamine-dependent anaplerosis, form a stereotyped platform supporting proliferation of diverse cell types.  We also consider regulation of theses fluxes by cellular mediators of signaling and gene expression, including PI3K/Akt/mTOR system, HIF-1, and Myc, during physiol. cell proliferation and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6L6_Q7sR9HLVg90H21EOLACvtfcHk0ljOY42HG4xLHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFSnsg%253D%253D&md5=59f193a636a840cde3044da9e08f62e7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DLum%26aufirst%3DJ.%2BJ.%26aulast%3DHatzivassiliou%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520Biology%2520of%2520Cancer%253A%2520Metabolic%2520Reprogramming%2520Fuels%2520Cell%2520Growth%2520and%2520Proliferation%26jtitle%3DCell%2520Metab.%26date%3D2008%26volume%3D7%26spage%3D11%26epage%3D20%26doi%3D10.1016%2Fj.cmet.2007.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vander
Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">1029</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.1126/science.1160809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1126%2Fscience.1160809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=19460998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1029-1033&author=M.+G.+Vander%0AHeidenauthor=L.+C.+Cantleyauthor=C.+B.+Thompson&title=Understanding+the+Warburg+Effect%3A+The+Metabolic+Requirements+of+Cell+Proliferation&doi=10.1126%2Fscience.1160809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span></div><div class="casAuthors">Vander Heiden, Matthew G.; Cantley, Lewis C.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5930</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect".  Aerobic glycolysis is an inefficient way to generate ATP, however, and the advantage it confers to cancer cells has been unclear.  Here we propose that the metab. of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell.  Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-assocd. mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP prodn.  A better understanding of the mechanistic links between cellular metab. and growth control may ultimately lead to better treatments for human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvLHGQ9TX77Vg90H21EOLACvtfcHk0ljm5eRGCOjgqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D&md5=f927402a43cdca471c3f4874dcbeb943</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1160809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1160809%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DUnderstanding%2520the%2520Warburg%2520Effect%253A%2520The%2520Metabolic%2520Requirements%2520of%2520Cell%2520Proliferation%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1029%26epage%3D1033%26doi%3D10.1126%2Fscience.1160809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poffenberger, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. G.</span></span> <span> </span><span class="NLM_article-title">Fueling Immunity: Insights into Metabolism and Lymphocyte Function</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">1242454</span>, <span class="refDoi"> DOI: 10.1126/science.1242454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1126%2Fscience.1242454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=24115444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FmvVSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=1242454&author=E.+L.+Pearceauthor=M.+C.+Poffenbergerauthor=C.-H.+Changauthor=R.+G.+Jones&title=Fueling+Immunity%3A+Insights+into+Metabolism+and+Lymphocyte+Function&doi=10.1126%2Fscience.1242454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Fueling immunity: insights into metabolism and lymphocyte function</span></div><div class="casAuthors">Pearce Erika L; Poffenberger Maya C; Chang Chih-Hao; Jones Russell G</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">6155</span>),
    <span class="NLM_cas:pages">1242454</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lymphocytes face major metabolic challenges upon activation.  They must meet the bioenergetic and biosynthetic demands of increased cell proliferation and also adapt to changing environmental conditions, in which nutrients and oxygen may be limiting.  An emerging theme in immunology is that metabolic reprogramming and lymphocyte activation are intricately linked.  However, why T cells adopt specific metabolic programs and the impact that these programs have on T cell function and, ultimately, immunological outcome remain unclear.  Research on tumor cell metabolism has provided valuable insight into metabolic pathways important for cell proliferation and the influence of metabolites themselves on signal transduction and epigenetic programming.  In this Review, we highlight emerging concepts regarding metabolic reprogramming in proliferating cells and discuss their potential impact on T cell fate and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3JRLcP1mfX8uCWE5mhx1RfW6udTcc2ebTzp4WwS5mmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FmvVSitw%253D%253D&md5=65e6e1a96424eb67615c030dba3f86da</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1242454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1242454%26sid%3Dliteratum%253Aachs%26aulast%3DPearce%26aufirst%3DE.%2BL.%26aulast%3DPoffenberger%26aufirst%3DM.%2BC.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DJones%26aufirst%3DR.%2BG.%26atitle%3DFueling%2520Immunity%253A%2520Insights%2520into%2520Metabolism%2520and%2520Lymphocyte%2520Function%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D1242454%26doi%3D10.1126%2Fscience.1242454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">Foundations of Immunometabolism and Implications for Metabolic Health and Disease</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">406</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2017.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.immuni.2017.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=28930657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFemtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=406-420&author=G.+S.+Hotamisligil&title=Foundations+of+Immunometabolism+and+Implications+for+Metabolic+Health+and+Disease&doi=10.1016%2Fj.immuni.2017.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Foundations of Immunometabolism and Implications for Metabolic Health and Disease</span></div><div class="casAuthors">Hotamisligil, Gokhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">406-420</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Highly ordered interactions between immune and metabolic responses are evolutionarily conserved and paramount for tissue and organismal health.  Disruption of these interactions underlies the emergence of many pathologies, particularly chronic non-communicable diseases such as obesity and diabetes.  Here, we examine decades of research identifying the complex immunometabolic signaling networks and the cellular and mol. events that occur in the setting of altered nutrient and energy exposures and offer a historical perspective.  Furthermore, we describe recent advances such as the discovery that a broad complement of immune cells play a role in immunometabolism and the emerging evidence that nutrients and metabolites modulate inflammatory pathways.  Lastly, we discuss how this work may eventually lead to tangible therapeutic advancements to promote health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDXcFJUOfD0LVg90H21EOLACvtfcHk0ljm5eRGCOjgqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFemtrbP&md5=918f9b1169ae07766735a1e883dc0b0e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2017.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2017.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DFoundations%2520of%2520Immunometabolism%2520and%2520Implications%2520for%2520Metabolic%2520Health%2520and%2520Disease%26jtitle%3DImmunity%26date%3D2017%26volume%3D47%26spage%3D406%26epage%3D420%26doi%3D10.1016%2Fj.immuni.2017.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balderson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christian, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, S. M.</span></span> <span> </span><span class="NLM_article-title">Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2015.00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.3389%2Ffimmu.2015.00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=25657648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eiu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1-6&author=C.+S.+Palmerauthor=M.+Ostrowskiauthor=B.+Baldersonauthor=N.+Christianauthor=S.+M.+Crowe&title=Glucose+Metabolism+Regulates+T+Cell+Activation%2C+Differentiation%2C+and+Functions&doi=10.3389%2Ffimmu.2015.00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose metabolism regulates T cell activation, differentiation, and functions</span></div><div class="casAuthors">Palmer, Clovis S.; Ostrowski, Matias; Balderson, Brad; Christian, Nicole; Crowe, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The adaptive immune system is equipped to eliminate both tumors and pathogenic microorganisms.  It requires a series of complex and coordinated signals to drive the activation, proliferation, and differentiation of appropriate T cell subsets.  It is now established that changes in cellular activation are coupled to profound changes in cellular metab.  In addn., emerging evidence now suggest that specific metabolic alterations assocd. with distinct T cell subsets may be ancillary to their differentiation and influential in their immune functions.  The "Warburg effect" originally used to describe a phenomenon in which most cancer cells relied on aerobic glycolysis for their growth is a key process that sustainT cell activation and differentiation.  Here,we review how different aspects of metab. inT cells influence their functions, focusing on the emerging role of key regulators of glucose metab. such as HIF-1a.  A thorough understanding of the role of metab. in T cell function could provide insights into mechanisms involved in inflammatory-mediated conditions, with the potential for developing novel therapeutic approaches to treat these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Gl967JQTb7Vg90H21EOLACvtfcHk0ljio3HXM1FZWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eiu77N&md5=39626de1cc1a43b8a261831f0b14deba</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00001%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DC.%2BS.%26aulast%3DOstrowski%26aufirst%3DM.%26aulast%3DBalderson%26aufirst%3DB.%26aulast%3DChristian%26aufirst%3DN.%26aulast%3DCrowe%26aufirst%3DS.%2BM.%26atitle%3DGlucose%2520Metabolism%2520Regulates%2520T%2520Cell%2520Activation%252C%2520Differentiation%252C%2520and%2520Functions%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D1%26epage%3D6%26doi%3D10.3389%2Ffimmu.2015.00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerriets, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deoliveira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathmell, J. C.</span></span> <span> </span><span class="NLM_article-title">The Glucose Transporter Glut1 Is Selectively Essential for Cd4 T Cell Activation and Effector Function</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2014.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.cmet.2014.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=24930970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFWmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=61-72&author=A.+N.+Macintyreauthor=V.+A.+Gerrietsauthor=A.+G.+Nicholsauthor=R.+D.+Michalekauthor=M.+C.+Rudolphauthor=D.+Deoliveiraauthor=S.+M.+Andersonauthor=E.+D.+Abelauthor=B.+J.+Chenauthor=L.+P.+Haleauthor=J.+C.+Rathmell&title=The+Glucose+Transporter+Glut1+Is+Selectively+Essential+for+Cd4+T+Cell+Activation+and+Effector+Function&doi=10.1016%2Fj.cmet.2014.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function</span></div><div class="casAuthors">Macintyre, Andrew N.; Gerriets, Valerie A.; Nichols, Amanda G.; Michalek, Ryan D.; Rudolph, Michael C.; Deoliveira, Divino; Anderson, Steven M.; Abel, E. Dale; Chen, Benny J.; Hale, Laura P.; Rathmell, Jeffrey C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-72</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">CD4 T cell activation leads to proliferation and differentiation into effector (Teff) or regulatory (Treg) cells that mediate or control immunity.  While each subset prefers distinct glycolytic or oxidative metabolic programs in vitro, requirements and mechanisms that control T cell glucose uptake and metab. in vivo are uncertain.  Despite expression of multiple glucose transporters, Glut1 deficiency selectively impaired metab. and function of thymocytes and Teff.  Resting T cells were normal until activated, when Glut1 deficiency prevented increased glucose uptake and glycolysis, growth, proliferation, and decreased Teff survival and differentiation.  Importantly, Glut1 deficiency decreased Teff expansion and the ability to induce inflammatory disease in vivo.  Treg cells, in contrast, were enriched in vivo and appeared functionally unaffected and able to suppress Teff, irresp. of Glut1 expression.  These data show a selective in vivo requirement for Glut1 in metabolic reprogramming of CD4 T cell activation and Teff expansion and survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp17xtn2ca7PbVg90H21EOLACvtfcHk0ljio3HXM1FZWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFWmsbw%253D&md5=5be0f77c6e21a18df8d94d80bafa8fe6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2014.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2014.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DMacintyre%26aufirst%3DA.%2BN.%26aulast%3DGerriets%26aufirst%3DV.%2BA.%26aulast%3DNichols%26aufirst%3DA.%2BG.%26aulast%3DMichalek%26aufirst%3DR.%2BD.%26aulast%3DRudolph%26aufirst%3DM.%2BC.%26aulast%3DDeoliveira%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DS.%2BM.%26aulast%3DAbel%26aufirst%3DE.%2BD.%26aulast%3DChen%26aufirst%3DB.%2BJ.%26aulast%3DHale%26aufirst%3DL.%2BP.%26aulast%3DRathmell%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520Glucose%2520Transporter%2520Glut1%2520Is%2520Selectively%2520Essential%2520for%2520Cd4%2520T%2520Cell%2520Activation%2520and%2520Effector%2520Function%26jtitle%3DCell%2520Metab.%26date%3D2014%26volume%3D20%26spage%3D61%26epage%3D72%26doi%3D10.1016%2Fj.cmet.2014.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Navale, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paranjape, A. N.</span></span> <span> </span><span class="NLM_article-title">Glucose Transporters: Physiological and Pathological Roles</span>. <i>Biophys. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1007/s12551-015-0186-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1007%2Fs12551-015-0186-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=28510148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtF2isb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=5-9&author=A.+M.+Navaleauthor=A.+N.+Paranjape&title=Glucose+Transporters%3A+Physiological+and+Pathological+Roles&doi=10.1007%2Fs12551-015-0186-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose transporters: physiological and pathological roles</span></div><div class="casAuthors">Navale, Archana M.; Paranjape, Archana N.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-9</span>CODEN:
                <span class="NLM_cas:coden">BRIECG</span>;
        ISSN:<span class="NLM_cas:issn">1867-2450</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Glucose is a primary energy source for most cells and an important substrate for many biochem. reactions.  As glucose is a need of each and every cell of the body, so are the glucose transporters.  Consequently, all cells express these important proteins on their surface.  In recent years developments in genetics have shed new light on the types and physiol. of various glucose transporters, of which there are two main types-sodium-glucose linked transporters (SGLTs) and facilitated diffusion glucose transporters (GLUT)-which can be divided into many more subclasses.  Transporters differ in terms of their substrate specificity, distribution and regulatory mechanisms.  Glucose transporters have also received much attention as therapeutic targets for various diseases.  In this review, we attempt to present a simplified view of this complex topic which may be of interest to researchers involved in biochem. and pharmacol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZHTI_CfH8WbVg90H21EOLACvtfcHk0ljio3HXM1FZWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtF2isb0%253D&md5=e328a4728ff6bca082764e1d06372066</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs12551-015-0186-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12551-015-0186-2%26sid%3Dliteratum%253Aachs%26aulast%3DNavale%26aufirst%3DA.%2BM.%26aulast%3DParanjape%26aufirst%3DA.%2BN.%26atitle%3DGlucose%2520Transporters%253A%2520Physiological%2520and%2520Pathological%2520Roles%26jtitle%3DBiophys.%2520Rev.%26date%3D2016%26volume%3D8%26spage%3D5%26epage%3D9%26doi%3D10.1007%2Fs12551-015-0186-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, N.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Human Glucose Transporter Glut1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>510</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1038/nature13306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1038%2Fnature13306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=24847886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFGitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2014&pages=121-125&author=D.+Dengauthor=C.+Xuauthor=P.+Sunauthor=J.+Wuauthor=C.+Yanauthor=M.+Huauthor=N.+Yan&title=Crystal+Structure+of+the+Human+Glucose+Transporter+Glut1&doi=10.1038%2Fnature13306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human glucose transporter GLUT1</span></div><div class="casAuthors">Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">7503</span>),
    <span class="NLM_cas:pages">121-125</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The glucose transporter GLUT1 catalyzes facilitative diffusion of glucose into erythrocytes and is responsible for glucose supply to the brain and other organs.  Dysfunctional mutations may lead to GLUT1 deficiency syndrome, whereas overexpression of GLUT1 is a prognostic indicator for cancer.  Despite decades of investigation, the structure of GLUT1 remains unknown.  Here we report the crystal structure of human GLUT1 at 3.2 Å resoln.  The full-length protein, which has a canonical major facilitator superfamily fold, is captured in an inward-open conformation.  This structure allows accurate mapping and potential mechanistic interpretation of disease-assocd. mutations in GLUT1.  Structure-based anal. of these mutations provides an insight into the alternating access mechanism of GLUT1 and other members of the sugar porter subfamily.  Structural comparison of the uniporter GLUT1 with its bacterial homolog XylE, a proton-coupled xylose symporter, allows examn. of the transport mechanisms of both passive facilitators and active transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeBmEBIMIurVg90H21EOLACvtfcHk0ljio3HXM1FZWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFGitL8%253D&md5=b9426a934cddf7347fdc6c9073aa8636</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature13306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13306%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DN.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Human%2520Glucose%2520Transporter%2520Glut1%26jtitle%3DNature%26date%3D2014%26volume%3D510%26spage%3D121%26epage%3D125%26doi%3D10.1038%2Fnature13306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, N.</span></span> <span> </span><span class="NLM_article-title">Molecular Basis of Ligand Recognition and Transport by Glucose Transporters</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>526</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1038/nature14655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1038%2Fnature14655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=26176916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyltLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2015&pages=391-396&author=D.+Dengauthor=P.+Sunauthor=C.+Yanauthor=M.+Keauthor=X.+Jiangauthor=L.+Xiongauthor=W.+Renauthor=K.+Hirataauthor=M.+Yamamotoauthor=S.+Fanauthor=N.+Yan&title=Molecular+Basis+of+Ligand+Recognition+and+Transport+by+Glucose+Transporters&doi=10.1038%2Fnature14655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of ligand recognition and transport by glucose transporters</span></div><div class="casAuthors">Deng, Dong; Sun, Pengcheng; Yan, Chuangye; Ke, Meng; Jiang, Xin; Xiong, Lei; Ren, Wenlin; Hirata, Kunio; Yamamoto, Masaki; Fan, Shilong; Yan, Nieng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue">7573</span>),
    <span class="NLM_cas:pages">391-396</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The major facilitator superfamily glucose transporters, exemplified by human GLUT1-4, have been central to the study of solute transport.  Using lipidic cubic phase crystn. and microfocus X-ray diffraction, we detd. the structure of human GLUT3 in complex with D-glucose at 1.5 Å resoln. in an outward-occluded conformation.  The high-resoln. structure allows discrimination of both α- and β-anomers of D-glucose.  Two addnl. structures of GLUT3 bound to the exofacial inhibitor maltose were obtained at 2.6 Å in the outward-open and 2.4 Å in the outward-occluded states.  In all three structures, the ligands are predominantly coordinated by polar residues from the carboxy terminal domain.  Conformational transition from outward-open to outward-occluded entails a prominent local rearrangement of the extracellular part of transmembrane segment TM7.  Comparison of the outward-facing GLUT3 structures with the inward-open GLUT1 provides insights into the alternating access cycle for GLUTs, whereby the C-terminal domain provides the primary substrate-binding site and the amino-terminal domain undergoes rigid-body rotation with respect to the C-terminal domain.  Our studies provide an important framework for the mechanistic and kinetic understanding of GLUTs and shed light on structure-guided ligand design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3p8Y2gV917LVg90H21EOLACvtfcHk0lh0GPP1vRsf5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyltLzO&md5=77ab999156155b38156394961682804d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature14655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14655%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DKe%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DXiong%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DW.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DN.%26atitle%3DMolecular%2520Basis%2520of%2520Ligand%2520Recognition%2520and%2520Transport%2520by%2520Glucose%2520Transporters%26jtitle%3DNature%26date%3D2015%26volume%3D526%26spage%3D391%26epage%3D396%26doi%3D10.1038%2Fnature14655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adekola, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugam, M.</span></span> <span> </span><span class="NLM_article-title">Glucose Transporters in Cancer Metabolism</span>. <i>Curr. Opin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1097/CCO.0b013e328356da72</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1097%2FCCO.0b013e328356da72" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=22913968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFCltr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=650-654&author=K.+Adekolaauthor=S.+T.+Rosenauthor=M.+Shanmugam&title=Glucose+Transporters+in+Cancer+Metabolism&doi=10.1097%2FCCO.0b013e328356da72"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose transporters in cancer metabolism</span></div><div class="casAuthors">Adekola, Kehinde; Rosen, Steven T.; Shanmugam, Mala</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">650-654</span>CODEN:
                <span class="NLM_cas:coden">CUOOE8</span>;
        ISSN:<span class="NLM_cas:issn">1040-8746</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Transformed cells exhibit a high rate of glucose consumption beyond that necessary for ATP synthesis.  Glucose aids in the generation of biomass and regulates cellular signaling crit. for oncogenic progression.  A key rate-limiting step in glucose utilization is the transport of glucose across the plasma membrane.  This review will highlight key glucose transporters (GLUTs) and current therapies targeting this class of proteins.  Recent findings: GLUTs, enabling the facilitative entry of glucose into a cell, are increasingly found to be deregulated in cancer.  Although cancer-specific expression patterns for GLUTs are being identified, comprehensive analyses substantiating a role for individual GLUTs are still required.  Studies defining GLUTs as being rate-limiting in specific tumor contexts, the identification of GLUT1 inhibitors via synthetic lethality screens, novel engagement of the insulin-responsive GLUT4 in myeloma and identification of GLUT9 being a urate transporter, are key advances underscoring the need for continued investigation of this large and enigmatic class of proteins.  Summary: Tumor cells exhibit elevated levels of glucose uptake, a phenomenon that has been capitalized upon for the prognostic and diagnostic imaging of a wide range of cancers using radio-labeled glucose analogs.  We have, however, not yet been able to target glucose entry in a tumor cell-specific manner for therapy.  GLUTs have been identified as rate-limiting in specific tumor contexts.  The identification and targeting of tumor-specific GLUTs provide a promising approach to block glucose-regulated metab. and signaling more comprehensively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGmT18-me7D7Vg90H21EOLACvtfcHk0lh0GPP1vRsf5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFCltr%252FL&md5=5ad6bc3f29caf6f7bb508123dcb256f1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2FCCO.0b013e328356da72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCCO.0b013e328356da72%26sid%3Dliteratum%253Aachs%26aulast%3DAdekola%26aufirst%3DK.%26aulast%3DRosen%26aufirst%3DS.%2BT.%26aulast%3DShanmugam%26aufirst%3DM.%26atitle%3DGlucose%2520Transporters%2520in%2520Cancer%2520Metabolism%26jtitle%3DCurr.%2520Opin.%2520Oncol.%26date%3D2012%26volume%3D24%26spage%3D650%26epage%3D654%26doi%3D10.1097%2FCCO.0b013e328356da72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Granchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fancelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minutolo, F.</span></span> <span> </span><span class="NLM_article-title">An Update on Therapeutic Opportunities Offered by Cancer Glycolytic Metabolism</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4915</span>– <span class="NLM_lpage">4925</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.bmcl.2014.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=25288186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eitbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4915-4925&author=C.+Granchiauthor=D.+Fancelliauthor=F.+Minutolo&title=An+Update+on+Therapeutic+Opportunities+Offered+by+Cancer+Glycolytic+Metabolism&doi=10.1016%2Fj.bmcl.2014.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An update on therapeutic opportunities offered by cancer glycolytic metabolism</span></div><div class="casAuthors">Granchi, Carlotta; Fancelli, Daniele; Minutolo, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4915-4925</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Almost all invasive cancers, regardless of tissue origin, are characterized by specific modifications of their cellular energy metab.  In fact, a strong predominance of aerobic glycolysis over oxidative phosphorylation (Warburg effect) is usually assocd. with aggressive tumor phenotypes.  This metabolic shift offers a survival advantage to cancer cells, since they may continue to produce energy and anabolites even when they are exposed to either transient or permanent hypoxic conditions.  Moreover, it ensures a high prodn. rate of glycolysis intermediates, useful as building blocks for fast cell proliferation of cancer cells.  This peculiar metabolic profile may constitute an ideal target for therapeutic interventions that selectively hit cancer cells with minimal residual systemic toxicity.  In this review we provide an update about some of the most recent advances in the discovery of new bioactive mols. that are able to interfere with cancer glycolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIdWP6wz_jRbVg90H21EOLACvtfcHk0lh0GPP1vRsf5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eitbzJ&md5=e8b3949321270dad2dcc4757c47b5aa6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DGranchi%26aufirst%3DC.%26aulast%3DFancelli%26aufirst%3DD.%26aulast%3DMinutolo%26aufirst%3DF.%26atitle%3DAn%2520Update%2520on%2520Therapeutic%2520Opportunities%2520Offered%2520by%2520Cancer%2520Glycolytic%2520Metabolism%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4915%26epage%3D4925%26doi%3D10.1016%2Fj.bmcl.2014.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barron, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsakiridis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsiani, E.</span></span> <span> </span><span class="NLM_article-title">Facilitative Glucose Transporters: Implications for Cancer Detection, Prognosis and Treatment</span>. <i>Metab., Clin. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2015.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.metabol.2015.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=26773935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGmtbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=124-139&author=C.+C.+Barronauthor=P.+J.+Bilanauthor=T.+Tsakiridisauthor=E.+Tsiani&title=Facilitative+Glucose+Transporters%3A+Implications+for+Cancer+Detection%2C+Prognosis+and+Treatment&doi=10.1016%2Fj.metabol.2015.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment</span></div><div class="casAuthors">Barron, Carly C.; Bilan, Philip J.; Tsakiridis, Theodoros; Tsiani, Evangelia</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-139</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">It is long recognized that cancer cells display increased glucose uptake and metab.  In a rate-limiting step for glucose metab., the glucose transporter (GLUT) proteins facilitate glucose uptake across the plasma membrane.  Fourteen members of the GLUT protein family have been identified in humans.  This review describes the major characteristics of each member of the GLUT family and highlights evidence of abnormal expression in tumors and cancer cells.  The regulation of GLUTs by key proliferation and pro-survival pathways including the phosphatidylinositol 3-kinase (PI3K)-Akt, hypoxia-inducible factor-1 (HIF-1), Ras, c-Myc and p53 pathways is discussed.  The clin. utility of GLUT expression in cancer has been recognized and evidence regarding the use of GLUTs as prognostic or predictive biomarkers is presented.  GLUTs represent attractive targets for cancer therapy and this review summarizes recent studies in which GLUT1, GLUT3, GLUT5 and others are inhibited to decrease cancer growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphlp2DpRZZZLVg90H21EOLACvtfcHk0lidYrW5m_Ra5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGmtbzJ&md5=17a6f1647a7ae6ad8d859d80459c0c04</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2015.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2015.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DBarron%26aufirst%3DC.%2BC.%26aulast%3DBilan%26aufirst%3DP.%2BJ.%26aulast%3DTsakiridis%26aufirst%3DT.%26aulast%3DTsiani%26aufirst%3DE.%26atitle%3DFacilitative%2520Glucose%2520Transporters%253A%2520Implications%2520for%2520Cancer%2520Detection%252C%2520Prognosis%2520and%2520Treatment%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2016%26volume%3D65%26spage%3D124%26epage%3D139%26doi%3D10.1016%2Fj.metabol.2015.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmeier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akbar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth in Vitro and in Vivo</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1672</span>– <span class="NLM_lpage">1682</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1158%2F1535-7163.MCT-12-0131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=22689530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOisL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1672-1682&author=Y.+Liuauthor=Y.+Caoauthor=W.+Zhangauthor=S.+Bergmeierauthor=Y.+Qianauthor=H.+Akbarauthor=R.+Colvinauthor=J.+Dingauthor=L.+Tongauthor=S.+Wuauthor=J.+Hinesauthor=X.+Chen&title=A+Small-Molecule+Inhibitor+of+Glucose+Transporter+1+Downregulates+Glycolysis%2C+Induces+Cell-Cycle+Arrest%2C+and+Inhibits+Cancer+Cell+Growth+in+Vitro+and+in+Vivo&doi=10.1158%2F1535-7163.MCT-12-0131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo</span></div><div class="casAuthors">Liu, Yi; Cao, Yanyan; Zhang, Weihe; Bergmeier, Stephen; Qian, Yanrong; Akbar, Huzoor; Colvin, Robert; Ding, Juan; Tong, Lingying; Wu, Shiyong; Hines, Jennifer; Chen, Xiaozhuo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1672-1682</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The functional and therapeutic importance of the Warburg effect is increasingly recognized, and glycolysis has become a target of anticancer strategies.  We recently reported the identification of a group of novel small compds. that inhibit basal glucose transport and reduce cancer cell growth by a glucose deprivation-like mechanism.  We hypothesized that the compds. target Glut1 and are efficacious in vivo as anticancer agents.  Here, we report that a novel representative compd. WZB117 not only inhibited cell growth in cancer cell lines but also inhibited cancer growth in a nude mouse model.  Daily i.p. injection of WZB117 at 10 mg/kg resulted in a more than 70% redn. in the size of human lung cancer of A549 cell origin.  Mechanism studies showed that WZB117 inhibited glucose transport in human red blood cells (RBC), which express Glut1 as their sole glucose transporter.  Cancer cell treatment with WZB117 led to decreases in levels of Glut1 protein, intracellular ATP, and glycolytic enzymes.  All these changes were followed by increase in ATP-sensing enzyme AMP-activated protein kinase (AMPK) and declines in cyclin E2 as well as phosphorylated retinoblastoma, resulting in cell-cycle arrest, senescence, and necrosis.  Addn. of extracellular ATP rescued compd.-treated cancer cells, suggesting that the redn. of intracellular ATP plays an important role in the anticancer mechanism of the mol.  Senescence induction and the essential role of ATP were reported for the first time in Glut1 inhibitor-treated cancer cells.  Thus, WZB117 is a prototype for further development of anticancer therapeutics targeting Glut1-mediated glucose transport and glucose metab.  Mol Cancer Ther; 11(8); 1672-82. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroXJWk_apZpbVg90H21EOLACvtfcHk0lidYrW5m_Ra5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOisL3P&md5=18bdfc78789600ba53f6149758aadcb4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0131%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBergmeier%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DAkbar%26aufirst%3DH.%26aulast%3DColvin%26aufirst%3DR.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DA%2520Small-Molecule%2520Inhibitor%2520of%2520Glucose%2520Transporter%25201%2520Downregulates%2520Glycolysis%252C%2520Induces%2520Cell-Cycle%2520Arrest%252C%2520and%2520Inhibits%2520Cancer%2520Cell%2520Growth%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D1672%26epage%3D1682%26doi%3D10.1158%2F1535-7163.MCT-12-0131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulp, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. S.</span></span> <span> </span><span class="NLM_article-title">Development of a Novel Class of Glucose Transporter Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3827</span>– <span class="NLM_lpage">3836</span>, <span class="refDoi"> DOI: 10.1021/jm300015m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300015m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFOntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3827-3836&author=D.+Wangauthor=P.+C.+Chuauthor=C.+N.+Yangauthor=R.+Yanauthor=Y.+C.+Chuangauthor=S.+K.+Kulpauthor=C.+S.+Chen&title=Development+of+a+Novel+Class+of+Glucose+Transporter+Inhibitors&doi=10.1021%2Fjm300015m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Novel Class of Glucose Transporter Inhibitors</span></div><div class="casAuthors">Wang, Dasheng; Chu, Po-Chen; Yang, Chia-Ning; Yan, Ribai; Chuang, Yu-Chung; Kulp, Samuel K.; Chen, Ching-Shih</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3827-3836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our finding that the antitumor effect of 5-{4-[(1-methylcyclohexyl)methoxy]benzyl}thiazolidine-2,4-dione, a thiazolidinedione peroxisome proliferator-activated receptor (PPAR)γ agonist, was, in part, attributable to its ability to block glucose uptake independently of PPARγ, we used its PPARγ-inactive analog to develop a novel class of glucose transporter (GLUT) inhibitors.  This lead optimization led to compd. 30 {5-(4-hydroxy-3-trifluoromethylbenzylidene)-3-[4,4,4-trifluoro-2-methyl-2-(2,2,2-trifluoroethyl)butyl]thiazolidine-2,4-dione} as the optimal agent, which exhibited high antitumor potency through the suppression of glucose uptake (IC50, 2.5 μM), while not cytotoxic to prostate and mammary epithelial cells.  This glucose uptake inhibition was assocd. with the inhibition of GLUT1 (IC50, 2 μM).  Moreover, the mechanism of antitumor action of compd. 30 was validated by its effect on a series of energy restriction-assocd. cellular responses.  Homol. modeling anal. suggests that the inhibitory effect of compd. 30 on glucose entry was attributable to its ability to bind to the GLUT1 channel at a site distinct from that of glucose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDoAgocTYYsLVg90H21EOLACvtfcHk0lidYrW5m_Ra5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFOntLk%253D&md5=c4c2893a7ff1aa1bc357e3858ce870e9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm300015m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300015m%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DP.%2BC.%26aulast%3DYang%26aufirst%3DC.%2BN.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DChuang%26aufirst%3DY.%2BC.%26aulast%3DKulp%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DC.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Novel%2520Class%2520of%2520Glucose%2520Transporter%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3827%26epage%3D3836%26doi%3D10.1021%2Fjm300015m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutphin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solow-Cordero, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouley, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Glut1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">94ra70</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.3002394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1126%2Fscitranslmed.3002394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=21813754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOisLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&author=D.+A.+Chanauthor=P.+D.+Sutphinauthor=P.+Nguyenauthor=S.+Turcotteauthor=E.+W.+Laiauthor=A.+Banhauthor=G.+E.+Reynoldsauthor=J.+T.+Chiauthor=J.+Wuauthor=D.+E.+Solow-Corderoauthor=M.+Bonnetauthor=J.+U.+Flanaganauthor=D.+M.+Bouleyauthor=E.+E.+Gravesauthor=W.+A.+Dennyauthor=M.+P.+Hayauthor=A.+J.+Giaccia&title=Targeting+Glut1+and+the+Warburg+Effect+in+Renal+Cell+Carcinoma+by+Chemical+Synthetic+Lethality&doi=10.1126%2Fscitranslmed.3002394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality</span></div><div class="casAuthors">Chan, Denise A.; Sutphin, Patrick D.; Nguyen, Phuong; Turcotte, Sandra; Lai, Edwin W.; Banh, Alice; Reynolds, Gloria E.; Chi, Jen-Tsan; Wu, Jason; Solow-Cordero, David E.; Bonnet, Muriel; Flanagan, Jack U.; Bouley, Donna M.; Graves, Edward E.; Denny, William A.; Hay, Michael P.; Giaccia, Amato J.</div><div class="citationInfo"><span class="NLM_cas:title">Science Translational Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">94</span>),
    <span class="NLM_cas:pages">94ra70</span>CODEN:
                <span class="NLM_cas:coden">STMCBQ</span>;
        ISSN:<span class="NLM_cas:issn">1946-6242</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Identifying new targeted therapies that kill tumor cells while sparing normal tissue is a major challenge of cancer research.  Using a high-throughput chem. synthetic lethal screen, we sought to identify compds. that exploit the loss of the von Hippel-Lindau (VHL) tumor suppressor gene, which occurs in about 80% of renal cell carcinomas (RCCs).  RCCs, like many other cancers, are dependent on aerobic glycolysis for ATP prodn., a phenomenon known as the Warburg effect.  The dependence of RCCs on glycolysis is in part a result of induction of glucose transporter 1 (GLUT1).  Here, we report the identification of a class of compds., the 3-series, exemplified by STF-31, which selectively kills RCCs by specifically targeting glucose uptake through GLUT1 and exploiting the unique dependence of these cells on GLUT1 for survival.  Treatment with these agents inhibits the growth of RCCs by binding GLUT1 directly and impeding glucose uptake in vivo without toxicity to normal tissue.  Activity of STF-31 in these exptl. renal tumors can be monitored by [18F] fluorodeoxyglucose uptake by micro-positron emission tomog. imaging, and therefore, these agents may be readily tested clin. in human tumors.  Our results show that the Warburg effect confers distinct characteristics on tumor cells that can be selectively targeted for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZodRjh_SzxrVg90H21EOLACvtfcHk0lhhUeSrcFMnxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOisLzK&md5=418628e65c3a96425353b4be2d692927</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3002394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3002394%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BA.%26aulast%3DSutphin%26aufirst%3DP.%2BD.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DTurcotte%26aufirst%3DS.%26aulast%3DLai%26aufirst%3DE.%2BW.%26aulast%3DBanh%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DG.%2BE.%26aulast%3DChi%26aufirst%3DJ.%2BT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSolow-Cordero%26aufirst%3DD.%2BE.%26aulast%3DBonnet%26aufirst%3DM.%26aulast%3DFlanagan%26aufirst%3DJ.%2BU.%26aulast%3DBouley%26aufirst%3DD.%2BM.%26aulast%3DGraves%26aufirst%3DE.%2BE.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DHay%26aufirst%3DM.%2BP.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Glut1%2520and%2520the%2520Warburg%2520Effect%2520in%2520Renal%2520Cell%2520Carcinoma%2520by%2520Chemical%2520Synthetic%2520Lethality%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26doi%3D10.1126%2Fscitranslmed.3002394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finer-Moore, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caboni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waight, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillig, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bringmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siebeneicher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R. M.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Inhibition of Human Glucose Transporter Glut1 Is Conserved between Cytochalasin B and Phenylalanine Amides</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">4711</span>– <span class="NLM_lpage">4716</span>, <span class="refDoi"> DOI: 10.1073/pnas.1603735113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1073%2Fpnas.1603735113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=27078104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvV2nsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=4711-4716&author=K.+Kapoorauthor=J.+S.+Finer-Mooreauthor=B.+P.+Pedersenauthor=L.+Caboniauthor=A.+Waightauthor=R.+C.+Hilligauthor=P.+Bringmannauthor=I.+Heislerauthor=T.+Mullerauthor=H.+Siebeneicherauthor=R.+M.+Stroud&title=Mechanism+of+Inhibition+of+Human+Glucose+Transporter+Glut1+Is+Conserved+between+Cytochalasin+B+and+Phenylalanine+Amides&doi=10.1073%2Fpnas.1603735113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides</span></div><div class="casAuthors">Kapoor, Khyati; Finer-Moore, Janet S.; Pedersen, Bjoern P.; Caboni, Laura; Waight, Andrew; Hillig, Roman C.; Bringmann, Peter; Heisler, Iring; Muller, Thomas; Siebeneicher, Holger; Stroud, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4711-4716</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cancerous cells have an acutely increased demand for energy, leading to increased levels of human glucose transporter 1 (hGLUT1).  This up-regulation suggests hGLUT1 as a target for therapeutic inhibitors addressing a multitude of cancer types.  Here, the authors present three inhibitor-bound, inward-open structures of WT-hGLUT1 crystd. with three different inhibitors: cytochalasin B, a nine-membered bicyclic ring fused to a 14-membered macrocycle, which has been described extensively in the literature of hGLUTs, and two previously undescribed Phe amide-derived inhibitors.  Despite very different chem. backbones, all three compds. bind in the central cavity of the inward-open state of hGLUT1, and all binding sites overlap the glucose-binding site.  The inhibitory action of the compds. was detd. for hGLUT family members, hGLUT1-4, using cell-based assays, and compared with homol. models for these hGLUT members.  This comparison uncovered a probable basis for the obsd. differences in inhibition between family members.  The authors pinpoint regions of the hGLUT proteins that can be targeted to achieve isoform selectivity, and show that these same regions are used for inhibitors with very distinct structural backbones.  The inhibitor cocomplex structures of hGLUT1 provide an important structural insight for the design of more selective inhibitors for hGLUTs and hGLUT1 in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopyfWMOg2jvLVg90H21EOLACvtfcHk0lhhUeSrcFMnxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvV2nsLw%253D&md5=473eb5209694681cf2df4be5603aaabc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1603735113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1603735113%26sid%3Dliteratum%253Aachs%26aulast%3DKapoor%26aufirst%3DK.%26aulast%3DFiner-Moore%26aufirst%3DJ.%2BS.%26aulast%3DPedersen%26aufirst%3DB.%2BP.%26aulast%3DCaboni%26aufirst%3DL.%26aulast%3DWaight%26aufirst%3DA.%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DBringmann%26aufirst%3DP.%26aulast%3DHeisler%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DT.%26aulast%3DSiebeneicher%26aufirst%3DH.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26atitle%3DMechanism%2520of%2520Inhibition%2520of%2520Human%2520Glucose%2520Transporter%2520Glut1%2520Is%2520Conserved%2520between%2520Cytochalasin%2520B%2520and%2520Phenylalanine%2520Amides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D4711%26epage%3D4716%26doi%3D10.1073%2Fpnas.1603735113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siebeneicher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorn, L.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel Glut Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1732</span>– <span class="NLM_lpage">1737</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.02.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.bmcl.2016.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=26949183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1akt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1732-1737&author=H.+Siebeneicherauthor=M.+Bauserauthor=B.+Buchmannauthor=I.+Heislerauthor=T.+Mullerauthor=R.+Neuhausauthor=H.+Rehwinkelauthor=J.+Telserauthor=L.+Zorn&title=Identification+of+Novel+Glut+Inhibitors&doi=10.1016%2Fj.bmcl.2016.02.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel GLUT inhibitors</span></div><div class="casAuthors">Siebeneicher, Holger; Bauser, Marcus; Buchmann, Bernd; Heisler, Iring; Mueller, Thomas; Neuhaus, Roland; Rehwinkel, Hartmut; Telser, Joachim; Zorn, Ludwig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1732-1737</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The compd. class of 1H-pyrazolo[3,4-d]pyrimidines was identified using HTS (high-throughput screening) as very potent inhibitors of facilitated glucose transporter 1 (GLUT1).  Extensive structure-activity relationship studies (SAR) of each ring system of the mol. framework was established revealing essential structural motives (i.e., ortho-methoxy substituted benzene, piperazine and pyrimidine).  The selectivity against GLUT2 was excellent and initial in vitro and in vivo pharmacokinetic (PK) studies are encouraging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvoI6G3pWwZrVg90H21EOLACvtfcHk0lhhUeSrcFMnxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1akt70%253D&md5=79f2a3d68a3e38656b0b3ed4c99bd636</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.02.050%26sid%3Dliteratum%253Aachs%26aulast%3DSiebeneicher%26aufirst%3DH.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBuchmann%26aufirst%3DB.%26aulast%3DHeisler%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DT.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DTelser%26aufirst%3DJ.%26aulast%3DZorn%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520Novel%2520Glut%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1732%26epage%3D1737%26doi%3D10.1016%2Fj.bmcl.2016.02.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siebeneicher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleve, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchmann, B.</span></span> <span> </span><span class="NLM_article-title">Identification and Optimization of the First Highly Selective Glut1 Inhibitor Bay-876</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2261</span>– <span class="NLM_lpage">2271</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1002%2Fcmdc.201600276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=27552707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyktr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2261-2271&author=H.+Siebeneicherauthor=A.+Cleveauthor=H.+Rehwinkelauthor=R.+Neuhausauthor=I.+Heislerauthor=T.+Mullerauthor=M.+Bauserauthor=B.+Buchmann&title=Identification+and+Optimization+of+the+First+Highly+Selective+Glut1+Inhibitor+Bay-876&doi=10.1002%2Fcmdc.201600276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876</span></div><div class="casAuthors">Siebeneicher, Holger; Cleve, Arwed; Rehwinkel, Hartmut; Neuhaus, Roland; Heisler, Iring; Mueller, Thomas; Bauser, Marcus; Buchmann, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2261-2271</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Despite the long-known fact that the facilitative glucose transporter GLUT1 is one of the key players safeguarding the increase in glucose consumption of many tumor entities even under conditions of normal oxygen supply (known as the Warburg effect), only few endeavors have been undertaken to find a GLUT1-selective small-mol. inhibitor.  Because other transporters of the GLUT1 family are involved in crucial processes, these transporters should not be addressed by such an inhibitor.  A high-throughput screen against a library of ∼3 million compds. was performed to find a small mol. with this challenging potency and selectivity profile.  The N-(1H-pyrazol-4-yl)quinoline-4-carboxamides were identified as an excellent starting point for further compd. optimization.  After extensive structure-activity relationship explorations, single-digit nanomolar inhibitors with a selectivity factor of >100 against GLUT2, GLUT3, and GLUT4 were obtained.  The most promising compd., BAY-876 [N4-[1-(4-cyanobenzyl)-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoroquinoline-2,4-dicarboxamide], showed good metabolic stability in vitro and high oral bioavailability in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFnF7Pnmxup7Vg90H21EOLACvtfcHk0ljgN2F89aNgog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyktr3L&md5=bcad707900882f937d137dc3925862a7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600276%26sid%3Dliteratum%253Aachs%26aulast%3DSiebeneicher%26aufirst%3DH.%26aulast%3DCleve%26aufirst%3DA.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DHeisler%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DT.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBuchmann%26aufirst%3DB.%26atitle%3DIdentification%2520and%2520Optimization%2520of%2520the%2520First%2520Highly%2520Selective%2520Glut1%2520Inhibitor%2520Bay-876%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2261%26epage%3D2271%26doi%3D10.1002%2Fcmdc.201600276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reckzeh, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karageorgis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalfenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceballos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowacki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroet, M. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binici, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choidas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth</span>. <i>Cell. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1214</span>– <span class="NLM_lpage">1228</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2019.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.chembiol.2019.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=31303578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKlu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=1214-1228&author=E.+S.+Reckzehauthor=G.+Karageorgisauthor=M.+Schwalfenbergauthor=J.+Ceballosauthor=J.+Nowackiauthor=M.+C.+M.+Stroetauthor=A.+Biniciauthor=L.+Knauerauthor=S.+Brandauthor=A.+Choidasauthor=C.+Strohmannauthor=S.+Zieglerauthor=H.+Waldmann&title=Inhibition+of+Glucose+Transporters+and+Glutaminase+Synergistically+Impairs+Tumor+Cell+Growth&doi=10.1016%2Fj.chembiol.2019.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth</span></div><div class="casAuthors">Reckzeh, Elena S.; Karageorgis, George; Schwalfenberg, Melanie; Ceballos, Javier; Nowacki, Jessica; Stroet, Marcus C. M.; Binici, Aylin; Knauer, Lena; Brand, Silke; Choidas, Axel; Strohmann, Carsten; Ziegler, Slava; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1214-1228.e25</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cancer cells sustain growth by altering their metab. to accelerated aerobic glycolysis accompanied by increased glucose demand and employ glutamine as addnl. nutrient source.  This metabolic adaptation induces upregulation of glucose transporters GLUT-1 and -3, and simultaneous targeting of both transporters and of glutamine metab. may offer a promising approach to inhibit cancer cell growth.  We describe the discovery of the very potent glucose uptake inhibitor Glutor, which targets glucose transporters GLUT-1, -2, and -3, attenuates glycolytic flux and potently and selectively suppresses growth of a variety of cancer cell lines.  Co-treatment of colon cancer cells with Glutor and glutaminase inhibitor CB-839 very potently and synergistically inhibits cancer cell growth.  Such a dual inhibition promises to be particularly effective because it targets the metabolic plasticity as well as metabolic rescue mechanisms in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHx4AfWvB7p7Vg90H21EOLACvtfcHk0ljgN2F89aNgog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKlu7bN&md5=d41d09c28312d8016566cfbec6409c73</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2019.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2019.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DReckzeh%26aufirst%3DE.%2BS.%26aulast%3DKarageorgis%26aufirst%3DG.%26aulast%3DSchwalfenberg%26aufirst%3DM.%26aulast%3DCeballos%26aufirst%3DJ.%26aulast%3DNowacki%26aufirst%3DJ.%26aulast%3DStroet%26aufirst%3DM.%2BC.%2BM.%26aulast%3DBinici%26aufirst%3DA.%26aulast%3DKnauer%26aufirst%3DL.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DChoidas%26aufirst%3DA.%26aulast%3DStrohmann%26aufirst%3DC.%26aulast%3DZiegler%26aufirst%3DS.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520Glucose%2520Transporters%2520and%2520Glutaminase%2520Synergistically%2520Impairs%2520Tumor%2520Cell%2520Growth%26jtitle%3DCell.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D1214%26epage%3D1228%26doi%3D10.1016%2Fj.chembiol.2019.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sergeant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of 3-O-Methylglucose Transport in Human Erythrocytes by Forskolin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>260</i></span>,  <span class="NLM_fpage">14677</span>– <span class="NLM_lpage">14682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=2997220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADyaL2MXlvV2ku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=14677-14682&author=S.+Sergeantauthor=H.+D.+Kim&title=Inhibition+of+3-O-Methylglucose+Transport+in+Human+Erythrocytes+by+Forskolin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of 3-O-methylglucose transport in human erythrocytes by forskolin</span></div><div class="casAuthors">Sergeant, Susan; Kim, Hyun Dju</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">14677-82</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The effect of forskolin  [66575-29-9], and activator of adenylate cyclase  [9012-42-4], was investigated on glucose  [50-99-7] transport in human erythrocytes.  Forskolin was a potent inhibitor of 3-O-methylglucose (3-O-MG) influx in human erythrocytes.  The inhibition of 3-O-MG transport was instantaneous and reversible.  The inhibitor effect of forskolin was concn.-dependent, having an IC50 value of 7.5 μM.  Forskolin caused a decrease in Vmax of carrier-mediated 3-O-MG transport.  Inhibition of influx was not reversed at high concns. of 3-O-MG.  In addn., forskolin inhibited the influx of other carbohydrates including galactose  [59-23-4], ribose  [50-69-1], and fructose  [57-48-7].  In contrast, forskolin was without effect on adenosine transport.  Erythrocytes treated with 50 μM forskolin exhibited an increase in cAMP  [60-92-4] content within 10 s after forskolin exposure.  However, erythrocytes in which cAMP was allowed to accumulate in excess of 10,000 times the basal level, by means of preincubation with exogenous cAMP, displayed 3-O-MG transport indistinguishable from that of cAMP-poor control cells.  Inhibition of 3-O-MG transport appears to be mediate by a mechanism other than by stimulating adenylate cyclase activity.  Moreover, forskolin appears to directly inactivate the 3-O-MG transport system since glucose-sensitive cytochalasin B binding to erythrocyte membranes is virtually abolished by 50 μM forskolin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWeeCrLXeZerVg90H21EOLACvtfcHk0ljgN2F89aNgog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlvV2ku7s%253D&md5=06e336a6bd9bf8bd2eca79e7e28c5155</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSergeant%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%2BD.%26atitle%3DInhibition%2520of%25203-O-Methylglucose%2520Transport%2520in%2520Human%2520Erythrocytes%2520by%2520Forskolin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D14677%26epage%3D14682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J.</span></span> <span> </span><span class="NLM_article-title">The Impact of Aromatic Ring Count on Compound Developability--Are Too Many Aromatic Rings a Liability in Drug Design?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1020</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2009.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.drudis.2009.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=19729075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1011-1020&author=T.+J.+Ritchieauthor=S.+J.+Macdonald&title=The+Impact+of+Aromatic+Ring+Count+on+Compound+Developability%2D%2DAre+Too+Many+Aromatic+Rings+a+Liability+in+Drug+Design%3F&doi=10.1016%2Fj.drudis.2009.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: Are too many aromatic rings a liability in drug design?</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">1011-1020</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of arom. ring count (the no. of arom. and heteroarom. rings) in mols. has been analyzed against various developability parameters, aq. soly., lipophilicity, serum albumin binding, CyP450 inhibition and hERG inhibition.  On the basis of this anal., it was concluded that the fewer arom. rings contained in an oral drug candidate, the more developable that candidate is probably to be; in addn., more than three arom. rings in a mol. correlates with poorer compd. developability and, thus, an increased risk of attrition in development.  Data are also presented that demonstrate that even within a defined lipophilicity range, increased arom. ring count leads to decreased aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2hOeD6TNGUbVg90H21EOLACvtfcHk0lgn9AqbqfhR3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP&md5=48454c9809e8225b4336ea76aad3f3ba</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520Impact%2520of%2520Aromatic%2520Ring%2520Count%2520on%2520Compound%2520Developability--Are%2520Too%2520Many%2520Aromatic%2520Rings%2520a%2520Liability%2520in%2520Drug%2520Design%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D1011%26epage%3D1020%26doi%3D10.1016%2Fj.drudis.2009.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lgn9AqbqfhR3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+Computational+Approaches+to+Estimate+Solubility+and+Permeability+in+Drug+Discovery+and+Development+Settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0liJ3yCNpAae4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520Computational%2520Approaches%2520to%2520Estimate%2520Solubility%2520and%2520Permeability%2520in%2520Drug%2520Discovery%2520and%2520Development%2520Settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Structure-Brain Exposure Relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7559</span>– <span class="NLM_lpage">7583</span>, <span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-Brain+Exposure+Relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0liJ3yCNpAae4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-Brain%2520Exposure%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving Beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (cns mpo) Approach to Enable Alignment of Druglike Properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+Beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28cns+mpo%29+Approach+to+Enable+Alignment+of+Druglike+Properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0liJ3yCNpAae4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520Beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528cns%2520mpo%2529%2520Approach%2520to%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbertz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudkins, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallamo, J. P.</span></span> <span> </span><span class="NLM_article-title">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1021/cn200100h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-Based%2C+Central+Nervous+System+%28CNS%29+Lead+Selection+and+Lead+Optimization+for+CNS+Drug+Discovery&doi=10.1021%2Fcn200100h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Hudkins, Robert L.; Dorsey, Bruce D.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central nervous system (CNS) is the major area that is affected by aging.  Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment.  Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process.  On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochem. and structural differences between CNS and non-CNS drugs may assist both research areas.  Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena.  Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compds., we analyzed the physicochem. property and the chem. structural profiles of 317 CNS and 626 non-CNS oral drugs.  The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process.  A list of substructural units that may be useful for CNS drug design was also provided here.  A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs.  The combined anal. provided the following guidelines for designing high-quality CNS drugs: (i) topol. mol. polar surface area of <76 Å2 (25-60 Å2), (ii) at least one (one or two, including one aliph. amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) vol. of 740-970 Å3, (vi) solvent accessible surface area of 460-580 Å2, and (vii) pos. QikProp parameter CNS.  The ranges within parentheses may be used during lead optimization.  One violation to this proposed profile may be acceptable.  The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozqfO0vq2i5bVg90H21EOLACvtfcHk0liJ3yCNpAae4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO&md5=4c20ba34c3d5397170b50242975ce25d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-Based%252C%2520Central%2520Nervous%2520System%2520%2528CNS%2529%2520Lead%2520Selection%2520and%2520Lead%2520Optimization%2520for%2520CNS%2520Drug%2520Discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D50%26epage%3D68%26doi%3D10.1021%2Fcn200100h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">Cns Physicochemical Property Space Shaped by a Diverse Set of Molecules with Experimentally Determined Exposure in the Mouse Brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5943</span>– <span class="NLM_lpage">5954</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01469</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01469" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1yqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5943-5954&author=Z.+Rankovic&title=Cns+Physicochemical+Property+Space+Shaped+by+a+Diverse+Set+of+Molecules+with+Experimentally+Determined+Exposure+in+the+Mouse+Brain&doi=10.1021%2Facs.jmedchem.6b01469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Physicochemical Property Space Shaped by a Diverse Set of Molecules with Experimentally Determined Exposure in the Mouse Brain</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5943-5954</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the "limits and boundaries" of the central nervous system (CNS) property space is a crit. aspect of modern CNS drug design.  Medicinal chemists are often guided by the physicochem. properties of marketed CNS drugs, which are heavily biased toward "traditional" aminergic targets and commonly described as small lipophilic amines.  This miniperspective describes the statistical anal. of the calcd. physicochem. properties for a diverse set of ligands for mostly "nontraditional" CNS targets and classified as either "brain penetrant" or "peripherally restricted" on the basis of the exptl. mouse brain exposure.  The results suggested that (a) the physicochem. property space conducive to brain exposure is larger than the one defined by the marketed CNS drugs and (b) the most crit. brain exposure determinants are descriptors of the mol. size and hydrogen bond capacity.  These findings led to a modified version of the CNS MPO scoring algorithm, termed CNS MPO.v2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4f3JpTCJ29rVg90H21EOLACvtfcHk0ljFsR6_mImnwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1yqsbk%253D&md5=bff2a3cd68c033d6cae235a7524cc528</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01469%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCns%2520Physicochemical%2520Property%2520Space%2520Shaped%2520by%2520a%2520Diverse%2520Set%2520of%2520Molecules%2520with%2520Experimentally%2520Determined%2520Exposure%2520in%2520the%2520Mouse%2520Brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5943%26epage%3D5954%26doi%3D10.1021%2Facs.jmedchem.6b01469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ros, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasjo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">Effect of Molecular Charge on Intestinal Epithelial Drug Transport: Ph-Dependent Transport of Cationic Drugs</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2FS0014-2999%2899%2900334-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10525056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADyaK1MXntFChtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1999&pages=435-443&author=K.+Palmauthor=K.+Luthmanauthor=J.+Rosauthor=J.+Grasjoauthor=P.+Artursson&title=Effect+of+Molecular+Charge+on+Intestinal+Epithelial+Drug+Transport%3A+Ph-Dependent+Transport+of+Cationic+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs</span></div><div class="casAuthors">Palm, Katrin; Luthman, Kristina; Ros, Jenny; Grasjo, Johan; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">435-443</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The aim of this study was to investigate the effect of ionization on drug transport across the intestinal epithelium to include this effect in structure-absorption relationships.  The pH-dependent permeation of one rapidly (alfentanil) and one slowly (cimetidine) transported basic model drug across Caco-2 cell monolayers was investigated.  Both drugs had pKa values in the physiol. pH range.  The permeability coeffs. (Pc) of the model drugs were obtained at varying apical buffer pHs, thus varying the degree of drug ionization (from 5 to 95%).  The relation between Pc and the fraction of the drug in un-ionized form (fu) was analyzed to delineate the permeability coeffs. of the un-ionized (Pc,u) and ionized (Pc,i) forms of the drugs.  Theor. ests. of the pKa values were also calcd. from ionization energies for each model compd.  For both drugs, a linear increase in Pc was obsd. with increasing fu.  Transport of the un-ionized form was 150- and 30-fold more rapid than transport of the ionized form for alfentanil and cimetidine, resp.  However, when fu < 0.1, the contribution of the ionized form was significant.  Because fu is <0.1 over the entire physiol. pH range for a large no. of drugs, these results will have implications on predictions of in vivo intestinal drug absorption both from in vitro studies in cell cultures and from computed structural properties of drug mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT8-YOYJTmtrVg90H21EOLACvtfcHk0ljFsR6_mImnwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFChtr8%253D&md5=c161433bb0305cb8d195107a16982bbc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2899%2900334-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252899%252900334-9%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%26aufirst%3DK.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DRos%26aufirst%3DJ.%26aulast%3DGrasjo%26aufirst%3DJ.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DEffect%2520of%2520Molecular%2520Charge%2520on%2520Intestinal%2520Epithelial%2520Drug%2520Transport%253A%2520Ph-Dependent%2520Transport%2520of%2520Cationic%2520Drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D291%26spage%3D435%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of Fluorine in Medicinal Chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+Fluorine+in+Medicinal+Chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0ljFsR6_mImnwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520Fluorine%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5822</span>– <span class="NLM_lpage">5880</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5822-5880&author=N.+A.+Meanwell&title=Fluorine+and+Fluorinated+Motifs+in+the+Design+and+Application+of+Bioisosteres+for+Drug+Design&doi=10.1021%2Facs.jmedchem.7b01788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5822-5880</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The electronic properties and relatively small size of fluorine endow it with considerable versatility as a bioisostere and it has found application as a substitute for lone pairs of electrons, the hydrogen atom, and the Me group while also acting as a functional mimetic of the carbonyl, carbinol, andnitrile moieties.  In this context, fluorine substitution can influence the potency, conformation, metab., membrane permeability, and P-gp recognition of a mol. and temper inhibition of the hERG channel by basic amines.  However, as a consequence of the unique properties of fluorine, it features prominently in the design of higher order structural metaphors that are more esoteric in their conception and which reflect a more sophisticated mol. construction that broadens biol. mimesis.  In this Perspective, applications of fluorine in the construction of bioisosteric elements designed to enhance the in vitro and in vivo properties of a mol. are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsoQvY950L3LVg90H21EOLACvtfcHk0lgivXvBpqQLaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D&md5=2d0ce3326c7ff932da8d7d26972ced14</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DFluorine%2520and%2520Fluorinated%2520Motifs%2520in%2520the%2520Design%2520and%2520Application%2520of%2520Bioisosteres%2520for%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5822%26epage%3D5880%26doi%3D10.1021%2Facs.jmedchem.7b01788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerebtzoff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennernaes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senner, F.</span></span> <span> </span><span class="NLM_article-title">Coexistence of Passive and Carrier-Mediated Processes in Drug Transport</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1038/nrd3187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1038%2Fnrd3187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=20671764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=597-614&author=K.+Suganoauthor=M.+Kansyauthor=P.+Arturssonauthor=A.+Avdeefauthor=S.+Bendelsauthor=L.+Diauthor=G.+F.+Eckerauthor=B.+Fallerauthor=H.+Fischerauthor=G.+Gerebtzoffauthor=H.+Lennernaesauthor=F.+Senner&title=Coexistence+of+Passive+and+Carrier-Mediated+Processes+in+Drug+Transport&doi=10.1038%2Fnrd3187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Coexistence of passive and carrier-mediated processes in drug transport</span></div><div class="casAuthors">Sugano, Kiyohiko; Kansy, Manfred; Artursson, Per; Avdeef, Alex; Bendels, Stefanie; Di, Li; Ecker, Gerhard F.; Faller, Bernard; Fischer, Holger; Gerebtzoff, Gregori; Lennernaes, Hans; Senner, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">597-614</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The permeability of biol. membranes is one of the most important determinants of the pharmacokinetic processes of a drug.  Although it is often accepted that many drug substances are transported across biol. membranes by passive transcellular diffusion, a recent hypothesis speculated that carrier-mediated mechanisms might account for the majority of membrane drug transport processes in biol. systems.  Based on evidence of the physicochem. characteristics and of in vitro and in vivo findings for marketed drugs, as well as results from real-life discovery and development projects, the authors present the view that both passive transcellular processes and carrier-mediated processes coexist and contribute to drug transport activities across biol. membranes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppGdYhfY0-BbVg90H21EOLACvtfcHk0lgivXvBpqQLaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCktrk%253D&md5=6e332ad6fa2c2ac8b3b1dc7940e73caf</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrd3187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3187%26sid%3Dliteratum%253Aachs%26aulast%3DSugano%26aufirst%3DK.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DGerebtzoff%26aufirst%3DG.%26aulast%3DLennernaes%26aufirst%3DH.%26aulast%3DSenner%26aufirst%3DF.%26atitle%3DCoexistence%2520of%2520Passive%2520and%2520Carrier-Mediated%2520Processes%2520in%2520Drug%2520Transport%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D597%26epage%3D614%26doi%3D10.1038%2Fnrd3187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bungay, P.</span></span> <span> </span><span class="NLM_article-title">Restricting Cns Penetration of Drugs to Minimise Adverse Events: Role of Drug Transporters</span>. <i>Drug Discovery Today: Technol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e79</span>– <span class="NLM_lpage">e85</span>, <span class="refDoi"> DOI: 10.1016/j.ddtec.2014.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.ddtec.2014.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=25027378" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=e79-e85&author=S.+Bagalauthor=P.+Bungay&title=Restricting+Cns+Penetration+of+Drugs+to+Minimise+Adverse+Events%3A+Role+of+Drug+Transporters&doi=10.1016%2Fj.ddtec.2014.03.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2014.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2014.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%26aulast%3DBungay%26aufirst%3DP.%26atitle%3DRestricting%2520Cns%2520Penetration%2520of%2520Drugs%2520to%2520Minimise%2520Adverse%2520Events%253A%2520Role%2520of%2520Drug%2520Transporters%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2014%26volume%3D12%26spage%3De79%26epage%3De85%26doi%3D10.1016%2Fj.ddtec.2014.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volpe, D. A.</span></span> <span> </span><span class="NLM_article-title">Drug-Permeability and Transporter Assays in Caco-2 and Mdck Cell Lines</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">2063</span>– <span class="NLM_lpage">2077</span>, <span class="refDoi"> DOI: 10.4155/fmc.11.149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.4155%2Ffmc.11.149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=22098353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVyksr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=2063-2077&author=D.+A.+Volpe&title=Drug-Permeability+and+Transporter+Assays+in+Caco-2+and+Mdck+Cell+Lines&doi=10.4155%2Ffmc.11.149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-permeability and transporter assays in Caco-2 and MDCK cell lines</span></div><div class="casAuthors">Volpe, Donna A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2063-2077</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The human colon adenocarcinoma Caco-2 and Madin-Darby canine kidney epithelial cell lines provide in vitro tools to assess a drug''s permeability and transporter interactions during discovery and development.  The cells, when cultured on semiporous filters, form confluent monolayers that model the intestinal epithelial barrier for permeability, transporter and drug-interaction assays.  The applications of these assays in pharmaceutical research include qual. prediction and ranking of absorption, detg. mechanism(s) of permeability, formulation effects on drug permeability, and the potential for transporter-mediated drug-drug interactions.  This review focuses on recent examples of Caco-2 and Madin-Darby canine kidney cells assays for drug permeability including transfected and knock-down cells, miniaturization and automation, and assay combinations to better understand and predict intestinal drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGDgJ3I35HPrVg90H21EOLACvtfcHk0lgivXvBpqQLaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVyksr3K&md5=3d13d17fc375ca5bd7c4cf26b8debb11</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.149%26sid%3Dliteratum%253Aachs%26aulast%3DVolpe%26aufirst%3DD.%2BA.%26atitle%3DDrug-Permeability%2520and%2520Transporter%2520Assays%2520in%2520Caco-2%2520and%2520Mdck%2520Cell%2520Lines%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D2063%26epage%3D2077%26doi%3D10.4155%2Ffmc.11.149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olszewski, K.</span>; <span class="NLM_string-name">Kim, J.-I.</span>; <span class="NLM_string-name">Poyurovsky, M.</span>; <span class="NLM_string-name">Liu, K.</span>; <span class="NLM_string-name">Barsotti, A.</span>; <span class="NLM_string-name">Morris, K.</span></span> <span> </span><span class="NLM_article-title">Preparation of Fused Pyrimidines as Glucose Uptake Inhibitors</span>. <span class="NLM_patent">WO2016210330A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+Olszewski&author=J.-I.+Kim&author=M.+Poyurovsky&author=K.+Liu&author=A.+Barsotti&author=K.+Morris&title=Preparation+of+Fused+Pyrimidines+as+Glucose+Uptake+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOlszewski%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520Fused%2520Pyrimidines%2520as%2520Glucose%2520Uptake%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Casiraghi</span>, <span class="hlFld-ContribAuthor ">Ariel  Bensimon</span>, <span class="hlFld-ContribAuthor ">Giulio  Superti-Furga</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in ligands and chemical probes targeting solute carrier transporters. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2021,</strong> <em>62 </em>, 53-63. <a href="https://doi.org/10.1016/j.cbpa.2021.01.012" title="DOI URL">https://doi.org/10.1016/j.cbpa.2021.01.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2021.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2021.01.012%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DRecent%252Bdevelopments%252Bin%252Bligands%252Band%252Bchemical%252Bprobes%252Btargeting%252Bsolute%252Bcarrier%252Btransporters%26aulast%3DCasiraghi%26aufirst%3DAndrea%26date%3D2021%26volume%3D62%26spage%3D53%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pranavi  Koppula</span>, <span class="hlFld-ContribAuthor ">Kellen  Olszewski</span>, <span class="hlFld-ContribAuthor ">Yilei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lavanya  Kondiparthi</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Liu</span>, <span class="hlFld-ContribAuthor ">Guang  Lei</span>, <span class="hlFld-ContribAuthor ">Molina  Das</span>, <span class="hlFld-ContribAuthor ">Bingliang  Fang</span>, <span class="hlFld-ContribAuthor ">Masha V.  Poyurovsky</span>, <span class="hlFld-ContribAuthor ">Boyi  Gan</span>. </span><span class="cited-content_cbyCitation_article-title">KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition. </span><span class="cited-content_cbyCitation_journal-name">iScience</span><span> <strong>2021,</strong> <em>24 </em>
                                    (6)
                                     , 102649. <a href="https://doi.org/10.1016/j.isci.2021.102649" title="DOI URL">https://doi.org/10.1016/j.isci.2021.102649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.isci.2021.102649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.isci.2021.102649%26sid%3Dliteratum%253Aachs%26jtitle%3DiScience%26atitle%3DKEAP1%252Bdeficiency%252Bdrives%252Bglucose%252Bdependency%252Band%252Bsensitizes%252Blung%252Bcancer%252Bcells%252Band%252Btumors%252Bto%252BGLUT%252Binhibition%26aulast%3DKoppula%26aufirst%3DPranavi%26date%3D2021%26volume%3D24%26issue%3D6%26spage%3D102649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias R.  Bauer</span>, <span class="hlFld-ContribAuthor ">Paolo  Di Fruscia</span>, <span class="hlFld-ContribAuthor ">Simon C. C.  Lucas</span>, <span class="hlFld-ContribAuthor ">Iacovos N.  Michaelides</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Nelson</span>, <span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Benjamin C.  Whitehurst</span>. </span><span class="cited-content_cbyCitation_article-title">Put a ring on it: application of small aliphatic rings in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 448-471. <a href="https://doi.org/10.1039/D0MD00370K" title="DOI URL">https://doi.org/10.1039/D0MD00370K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00370K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00370K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPut%252Ba%252Bring%252Bon%252Bit%25253A%252Bapplication%252Bof%252Bsmall%252Baliphatic%252Brings%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DBauer%26aufirst%3DMatthias%2BR.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D4%26spage%3D448%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana C. Contreras  Healey</span>, <span class="hlFld-ContribAuthor ">Jacqueline Y.  Cephus</span>, <span class="hlFld-ContribAuthor ">Sierra M.  Barone</span>, <span class="hlFld-ContribAuthor ">Nowrin U.  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Debolanle O.  Dahunsi</span>, <span class="hlFld-ContribAuthor ">Matthew Z.  Madden</span>, <span class="hlFld-ContribAuthor ">Xiang  Ye</span>, <span class="hlFld-ContribAuthor ">Xuemei  Yu</span>, <span class="hlFld-ContribAuthor ">Kellen  Olszewski</span>, <span class="hlFld-ContribAuthor ">Kirsten  Young</span>, <span class="hlFld-ContribAuthor ">Valerie A.  Gerriets</span>, <span class="hlFld-ContribAuthor ">Peter J.  Siska</span>, <span class="hlFld-ContribAuthor ">Ryszard  Dworski</span>, <span class="hlFld-ContribAuthor ">Jonathan  Hemler</span>, <span class="hlFld-ContribAuthor ">Jason W.  Locasale</span>, <span class="hlFld-ContribAuthor ">Masha V.  Poyurovsky</span>, <span class="hlFld-ContribAuthor ">R. Stokes  Peebles</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Irish</span>, <span class="hlFld-ContribAuthor ">Dawn C.  Newcomb</span>, <span class="hlFld-ContribAuthor ">Jeffrey C.  Rathmell</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Immunology</span><span> <strong>2021,</strong> <em>206 </em>
                                    (6)
                                     , 1127-1139. <a href="https://doi.org/10.4049/jimmunol.2001029" title="DOI URL">https://doi.org/10.4049/jimmunol.2001029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4049/jimmunol.2001029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4049%2Fjimmunol.2001029%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Immunology%26atitle%3DTargeting%252BIn%252BVivo%252BMetabolic%252BVulnerabilities%252Bof%252BTh2%252Band%252BTh17%252BCells%252BReduces%252BAirway%252BInflammation%26aulast%3DHealey%26aufirst%3DDiana%2BC.%2BContreras%26date%3D2021%26date%3D2021%26volume%3D206%26issue%3D6%26spage%3D1127%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liu Zeng  Chen</span>, <span class="hlFld-ContribAuthor ">Hai Yang  Shu</span>, <span class="hlFld-ContribAuthor ">Jing  Wu</span>, <span class="hlFld-ContribAuthor ">Yun Long  Yu</span>, <span class="hlFld-ContribAuthor ">Duo  Ma</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Ming Ming  Liu</span>, <span class="hlFld-ContribAuthor ">Xin Hua  Liu</span>, <span class="hlFld-ContribAuthor ">Jing Bo  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113174. <a href="https://doi.org/10.1016/j.ejmech.2021.113174" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113174%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252Bnovel%252Bpyrimidine%252Band%252Bpyrazolo%25252Fthieno-fused%252Bpyrimidine%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Bactive%252Binducible%252Bnitric%252Boxide%252Bsynthase%252Bdimerization%252Binhibitor%252Bwith%252Befficacy%252Bfor%252Barthritis%26aulast%3DChen%26aufirst%3DLiu%2BZeng%26date%3D2021%26volume%3D213%26spage%3D113174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0001.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Known GLUT Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Screening hit and optimization strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>8</b> is competitive with glucose. GLUT1 IC<sub>50</sub> values for cytochalasin B and compound <b>8</b> at different glucose concentrations. The graph shows the calculated IC<sub>50</sub> values ± the 95% confidence interval.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of brain and plasma exposure ratio (B/P) at 1 h following oral administration at 100 mg/kg in CD-1 mice versus Caco-2 efflux ratio.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Boronic Esters and THP Protected 4-Aminophenylpyrazole Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-chloroacetyl chloride, Na<sub>2</sub>CO<sub>3</sub>, water, rt, 1 h; (b) 3-bromophenol, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h; (c) 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi-1,3,2-dioxaborolane, Pd(dppf)Cl<sub>2</sub>, AcOK, dioxane, 85 °C, 16 h; (d) 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h; (e) DHP, <i>p</i>-TsOH, DCM, 20 °C, 4 h; (f) 4-bromoaniline, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/water, 100 °C, 16 h.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>8</b>, <b>9a</b>–<b>f</b>, and <b>9h</b>–<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-(1<i>H</i>-pyrazol-4-yl) aniline, <i>i</i>Pr<sub>2</sub>NEt, DMF, 90–110 °C, 3 h; (b) <b>23</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 9:1 dioxane/water, Na<sub>2</sub>CO<sub>3</sub>, microwave, 180 °C, 2 h; (c) Boc<sub>2</sub>O, DMAP, TEA, DCM, 50 °C, 1.5 h; (d) <b>26</b>, <i>i</i>Pr<sub>2</sub>NEt, <i>n</i>-BuOH, 90−110 °C, 16 h; (e) Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/water, 100 °C, 16 h; (f) HCl in dioxane or TFA/DCM, rt, 2 h.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>9g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3-methoxybenzoyl chloride, TEA, DCM, rt, 16 h; (b) NH<sub>3</sub>, MeOH, rt, 16 h; (c) NaOH, <i>i</i>PrOH, 90 °C, 3 h; (d) POCl<sub>3</sub>, <i>i</i>Pr<sub>2</sub>NEt, 80 °C, 14 h; (e) 4-bromoaniline, THF, 60 °C, 16 h; (f) BBr<sub>3</sub>, 35 °C, 16 h; (g) methyl 2-bromoacetate, K<sub>2</sub>CO<sub>3</sub>, DMF, 40 °C, 1 h; (h) <b>25</b>, Pd(dppf)Cl<sub>2</sub>, dioxane/water, 100 °C, 16 h; (i) LiOH, THF/water, 15 °C, 16 h; (j) HCl in dioxane, 15 °C, 1 h.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthesis of Tetrahydropyridopyrimidine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>26</b>, <i>i</i>Pr<sub>2</sub>NEt, <i>n</i>-BuOH, 100 °C, 16 h; (b) <b>23</b>, Pd(dppf)Cl<sub>2</sub>, dioxane/water, 100 °C, 16 h; (c) HCl/dioxane/water, rt, 15 h; (d) aldehyde, NaBH<sub>3</sub>CN, HOAc, MeOH, rt, 16 h; (e) R’Br, DMF, rt, 16 h.</p></p></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Second General Synthesis of Tetrahydropyridopyrimidine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ethyl acrylate, EtOH, rt, 72 h; (b) LiHMDS, THF, rt, 2 h; (c) urea, NaOMe, MeOH, 80 °C, 16 h; (d) POCl<sub>3</sub>, <i>i</i>Pr<sub>2</sub>NEt, 90 °C, 16 h; (e) <b>26</b>, <i>i</i>Pr<sub>2</sub>NEt, <i>n</i>-BuOH, 100 °C, 16 h; (f) <b>23</b>, Pd(dppf)Cl<sub>2</sub>, dioxane/water, 100 °C, 16 h; (g) HCl/dioxane/water, rt, 15 h.</p></p></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/medium/jm9b02153_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>15b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02153/20200520/images/large/jm9b02153_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02153&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-chloroacetyl chloride, TEA, DCM, −5 to 20 °C, 2 h, 72%; (b) 3-cyanophenol, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 10 to 80 °C, 24 h, 64%; (c) (i) AcCl, EtOH, 0 to 20 °C, 12 h; (ii) NH<sub>3</sub>, EtOH, 20 to 25 °C, 11 h; (d) ethyl acrylate, EtOH, 20 °C, 72 h, 72%; (e) LiHMDS, THF, 20 °C, 2 h, 98%; (f) 58, NaOMe, 80 °C, 9 h, 60%; (g) SOCl<sub>2</sub>, DMF, 0 to 20 °C, 9.5 h, 52%; (h) 4-(1<i>H</i> pyrazol-4-yl) aniline, NMP, 145 °C, 5 h, 51%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warburg, O.</span></span> <span> </span><span class="NLM_article-title">ÜBer Den Stoffwechsel Der Carcinomzelle</span>. <i>Naturwissenschaften</i> <span class="NLM_year" style="font-weight: bold;">1924</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1131</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1007/BF01504608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1007%2FBF01504608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADyaB2MXosFSk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1924&pages=1131-1137&author=O.+Warburg&title=%C3%9CBer+Den+Stoffwechsel+Der+Carcinomzelle&doi=10.1007%2FBF01504608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of carcinoma cells</span></div><div class="casAuthors">Warburg, O.</div><div class="citationInfo"><span class="NLM_cas:title">Naturwissenschaften</span>
        (<span class="NLM_cas:date">1924</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1131-7</span>CODEN:
                <span class="NLM_cas:coden">NATWAY</span>;
        ISSN:<span class="NLM_cas:issn">0028-1042</span>.
    </div><div class="casAbstract">Review.  Cf. C. A. 18, 2036.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVz66JIWvuLrVg90H21EOLACvtfcHk0lgnvGU_gbPnxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaB2MXosFSk&md5=337ec5943b458b1ea0c68bd27c1ac109</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2FBF01504608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01504608%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3D%25C3%259CBer%2520Den%2520Stoffwechsel%2520Der%2520Carcinomzelle%26jtitle%3DNaturwissenschaften%26date%3D1924%26volume%3D12%26spage%3D1131%26epage%3D1137%26doi%3D10.1007%2FBF01504608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warburg, O.</span></span> <span> </span><span class="NLM_article-title">On the Origin of Cancer Cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1126/science.123.3191.309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1126%2Fscience.123.3191.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=13298683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1956&pages=309-314&author=O.+Warburg&title=On+the+Origin+of+Cancer+Cells&doi=10.1126%2Fscience.123.3191.309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">On the origin of cancer cells</span></div><div class="casAuthors">WARBURG O</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3191</span>),
    <span class="NLM_cas:pages">309-14</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsp1coYpQW669lAbTj9rGfW6udTcc2ebs5cvNetxlq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D&md5=860d5ce9456831968fcc897b37d6d9c2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.123.3191.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.123.3191.309%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DOn%2520the%2520Origin%2520of%2520Cancer%2520Cells%26jtitle%3DScience%26date%3D1956%26volume%3D123%26spage%3D309%26epage%3D314%26doi%3D10.1126%2Fscience.123.3191.309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greulich, K. O.</span></span> <span> </span><span class="NLM_article-title">Genes of Glycolysis Are Ubiquitously Overexpressed in 24 Cancer Classes</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1014</span>– <span class="NLM_lpage">1020</span>, <span class="refDoi"> DOI: 10.1016/j.ygeno.2004.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.ygeno.2004.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=15533718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlykt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=1014-1020&author=B.+Altenbergauthor=K.+O.+Greulich&title=Genes+of+Glycolysis+Are+Ubiquitously+Overexpressed+in+24+Cancer+Classes&doi=10.1016%2Fj.ygeno.2004.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes</span></div><div class="casAuthors">Altenberg, B.; Greulich, K. O.</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1014-1020</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Using NIH's public database dbEST for expression of genes and ESTs, genes of the glycolysis pathway have been found to be overexpressed in a set of 24 cancers representing more than 70% of human cancer cases worldwide.  Genes can be classified as those that are almost ubiquitously overexpressed, particularly glyceraldehyde-3-phosphate dehydrogenase, enolase 1, and also pyruvate kinase, and those that are overexpressed in less than 50% of the investigated cancers.  Cancers can be classified as those with overexpression of the majority of the glycolysis genes, particularly lymph node, prostate, and brain cancer, in which essentially all glycolysis genes are overexpressed, and those with only sporadic overexpression, particularly cancers of the cartilage or bone marrow.  This classification may be useful when cancer therapies aimed at the Warburg effect are designed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXdbCc2JC3I7Vg90H21EOLACvtfcHk0lgnvGU_gbPnxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlykt78%253D&md5=6b9515a2e3a4781acc4960f92f31ad4f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ygeno.2004.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygeno.2004.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DAltenberg%26aufirst%3DB.%26aulast%3DGreulich%26aufirst%3DK.%2BO.%26atitle%3DGenes%2520of%2520Glycolysis%2520Are%2520Ubiquitously%2520Overexpressed%2520in%252024%2520Cancer%2520Classes%26jtitle%3DGenomics%26date%3D2004%26volume%3D84%26spage%3D1014%26epage%3D1020%26doi%3D10.1016%2Fj.ygeno.2004.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Upadhyay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandpal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivekanandan, P.</span></span> <span> </span><span class="NLM_article-title">The Warburg Effect: Insights from the Past Decade</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2012.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.pharmthera.2012.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=23159371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKqt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2013&pages=318-330&author=M.+Upadhyayauthor=J.+Samalauthor=M.+Kandpalauthor=O.+V.+Singhauthor=P.+Vivekanandan&title=The+Warburg+Effect%3A+Insights+from+the+Past+Decade&doi=10.1016%2Fj.pharmthera.2012.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Warburg effect: Insights from the past decade</span></div><div class="casAuthors">Upadhyay, Mohita; Samal, Jasmine; Kandpal, Manish; Singh, Om Vir; Vivekanandan, Perumal</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">318-330</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Several decades ago, Otto Warburg discovered that cancer cells produce energy predominantly by glycolysis; a phenomenon now termed "Warburg effect".  Warburg linked mitochondrial respiratory defects in cancer cells to aerobic glycolysis; this theory of his gradually lost its importance with the lack of conclusive evidence confirming the presence of mitochondrial defects in cancer cells.  Scientists began to believe that this altered mechanism of energy prodn. in cancer cells was more of an effect than the cause.  More than 50 years later, the clin. use of FDG-PET imaging in the diagnosis and monitoring of cancers rekindled the interest of the scientific community in Warburg's hypothesis.  In the last ten years considerable progress in the field has advanced our understanding of the Warburg effect.  However, it still remains unclear if the Warburg effect plays a causal role in cancers or it is an epiphenomenon in tumorigenesis.  In this review we aim to discuss the mol. mechanisms assocd. with the Warburg effect with emphasis on recent advances in the field including the role of epigenetic changes, miRNAs and post-translational modification of proteins.  In addn., we also discuss emerging therapeutic strategies that target the dependence of cancer cells on altered energy processing through aerobic glycolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKDpFSBEDbr7Vg90H21EOLACvtfcHk0ljP69AJTv7pxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKqt7nP&md5=f0f2c0c0f81cb19b9a9ea75feec4b5f6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DUpadhyay%26aufirst%3DM.%26aulast%3DSamal%26aufirst%3DJ.%26aulast%3DKandpal%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DO.%2BV.%26aulast%3DVivekanandan%26aufirst%3DP.%26atitle%3DThe%2520Warburg%2520Effect%253A%2520Insights%2520from%2520the%2520Past%2520Decade%26jtitle%3DPharmacol.%2520Ther.%26date%3D2013%26volume%3D137%26spage%3D318%26epage%3D330%26doi%3D10.1016%2Fj.pharmthera.2012.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzivassiliou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2007.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.cmet.2007.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=18177721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFSnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=11-20&author=R.+J.+DeBerardinisauthor=J.+J.+Lumauthor=G.+Hatzivassiliouauthor=C.+B.+Thompson&title=The+Biology+of+Cancer%3A+Metabolic+Reprogramming+Fuels+Cell+Growth+and+Proliferation&doi=10.1016%2Fj.cmet.2007.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of cancer: metabolic reprogramming fuels cell growth and proliferation</span></div><div class="casAuthors">DeBerardinis, Ralph J.; Lum, Julian J.; Hatzivassiliou, Georgia; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-20</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Cell proliferation requires nutrients, energy and biosynthetic activity to duplicate all macromol. components during each passage through the cell cycle.  It is therefore not surprising that metabolic activities in proliferating cells are fundamentally different from those of nonproliferating cells.  This review examines the idea that several core fluxes, including aerobic glycolysis, de novo lipid biosynthesis, and glutamine-dependent anaplerosis, form a stereotyped platform supporting proliferation of diverse cell types.  We also consider regulation of theses fluxes by cellular mediators of signaling and gene expression, including PI3K/Akt/mTOR system, HIF-1, and Myc, during physiol. cell proliferation and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6L6_Q7sR9HLVg90H21EOLACvtfcHk0ljP69AJTv7pxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFSnsg%253D%253D&md5=59f193a636a840cde3044da9e08f62e7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DLum%26aufirst%3DJ.%2BJ.%26aulast%3DHatzivassiliou%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520Biology%2520of%2520Cancer%253A%2520Metabolic%2520Reprogramming%2520Fuels%2520Cell%2520Growth%2520and%2520Proliferation%26jtitle%3DCell%2520Metab.%26date%3D2008%26volume%3D7%26spage%3D11%26epage%3D20%26doi%3D10.1016%2Fj.cmet.2007.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vander
Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">1029</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.1126/science.1160809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1126%2Fscience.1160809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=19460998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1029-1033&author=M.+G.+Vander%0AHeidenauthor=L.+C.+Cantleyauthor=C.+B.+Thompson&title=Understanding+the+Warburg+Effect%3A+The+Metabolic+Requirements+of+Cell+Proliferation&doi=10.1126%2Fscience.1160809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span></div><div class="casAuthors">Vander Heiden, Matthew G.; Cantley, Lewis C.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5930</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect".  Aerobic glycolysis is an inefficient way to generate ATP, however, and the advantage it confers to cancer cells has been unclear.  Here we propose that the metab. of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell.  Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-assocd. mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP prodn.  A better understanding of the mechanistic links between cellular metab. and growth control may ultimately lead to better treatments for human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvLHGQ9TX77Vg90H21EOLACvtfcHk0ljP69AJTv7pxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D&md5=f927402a43cdca471c3f4874dcbeb943</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1160809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1160809%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DUnderstanding%2520the%2520Warburg%2520Effect%253A%2520The%2520Metabolic%2520Requirements%2520of%2520Cell%2520Proliferation%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1029%26epage%3D1033%26doi%3D10.1126%2Fscience.1160809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poffenberger, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. G.</span></span> <span> </span><span class="NLM_article-title">Fueling Immunity: Insights into Metabolism and Lymphocyte Function</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">1242454</span>, <span class="refDoi"> DOI: 10.1126/science.1242454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1126%2Fscience.1242454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=24115444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FmvVSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=1242454&author=E.+L.+Pearceauthor=M.+C.+Poffenbergerauthor=C.-H.+Changauthor=R.+G.+Jones&title=Fueling+Immunity%3A+Insights+into+Metabolism+and+Lymphocyte+Function&doi=10.1126%2Fscience.1242454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Fueling immunity: insights into metabolism and lymphocyte function</span></div><div class="casAuthors">Pearce Erika L; Poffenberger Maya C; Chang Chih-Hao; Jones Russell G</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">6155</span>),
    <span class="NLM_cas:pages">1242454</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lymphocytes face major metabolic challenges upon activation.  They must meet the bioenergetic and biosynthetic demands of increased cell proliferation and also adapt to changing environmental conditions, in which nutrients and oxygen may be limiting.  An emerging theme in immunology is that metabolic reprogramming and lymphocyte activation are intricately linked.  However, why T cells adopt specific metabolic programs and the impact that these programs have on T cell function and, ultimately, immunological outcome remain unclear.  Research on tumor cell metabolism has provided valuable insight into metabolic pathways important for cell proliferation and the influence of metabolites themselves on signal transduction and epigenetic programming.  In this Review, we highlight emerging concepts regarding metabolic reprogramming in proliferating cells and discuss their potential impact on T cell fate and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3JRLcP1mfX8uCWE5mhx1RfW6udTcc2eZyrFsIlrKv4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FmvVSitw%253D%253D&md5=65e6e1a96424eb67615c030dba3f86da</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1242454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1242454%26sid%3Dliteratum%253Aachs%26aulast%3DPearce%26aufirst%3DE.%2BL.%26aulast%3DPoffenberger%26aufirst%3DM.%2BC.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DJones%26aufirst%3DR.%2BG.%26atitle%3DFueling%2520Immunity%253A%2520Insights%2520into%2520Metabolism%2520and%2520Lymphocyte%2520Function%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D1242454%26doi%3D10.1126%2Fscience.1242454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">Foundations of Immunometabolism and Implications for Metabolic Health and Disease</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">406</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2017.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.immuni.2017.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=28930657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFemtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=406-420&author=G.+S.+Hotamisligil&title=Foundations+of+Immunometabolism+and+Implications+for+Metabolic+Health+and+Disease&doi=10.1016%2Fj.immuni.2017.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Foundations of Immunometabolism and Implications for Metabolic Health and Disease</span></div><div class="casAuthors">Hotamisligil, Gokhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">406-420</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Highly ordered interactions between immune and metabolic responses are evolutionarily conserved and paramount for tissue and organismal health.  Disruption of these interactions underlies the emergence of many pathologies, particularly chronic non-communicable diseases such as obesity and diabetes.  Here, we examine decades of research identifying the complex immunometabolic signaling networks and the cellular and mol. events that occur in the setting of altered nutrient and energy exposures and offer a historical perspective.  Furthermore, we describe recent advances such as the discovery that a broad complement of immune cells play a role in immunometabolism and the emerging evidence that nutrients and metabolites modulate inflammatory pathways.  Lastly, we discuss how this work may eventually lead to tangible therapeutic advancements to promote health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDXcFJUOfD0LVg90H21EOLACvtfcHk0lgQxw2Nizz0TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFemtrbP&md5=918f9b1169ae07766735a1e883dc0b0e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2017.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2017.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DFoundations%2520of%2520Immunometabolism%2520and%2520Implications%2520for%2520Metabolic%2520Health%2520and%2520Disease%26jtitle%3DImmunity%26date%3D2017%26volume%3D47%26spage%3D406%26epage%3D420%26doi%3D10.1016%2Fj.immuni.2017.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balderson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christian, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, S. M.</span></span> <span> </span><span class="NLM_article-title">Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2015.00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.3389%2Ffimmu.2015.00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=25657648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eiu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1-6&author=C.+S.+Palmerauthor=M.+Ostrowskiauthor=B.+Baldersonauthor=N.+Christianauthor=S.+M.+Crowe&title=Glucose+Metabolism+Regulates+T+Cell+Activation%2C+Differentiation%2C+and+Functions&doi=10.3389%2Ffimmu.2015.00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose metabolism regulates T cell activation, differentiation, and functions</span></div><div class="casAuthors">Palmer, Clovis S.; Ostrowski, Matias; Balderson, Brad; Christian, Nicole; Crowe, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The adaptive immune system is equipped to eliminate both tumors and pathogenic microorganisms.  It requires a series of complex and coordinated signals to drive the activation, proliferation, and differentiation of appropriate T cell subsets.  It is now established that changes in cellular activation are coupled to profound changes in cellular metab.  In addn., emerging evidence now suggest that specific metabolic alterations assocd. with distinct T cell subsets may be ancillary to their differentiation and influential in their immune functions.  The "Warburg effect" originally used to describe a phenomenon in which most cancer cells relied on aerobic glycolysis for their growth is a key process that sustainT cell activation and differentiation.  Here,we review how different aspects of metab. inT cells influence their functions, focusing on the emerging role of key regulators of glucose metab. such as HIF-1a.  A thorough understanding of the role of metab. in T cell function could provide insights into mechanisms involved in inflammatory-mediated conditions, with the potential for developing novel therapeutic approaches to treat these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Gl967JQTb7Vg90H21EOLACvtfcHk0lgQxw2Nizz0TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eiu77N&md5=39626de1cc1a43b8a261831f0b14deba</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00001%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DC.%2BS.%26aulast%3DOstrowski%26aufirst%3DM.%26aulast%3DBalderson%26aufirst%3DB.%26aulast%3DChristian%26aufirst%3DN.%26aulast%3DCrowe%26aufirst%3DS.%2BM.%26atitle%3DGlucose%2520Metabolism%2520Regulates%2520T%2520Cell%2520Activation%252C%2520Differentiation%252C%2520and%2520Functions%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D1%26epage%3D6%26doi%3D10.3389%2Ffimmu.2015.00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerriets, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deoliveira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathmell, J. C.</span></span> <span> </span><span class="NLM_article-title">The Glucose Transporter Glut1 Is Selectively Essential for Cd4 T Cell Activation and Effector Function</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2014.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.cmet.2014.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=24930970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFWmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=61-72&author=A.+N.+Macintyreauthor=V.+A.+Gerrietsauthor=A.+G.+Nicholsauthor=R.+D.+Michalekauthor=M.+C.+Rudolphauthor=D.+Deoliveiraauthor=S.+M.+Andersonauthor=E.+D.+Abelauthor=B.+J.+Chenauthor=L.+P.+Haleauthor=J.+C.+Rathmell&title=The+Glucose+Transporter+Glut1+Is+Selectively+Essential+for+Cd4+T+Cell+Activation+and+Effector+Function&doi=10.1016%2Fj.cmet.2014.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function</span></div><div class="casAuthors">Macintyre, Andrew N.; Gerriets, Valerie A.; Nichols, Amanda G.; Michalek, Ryan D.; Rudolph, Michael C.; Deoliveira, Divino; Anderson, Steven M.; Abel, E. Dale; Chen, Benny J.; Hale, Laura P.; Rathmell, Jeffrey C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-72</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">CD4 T cell activation leads to proliferation and differentiation into effector (Teff) or regulatory (Treg) cells that mediate or control immunity.  While each subset prefers distinct glycolytic or oxidative metabolic programs in vitro, requirements and mechanisms that control T cell glucose uptake and metab. in vivo are uncertain.  Despite expression of multiple glucose transporters, Glut1 deficiency selectively impaired metab. and function of thymocytes and Teff.  Resting T cells were normal until activated, when Glut1 deficiency prevented increased glucose uptake and glycolysis, growth, proliferation, and decreased Teff survival and differentiation.  Importantly, Glut1 deficiency decreased Teff expansion and the ability to induce inflammatory disease in vivo.  Treg cells, in contrast, were enriched in vivo and appeared functionally unaffected and able to suppress Teff, irresp. of Glut1 expression.  These data show a selective in vivo requirement for Glut1 in metabolic reprogramming of CD4 T cell activation and Teff expansion and survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp17xtn2ca7PbVg90H21EOLACvtfcHk0lgQxw2Nizz0TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFWmsbw%253D&md5=5be0f77c6e21a18df8d94d80bafa8fe6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2014.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2014.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DMacintyre%26aufirst%3DA.%2BN.%26aulast%3DGerriets%26aufirst%3DV.%2BA.%26aulast%3DNichols%26aufirst%3DA.%2BG.%26aulast%3DMichalek%26aufirst%3DR.%2BD.%26aulast%3DRudolph%26aufirst%3DM.%2BC.%26aulast%3DDeoliveira%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DS.%2BM.%26aulast%3DAbel%26aufirst%3DE.%2BD.%26aulast%3DChen%26aufirst%3DB.%2BJ.%26aulast%3DHale%26aufirst%3DL.%2BP.%26aulast%3DRathmell%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520Glucose%2520Transporter%2520Glut1%2520Is%2520Selectively%2520Essential%2520for%2520Cd4%2520T%2520Cell%2520Activation%2520and%2520Effector%2520Function%26jtitle%3DCell%2520Metab.%26date%3D2014%26volume%3D20%26spage%3D61%26epage%3D72%26doi%3D10.1016%2Fj.cmet.2014.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Navale, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paranjape, A. N.</span></span> <span> </span><span class="NLM_article-title">Glucose Transporters: Physiological and Pathological Roles</span>. <i>Biophys. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1007/s12551-015-0186-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1007%2Fs12551-015-0186-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=28510148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtF2isb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=5-9&author=A.+M.+Navaleauthor=A.+N.+Paranjape&title=Glucose+Transporters%3A+Physiological+and+Pathological+Roles&doi=10.1007%2Fs12551-015-0186-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose transporters: physiological and pathological roles</span></div><div class="casAuthors">Navale, Archana M.; Paranjape, Archana N.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-9</span>CODEN:
                <span class="NLM_cas:coden">BRIECG</span>;
        ISSN:<span class="NLM_cas:issn">1867-2450</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Glucose is a primary energy source for most cells and an important substrate for many biochem. reactions.  As glucose is a need of each and every cell of the body, so are the glucose transporters.  Consequently, all cells express these important proteins on their surface.  In recent years developments in genetics have shed new light on the types and physiol. of various glucose transporters, of which there are two main types-sodium-glucose linked transporters (SGLTs) and facilitated diffusion glucose transporters (GLUT)-which can be divided into many more subclasses.  Transporters differ in terms of their substrate specificity, distribution and regulatory mechanisms.  Glucose transporters have also received much attention as therapeutic targets for various diseases.  In this review, we attempt to present a simplified view of this complex topic which may be of interest to researchers involved in biochem. and pharmacol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZHTI_CfH8WbVg90H21EOLACvtfcHk0lh2NqeQxxwaWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtF2isb0%253D&md5=e328a4728ff6bca082764e1d06372066</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs12551-015-0186-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12551-015-0186-2%26sid%3Dliteratum%253Aachs%26aulast%3DNavale%26aufirst%3DA.%2BM.%26aulast%3DParanjape%26aufirst%3DA.%2BN.%26atitle%3DGlucose%2520Transporters%253A%2520Physiological%2520and%2520Pathological%2520Roles%26jtitle%3DBiophys.%2520Rev.%26date%3D2016%26volume%3D8%26spage%3D5%26epage%3D9%26doi%3D10.1007%2Fs12551-015-0186-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, N.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Human Glucose Transporter Glut1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>510</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1038/nature13306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1038%2Fnature13306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=24847886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFGitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2014&pages=121-125&author=D.+Dengauthor=C.+Xuauthor=P.+Sunauthor=J.+Wuauthor=C.+Yanauthor=M.+Huauthor=N.+Yan&title=Crystal+Structure+of+the+Human+Glucose+Transporter+Glut1&doi=10.1038%2Fnature13306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human glucose transporter GLUT1</span></div><div class="casAuthors">Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">7503</span>),
    <span class="NLM_cas:pages">121-125</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The glucose transporter GLUT1 catalyzes facilitative diffusion of glucose into erythrocytes and is responsible for glucose supply to the brain and other organs.  Dysfunctional mutations may lead to GLUT1 deficiency syndrome, whereas overexpression of GLUT1 is a prognostic indicator for cancer.  Despite decades of investigation, the structure of GLUT1 remains unknown.  Here we report the crystal structure of human GLUT1 at 3.2 Å resoln.  The full-length protein, which has a canonical major facilitator superfamily fold, is captured in an inward-open conformation.  This structure allows accurate mapping and potential mechanistic interpretation of disease-assocd. mutations in GLUT1.  Structure-based anal. of these mutations provides an insight into the alternating access mechanism of GLUT1 and other members of the sugar porter subfamily.  Structural comparison of the uniporter GLUT1 with its bacterial homolog XylE, a proton-coupled xylose symporter, allows examn. of the transport mechanisms of both passive facilitators and active transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeBmEBIMIurVg90H21EOLACvtfcHk0lh2NqeQxxwaWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFGitL8%253D&md5=b9426a934cddf7347fdc6c9073aa8636</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature13306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13306%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DN.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Human%2520Glucose%2520Transporter%2520Glut1%26jtitle%3DNature%26date%3D2014%26volume%3D510%26spage%3D121%26epage%3D125%26doi%3D10.1038%2Fnature13306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, N.</span></span> <span> </span><span class="NLM_article-title">Molecular Basis of Ligand Recognition and Transport by Glucose Transporters</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>526</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1038/nature14655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1038%2Fnature14655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=26176916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyltLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2015&pages=391-396&author=D.+Dengauthor=P.+Sunauthor=C.+Yanauthor=M.+Keauthor=X.+Jiangauthor=L.+Xiongauthor=W.+Renauthor=K.+Hirataauthor=M.+Yamamotoauthor=S.+Fanauthor=N.+Yan&title=Molecular+Basis+of+Ligand+Recognition+and+Transport+by+Glucose+Transporters&doi=10.1038%2Fnature14655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of ligand recognition and transport by glucose transporters</span></div><div class="casAuthors">Deng, Dong; Sun, Pengcheng; Yan, Chuangye; Ke, Meng; Jiang, Xin; Xiong, Lei; Ren, Wenlin; Hirata, Kunio; Yamamoto, Masaki; Fan, Shilong; Yan, Nieng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue">7573</span>),
    <span class="NLM_cas:pages">391-396</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The major facilitator superfamily glucose transporters, exemplified by human GLUT1-4, have been central to the study of solute transport.  Using lipidic cubic phase crystn. and microfocus X-ray diffraction, we detd. the structure of human GLUT3 in complex with D-glucose at 1.5 Å resoln. in an outward-occluded conformation.  The high-resoln. structure allows discrimination of both α- and β-anomers of D-glucose.  Two addnl. structures of GLUT3 bound to the exofacial inhibitor maltose were obtained at 2.6 Å in the outward-open and 2.4 Å in the outward-occluded states.  In all three structures, the ligands are predominantly coordinated by polar residues from the carboxy terminal domain.  Conformational transition from outward-open to outward-occluded entails a prominent local rearrangement of the extracellular part of transmembrane segment TM7.  Comparison of the outward-facing GLUT3 structures with the inward-open GLUT1 provides insights into the alternating access cycle for GLUTs, whereby the C-terminal domain provides the primary substrate-binding site and the amino-terminal domain undergoes rigid-body rotation with respect to the C-terminal domain.  Our studies provide an important framework for the mechanistic and kinetic understanding of GLUTs and shed light on structure-guided ligand design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3p8Y2gV917LVg90H21EOLACvtfcHk0lh2NqeQxxwaWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyltLzO&md5=77ab999156155b38156394961682804d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature14655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14655%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DKe%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DXiong%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DW.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DN.%26atitle%3DMolecular%2520Basis%2520of%2520Ligand%2520Recognition%2520and%2520Transport%2520by%2520Glucose%2520Transporters%26jtitle%3DNature%26date%3D2015%26volume%3D526%26spage%3D391%26epage%3D396%26doi%3D10.1038%2Fnature14655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adekola, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugam, M.</span></span> <span> </span><span class="NLM_article-title">Glucose Transporters in Cancer Metabolism</span>. <i>Curr. Opin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1097/CCO.0b013e328356da72</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1097%2FCCO.0b013e328356da72" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=22913968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFCltr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=650-654&author=K.+Adekolaauthor=S.+T.+Rosenauthor=M.+Shanmugam&title=Glucose+Transporters+in+Cancer+Metabolism&doi=10.1097%2FCCO.0b013e328356da72"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose transporters in cancer metabolism</span></div><div class="casAuthors">Adekola, Kehinde; Rosen, Steven T.; Shanmugam, Mala</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">650-654</span>CODEN:
                <span class="NLM_cas:coden">CUOOE8</span>;
        ISSN:<span class="NLM_cas:issn">1040-8746</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Transformed cells exhibit a high rate of glucose consumption beyond that necessary for ATP synthesis.  Glucose aids in the generation of biomass and regulates cellular signaling crit. for oncogenic progression.  A key rate-limiting step in glucose utilization is the transport of glucose across the plasma membrane.  This review will highlight key glucose transporters (GLUTs) and current therapies targeting this class of proteins.  Recent findings: GLUTs, enabling the facilitative entry of glucose into a cell, are increasingly found to be deregulated in cancer.  Although cancer-specific expression patterns for GLUTs are being identified, comprehensive analyses substantiating a role for individual GLUTs are still required.  Studies defining GLUTs as being rate-limiting in specific tumor contexts, the identification of GLUT1 inhibitors via synthetic lethality screens, novel engagement of the insulin-responsive GLUT4 in myeloma and identification of GLUT9 being a urate transporter, are key advances underscoring the need for continued investigation of this large and enigmatic class of proteins.  Summary: Tumor cells exhibit elevated levels of glucose uptake, a phenomenon that has been capitalized upon for the prognostic and diagnostic imaging of a wide range of cancers using radio-labeled glucose analogs.  We have, however, not yet been able to target glucose entry in a tumor cell-specific manner for therapy.  GLUTs have been identified as rate-limiting in specific tumor contexts.  The identification and targeting of tumor-specific GLUTs provide a promising approach to block glucose-regulated metab. and signaling more comprehensively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGmT18-me7D7Vg90H21EOLACvtfcHk0lgfTyuCL7mFSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFCltr%252FL&md5=5ad6bc3f29caf6f7bb508123dcb256f1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2FCCO.0b013e328356da72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCCO.0b013e328356da72%26sid%3Dliteratum%253Aachs%26aulast%3DAdekola%26aufirst%3DK.%26aulast%3DRosen%26aufirst%3DS.%2BT.%26aulast%3DShanmugam%26aufirst%3DM.%26atitle%3DGlucose%2520Transporters%2520in%2520Cancer%2520Metabolism%26jtitle%3DCurr.%2520Opin.%2520Oncol.%26date%3D2012%26volume%3D24%26spage%3D650%26epage%3D654%26doi%3D10.1097%2FCCO.0b013e328356da72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Granchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fancelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minutolo, F.</span></span> <span> </span><span class="NLM_article-title">An Update on Therapeutic Opportunities Offered by Cancer Glycolytic Metabolism</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4915</span>– <span class="NLM_lpage">4925</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.bmcl.2014.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=25288186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eitbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4915-4925&author=C.+Granchiauthor=D.+Fancelliauthor=F.+Minutolo&title=An+Update+on+Therapeutic+Opportunities+Offered+by+Cancer+Glycolytic+Metabolism&doi=10.1016%2Fj.bmcl.2014.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An update on therapeutic opportunities offered by cancer glycolytic metabolism</span></div><div class="casAuthors">Granchi, Carlotta; Fancelli, Daniele; Minutolo, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4915-4925</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Almost all invasive cancers, regardless of tissue origin, are characterized by specific modifications of their cellular energy metab.  In fact, a strong predominance of aerobic glycolysis over oxidative phosphorylation (Warburg effect) is usually assocd. with aggressive tumor phenotypes.  This metabolic shift offers a survival advantage to cancer cells, since they may continue to produce energy and anabolites even when they are exposed to either transient or permanent hypoxic conditions.  Moreover, it ensures a high prodn. rate of glycolysis intermediates, useful as building blocks for fast cell proliferation of cancer cells.  This peculiar metabolic profile may constitute an ideal target for therapeutic interventions that selectively hit cancer cells with minimal residual systemic toxicity.  In this review we provide an update about some of the most recent advances in the discovery of new bioactive mols. that are able to interfere with cancer glycolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIdWP6wz_jRbVg90H21EOLACvtfcHk0lgfTyuCL7mFSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eitbzJ&md5=e8b3949321270dad2dcc4757c47b5aa6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DGranchi%26aufirst%3DC.%26aulast%3DFancelli%26aufirst%3DD.%26aulast%3DMinutolo%26aufirst%3DF.%26atitle%3DAn%2520Update%2520on%2520Therapeutic%2520Opportunities%2520Offered%2520by%2520Cancer%2520Glycolytic%2520Metabolism%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4915%26epage%3D4925%26doi%3D10.1016%2Fj.bmcl.2014.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barron, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsakiridis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsiani, E.</span></span> <span> </span><span class="NLM_article-title">Facilitative Glucose Transporters: Implications for Cancer Detection, Prognosis and Treatment</span>. <i>Metab., Clin. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2015.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.metabol.2015.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=26773935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGmtbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=124-139&author=C.+C.+Barronauthor=P.+J.+Bilanauthor=T.+Tsakiridisauthor=E.+Tsiani&title=Facilitative+Glucose+Transporters%3A+Implications+for+Cancer+Detection%2C+Prognosis+and+Treatment&doi=10.1016%2Fj.metabol.2015.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment</span></div><div class="casAuthors">Barron, Carly C.; Bilan, Philip J.; Tsakiridis, Theodoros; Tsiani, Evangelia</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-139</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">It is long recognized that cancer cells display increased glucose uptake and metab.  In a rate-limiting step for glucose metab., the glucose transporter (GLUT) proteins facilitate glucose uptake across the plasma membrane.  Fourteen members of the GLUT protein family have been identified in humans.  This review describes the major characteristics of each member of the GLUT family and highlights evidence of abnormal expression in tumors and cancer cells.  The regulation of GLUTs by key proliferation and pro-survival pathways including the phosphatidylinositol 3-kinase (PI3K)-Akt, hypoxia-inducible factor-1 (HIF-1), Ras, c-Myc and p53 pathways is discussed.  The clin. utility of GLUT expression in cancer has been recognized and evidence regarding the use of GLUTs as prognostic or predictive biomarkers is presented.  GLUTs represent attractive targets for cancer therapy and this review summarizes recent studies in which GLUT1, GLUT3, GLUT5 and others are inhibited to decrease cancer growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphlp2DpRZZZLVg90H21EOLACvtfcHk0lgfTyuCL7mFSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGmtbzJ&md5=17a6f1647a7ae6ad8d859d80459c0c04</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2015.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2015.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DBarron%26aufirst%3DC.%2BC.%26aulast%3DBilan%26aufirst%3DP.%2BJ.%26aulast%3DTsakiridis%26aufirst%3DT.%26aulast%3DTsiani%26aufirst%3DE.%26atitle%3DFacilitative%2520Glucose%2520Transporters%253A%2520Implications%2520for%2520Cancer%2520Detection%252C%2520Prognosis%2520and%2520Treatment%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2016%26volume%3D65%26spage%3D124%26epage%3D139%26doi%3D10.1016%2Fj.metabol.2015.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmeier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akbar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth in Vitro and in Vivo</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1672</span>– <span class="NLM_lpage">1682</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1158%2F1535-7163.MCT-12-0131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=22689530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOisL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1672-1682&author=Y.+Liuauthor=Y.+Caoauthor=W.+Zhangauthor=S.+Bergmeierauthor=Y.+Qianauthor=H.+Akbarauthor=R.+Colvinauthor=J.+Dingauthor=L.+Tongauthor=S.+Wuauthor=J.+Hinesauthor=X.+Chen&title=A+Small-Molecule+Inhibitor+of+Glucose+Transporter+1+Downregulates+Glycolysis%2C+Induces+Cell-Cycle+Arrest%2C+and+Inhibits+Cancer+Cell+Growth+in+Vitro+and+in+Vivo&doi=10.1158%2F1535-7163.MCT-12-0131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo</span></div><div class="casAuthors">Liu, Yi; Cao, Yanyan; Zhang, Weihe; Bergmeier, Stephen; Qian, Yanrong; Akbar, Huzoor; Colvin, Robert; Ding, Juan; Tong, Lingying; Wu, Shiyong; Hines, Jennifer; Chen, Xiaozhuo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1672-1682</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The functional and therapeutic importance of the Warburg effect is increasingly recognized, and glycolysis has become a target of anticancer strategies.  We recently reported the identification of a group of novel small compds. that inhibit basal glucose transport and reduce cancer cell growth by a glucose deprivation-like mechanism.  We hypothesized that the compds. target Glut1 and are efficacious in vivo as anticancer agents.  Here, we report that a novel representative compd. WZB117 not only inhibited cell growth in cancer cell lines but also inhibited cancer growth in a nude mouse model.  Daily i.p. injection of WZB117 at 10 mg/kg resulted in a more than 70% redn. in the size of human lung cancer of A549 cell origin.  Mechanism studies showed that WZB117 inhibited glucose transport in human red blood cells (RBC), which express Glut1 as their sole glucose transporter.  Cancer cell treatment with WZB117 led to decreases in levels of Glut1 protein, intracellular ATP, and glycolytic enzymes.  All these changes were followed by increase in ATP-sensing enzyme AMP-activated protein kinase (AMPK) and declines in cyclin E2 as well as phosphorylated retinoblastoma, resulting in cell-cycle arrest, senescence, and necrosis.  Addn. of extracellular ATP rescued compd.-treated cancer cells, suggesting that the redn. of intracellular ATP plays an important role in the anticancer mechanism of the mol.  Senescence induction and the essential role of ATP were reported for the first time in Glut1 inhibitor-treated cancer cells.  Thus, WZB117 is a prototype for further development of anticancer therapeutics targeting Glut1-mediated glucose transport and glucose metab.  Mol Cancer Ther; 11(8); 1672-82. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroXJWk_apZpbVg90H21EOLACvtfcHk0lg7KXy41DTn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOisL3P&md5=18bdfc78789600ba53f6149758aadcb4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0131%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBergmeier%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DAkbar%26aufirst%3DH.%26aulast%3DColvin%26aufirst%3DR.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DA%2520Small-Molecule%2520Inhibitor%2520of%2520Glucose%2520Transporter%25201%2520Downregulates%2520Glycolysis%252C%2520Induces%2520Cell-Cycle%2520Arrest%252C%2520and%2520Inhibits%2520Cancer%2520Cell%2520Growth%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D1672%26epage%3D1682%26doi%3D10.1158%2F1535-7163.MCT-12-0131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulp, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. S.</span></span> <span> </span><span class="NLM_article-title">Development of a Novel Class of Glucose Transporter Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3827</span>– <span class="NLM_lpage">3836</span>, <span class="refDoi"> DOI: 10.1021/jm300015m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300015m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFOntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3827-3836&author=D.+Wangauthor=P.+C.+Chuauthor=C.+N.+Yangauthor=R.+Yanauthor=Y.+C.+Chuangauthor=S.+K.+Kulpauthor=C.+S.+Chen&title=Development+of+a+Novel+Class+of+Glucose+Transporter+Inhibitors&doi=10.1021%2Fjm300015m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Novel Class of Glucose Transporter Inhibitors</span></div><div class="casAuthors">Wang, Dasheng; Chu, Po-Chen; Yang, Chia-Ning; Yan, Ribai; Chuang, Yu-Chung; Kulp, Samuel K.; Chen, Ching-Shih</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3827-3836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our finding that the antitumor effect of 5-{4-[(1-methylcyclohexyl)methoxy]benzyl}thiazolidine-2,4-dione, a thiazolidinedione peroxisome proliferator-activated receptor (PPAR)γ agonist, was, in part, attributable to its ability to block glucose uptake independently of PPARγ, we used its PPARγ-inactive analog to develop a novel class of glucose transporter (GLUT) inhibitors.  This lead optimization led to compd. 30 {5-(4-hydroxy-3-trifluoromethylbenzylidene)-3-[4,4,4-trifluoro-2-methyl-2-(2,2,2-trifluoroethyl)butyl]thiazolidine-2,4-dione} as the optimal agent, which exhibited high antitumor potency through the suppression of glucose uptake (IC50, 2.5 μM), while not cytotoxic to prostate and mammary epithelial cells.  This glucose uptake inhibition was assocd. with the inhibition of GLUT1 (IC50, 2 μM).  Moreover, the mechanism of antitumor action of compd. 30 was validated by its effect on a series of energy restriction-assocd. cellular responses.  Homol. modeling anal. suggests that the inhibitory effect of compd. 30 on glucose entry was attributable to its ability to bind to the GLUT1 channel at a site distinct from that of glucose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDoAgocTYYsLVg90H21EOLACvtfcHk0lg7KXy41DTn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFOntLk%253D&md5=c4c2893a7ff1aa1bc357e3858ce870e9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm300015m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300015m%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DP.%2BC.%26aulast%3DYang%26aufirst%3DC.%2BN.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DChuang%26aufirst%3DY.%2BC.%26aulast%3DKulp%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DC.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Novel%2520Class%2520of%2520Glucose%2520Transporter%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3827%26epage%3D3836%26doi%3D10.1021%2Fjm300015m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutphin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solow-Cordero, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouley, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Glut1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">94ra70</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.3002394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1126%2Fscitranslmed.3002394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=21813754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOisLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&author=D.+A.+Chanauthor=P.+D.+Sutphinauthor=P.+Nguyenauthor=S.+Turcotteauthor=E.+W.+Laiauthor=A.+Banhauthor=G.+E.+Reynoldsauthor=J.+T.+Chiauthor=J.+Wuauthor=D.+E.+Solow-Corderoauthor=M.+Bonnetauthor=J.+U.+Flanaganauthor=D.+M.+Bouleyauthor=E.+E.+Gravesauthor=W.+A.+Dennyauthor=M.+P.+Hayauthor=A.+J.+Giaccia&title=Targeting+Glut1+and+the+Warburg+Effect+in+Renal+Cell+Carcinoma+by+Chemical+Synthetic+Lethality&doi=10.1126%2Fscitranslmed.3002394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality</span></div><div class="casAuthors">Chan, Denise A.; Sutphin, Patrick D.; Nguyen, Phuong; Turcotte, Sandra; Lai, Edwin W.; Banh, Alice; Reynolds, Gloria E.; Chi, Jen-Tsan; Wu, Jason; Solow-Cordero, David E.; Bonnet, Muriel; Flanagan, Jack U.; Bouley, Donna M.; Graves, Edward E.; Denny, William A.; Hay, Michael P.; Giaccia, Amato J.</div><div class="citationInfo"><span class="NLM_cas:title">Science Translational Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">94</span>),
    <span class="NLM_cas:pages">94ra70</span>CODEN:
                <span class="NLM_cas:coden">STMCBQ</span>;
        ISSN:<span class="NLM_cas:issn">1946-6242</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Identifying new targeted therapies that kill tumor cells while sparing normal tissue is a major challenge of cancer research.  Using a high-throughput chem. synthetic lethal screen, we sought to identify compds. that exploit the loss of the von Hippel-Lindau (VHL) tumor suppressor gene, which occurs in about 80% of renal cell carcinomas (RCCs).  RCCs, like many other cancers, are dependent on aerobic glycolysis for ATP prodn., a phenomenon known as the Warburg effect.  The dependence of RCCs on glycolysis is in part a result of induction of glucose transporter 1 (GLUT1).  Here, we report the identification of a class of compds., the 3-series, exemplified by STF-31, which selectively kills RCCs by specifically targeting glucose uptake through GLUT1 and exploiting the unique dependence of these cells on GLUT1 for survival.  Treatment with these agents inhibits the growth of RCCs by binding GLUT1 directly and impeding glucose uptake in vivo without toxicity to normal tissue.  Activity of STF-31 in these exptl. renal tumors can be monitored by [18F] fluorodeoxyglucose uptake by micro-positron emission tomog. imaging, and therefore, these agents may be readily tested clin. in human tumors.  Our results show that the Warburg effect confers distinct characteristics on tumor cells that can be selectively targeted for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZodRjh_SzxrVg90H21EOLACvtfcHk0lg7KXy41DTn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOisLzK&md5=418628e65c3a96425353b4be2d692927</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3002394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3002394%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BA.%26aulast%3DSutphin%26aufirst%3DP.%2BD.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DTurcotte%26aufirst%3DS.%26aulast%3DLai%26aufirst%3DE.%2BW.%26aulast%3DBanh%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DG.%2BE.%26aulast%3DChi%26aufirst%3DJ.%2BT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSolow-Cordero%26aufirst%3DD.%2BE.%26aulast%3DBonnet%26aufirst%3DM.%26aulast%3DFlanagan%26aufirst%3DJ.%2BU.%26aulast%3DBouley%26aufirst%3DD.%2BM.%26aulast%3DGraves%26aufirst%3DE.%2BE.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DHay%26aufirst%3DM.%2BP.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Glut1%2520and%2520the%2520Warburg%2520Effect%2520in%2520Renal%2520Cell%2520Carcinoma%2520by%2520Chemical%2520Synthetic%2520Lethality%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26doi%3D10.1126%2Fscitranslmed.3002394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finer-Moore, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caboni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waight, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillig, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bringmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siebeneicher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R. M.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Inhibition of Human Glucose Transporter Glut1 Is Conserved between Cytochalasin B and Phenylalanine Amides</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">4711</span>– <span class="NLM_lpage">4716</span>, <span class="refDoi"> DOI: 10.1073/pnas.1603735113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1073%2Fpnas.1603735113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=27078104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvV2nsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=4711-4716&author=K.+Kapoorauthor=J.+S.+Finer-Mooreauthor=B.+P.+Pedersenauthor=L.+Caboniauthor=A.+Waightauthor=R.+C.+Hilligauthor=P.+Bringmannauthor=I.+Heislerauthor=T.+Mullerauthor=H.+Siebeneicherauthor=R.+M.+Stroud&title=Mechanism+of+Inhibition+of+Human+Glucose+Transporter+Glut1+Is+Conserved+between+Cytochalasin+B+and+Phenylalanine+Amides&doi=10.1073%2Fpnas.1603735113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides</span></div><div class="casAuthors">Kapoor, Khyati; Finer-Moore, Janet S.; Pedersen, Bjoern P.; Caboni, Laura; Waight, Andrew; Hillig, Roman C.; Bringmann, Peter; Heisler, Iring; Muller, Thomas; Siebeneicher, Holger; Stroud, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4711-4716</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cancerous cells have an acutely increased demand for energy, leading to increased levels of human glucose transporter 1 (hGLUT1).  This up-regulation suggests hGLUT1 as a target for therapeutic inhibitors addressing a multitude of cancer types.  Here, the authors present three inhibitor-bound, inward-open structures of WT-hGLUT1 crystd. with three different inhibitors: cytochalasin B, a nine-membered bicyclic ring fused to a 14-membered macrocycle, which has been described extensively in the literature of hGLUTs, and two previously undescribed Phe amide-derived inhibitors.  Despite very different chem. backbones, all three compds. bind in the central cavity of the inward-open state of hGLUT1, and all binding sites overlap the glucose-binding site.  The inhibitory action of the compds. was detd. for hGLUT family members, hGLUT1-4, using cell-based assays, and compared with homol. models for these hGLUT members.  This comparison uncovered a probable basis for the obsd. differences in inhibition between family members.  The authors pinpoint regions of the hGLUT proteins that can be targeted to achieve isoform selectivity, and show that these same regions are used for inhibitors with very distinct structural backbones.  The inhibitor cocomplex structures of hGLUT1 provide an important structural insight for the design of more selective inhibitors for hGLUTs and hGLUT1 in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopyfWMOg2jvLVg90H21EOLACvtfcHk0lhn88eprtOwgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvV2nsLw%253D&md5=473eb5209694681cf2df4be5603aaabc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1603735113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1603735113%26sid%3Dliteratum%253Aachs%26aulast%3DKapoor%26aufirst%3DK.%26aulast%3DFiner-Moore%26aufirst%3DJ.%2BS.%26aulast%3DPedersen%26aufirst%3DB.%2BP.%26aulast%3DCaboni%26aufirst%3DL.%26aulast%3DWaight%26aufirst%3DA.%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DBringmann%26aufirst%3DP.%26aulast%3DHeisler%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DT.%26aulast%3DSiebeneicher%26aufirst%3DH.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26atitle%3DMechanism%2520of%2520Inhibition%2520of%2520Human%2520Glucose%2520Transporter%2520Glut1%2520Is%2520Conserved%2520between%2520Cytochalasin%2520B%2520and%2520Phenylalanine%2520Amides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D4711%26epage%3D4716%26doi%3D10.1073%2Fpnas.1603735113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siebeneicher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorn, L.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel Glut Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1732</span>– <span class="NLM_lpage">1737</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.02.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.bmcl.2016.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=26949183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1akt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1732-1737&author=H.+Siebeneicherauthor=M.+Bauserauthor=B.+Buchmannauthor=I.+Heislerauthor=T.+Mullerauthor=R.+Neuhausauthor=H.+Rehwinkelauthor=J.+Telserauthor=L.+Zorn&title=Identification+of+Novel+Glut+Inhibitors&doi=10.1016%2Fj.bmcl.2016.02.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel GLUT inhibitors</span></div><div class="casAuthors">Siebeneicher, Holger; Bauser, Marcus; Buchmann, Bernd; Heisler, Iring; Mueller, Thomas; Neuhaus, Roland; Rehwinkel, Hartmut; Telser, Joachim; Zorn, Ludwig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1732-1737</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The compd. class of 1H-pyrazolo[3,4-d]pyrimidines was identified using HTS (high-throughput screening) as very potent inhibitors of facilitated glucose transporter 1 (GLUT1).  Extensive structure-activity relationship studies (SAR) of each ring system of the mol. framework was established revealing essential structural motives (i.e., ortho-methoxy substituted benzene, piperazine and pyrimidine).  The selectivity against GLUT2 was excellent and initial in vitro and in vivo pharmacokinetic (PK) studies are encouraging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvoI6G3pWwZrVg90H21EOLACvtfcHk0lhn88eprtOwgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1akt70%253D&md5=79f2a3d68a3e38656b0b3ed4c99bd636</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.02.050%26sid%3Dliteratum%253Aachs%26aulast%3DSiebeneicher%26aufirst%3DH.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBuchmann%26aufirst%3DB.%26aulast%3DHeisler%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DT.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DTelser%26aufirst%3DJ.%26aulast%3DZorn%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520Novel%2520Glut%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1732%26epage%3D1737%26doi%3D10.1016%2Fj.bmcl.2016.02.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siebeneicher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleve, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchmann, B.</span></span> <span> </span><span class="NLM_article-title">Identification and Optimization of the First Highly Selective Glut1 Inhibitor Bay-876</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2261</span>– <span class="NLM_lpage">2271</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1002%2Fcmdc.201600276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=27552707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyktr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2261-2271&author=H.+Siebeneicherauthor=A.+Cleveauthor=H.+Rehwinkelauthor=R.+Neuhausauthor=I.+Heislerauthor=T.+Mullerauthor=M.+Bauserauthor=B.+Buchmann&title=Identification+and+Optimization+of+the+First+Highly+Selective+Glut1+Inhibitor+Bay-876&doi=10.1002%2Fcmdc.201600276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876</span></div><div class="casAuthors">Siebeneicher, Holger; Cleve, Arwed; Rehwinkel, Hartmut; Neuhaus, Roland; Heisler, Iring; Mueller, Thomas; Bauser, Marcus; Buchmann, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2261-2271</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Despite the long-known fact that the facilitative glucose transporter GLUT1 is one of the key players safeguarding the increase in glucose consumption of many tumor entities even under conditions of normal oxygen supply (known as the Warburg effect), only few endeavors have been undertaken to find a GLUT1-selective small-mol. inhibitor.  Because other transporters of the GLUT1 family are involved in crucial processes, these transporters should not be addressed by such an inhibitor.  A high-throughput screen against a library of ∼3 million compds. was performed to find a small mol. with this challenging potency and selectivity profile.  The N-(1H-pyrazol-4-yl)quinoline-4-carboxamides were identified as an excellent starting point for further compd. optimization.  After extensive structure-activity relationship explorations, single-digit nanomolar inhibitors with a selectivity factor of >100 against GLUT2, GLUT3, and GLUT4 were obtained.  The most promising compd., BAY-876 [N4-[1-(4-cyanobenzyl)-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoroquinoline-2,4-dicarboxamide], showed good metabolic stability in vitro and high oral bioavailability in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFnF7Pnmxup7Vg90H21EOLACvtfcHk0lhn88eprtOwgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyktr3L&md5=bcad707900882f937d137dc3925862a7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600276%26sid%3Dliteratum%253Aachs%26aulast%3DSiebeneicher%26aufirst%3DH.%26aulast%3DCleve%26aufirst%3DA.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DHeisler%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DT.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBuchmann%26aufirst%3DB.%26atitle%3DIdentification%2520and%2520Optimization%2520of%2520the%2520First%2520Highly%2520Selective%2520Glut1%2520Inhibitor%2520Bay-876%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2261%26epage%3D2271%26doi%3D10.1002%2Fcmdc.201600276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reckzeh, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karageorgis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalfenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceballos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowacki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroet, M. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binici, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choidas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth</span>. <i>Cell. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1214</span>– <span class="NLM_lpage">1228</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2019.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.chembiol.2019.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=31303578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKlu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=1214-1228&author=E.+S.+Reckzehauthor=G.+Karageorgisauthor=M.+Schwalfenbergauthor=J.+Ceballosauthor=J.+Nowackiauthor=M.+C.+M.+Stroetauthor=A.+Biniciauthor=L.+Knauerauthor=S.+Brandauthor=A.+Choidasauthor=C.+Strohmannauthor=S.+Zieglerauthor=H.+Waldmann&title=Inhibition+of+Glucose+Transporters+and+Glutaminase+Synergistically+Impairs+Tumor+Cell+Growth&doi=10.1016%2Fj.chembiol.2019.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth</span></div><div class="casAuthors">Reckzeh, Elena S.; Karageorgis, George; Schwalfenberg, Melanie; Ceballos, Javier; Nowacki, Jessica; Stroet, Marcus C. M.; Binici, Aylin; Knauer, Lena; Brand, Silke; Choidas, Axel; Strohmann, Carsten; Ziegler, Slava; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1214-1228.e25</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cancer cells sustain growth by altering their metab. to accelerated aerobic glycolysis accompanied by increased glucose demand and employ glutamine as addnl. nutrient source.  This metabolic adaptation induces upregulation of glucose transporters GLUT-1 and -3, and simultaneous targeting of both transporters and of glutamine metab. may offer a promising approach to inhibit cancer cell growth.  We describe the discovery of the very potent glucose uptake inhibitor Glutor, which targets glucose transporters GLUT-1, -2, and -3, attenuates glycolytic flux and potently and selectively suppresses growth of a variety of cancer cell lines.  Co-treatment of colon cancer cells with Glutor and glutaminase inhibitor CB-839 very potently and synergistically inhibits cancer cell growth.  Such a dual inhibition promises to be particularly effective because it targets the metabolic plasticity as well as metabolic rescue mechanisms in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHx4AfWvB7p7Vg90H21EOLACvtfcHk0lgcG_zdTcwArQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKlu7bN&md5=d41d09c28312d8016566cfbec6409c73</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2019.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2019.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DReckzeh%26aufirst%3DE.%2BS.%26aulast%3DKarageorgis%26aufirst%3DG.%26aulast%3DSchwalfenberg%26aufirst%3DM.%26aulast%3DCeballos%26aufirst%3DJ.%26aulast%3DNowacki%26aufirst%3DJ.%26aulast%3DStroet%26aufirst%3DM.%2BC.%2BM.%26aulast%3DBinici%26aufirst%3DA.%26aulast%3DKnauer%26aufirst%3DL.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DChoidas%26aufirst%3DA.%26aulast%3DStrohmann%26aufirst%3DC.%26aulast%3DZiegler%26aufirst%3DS.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520Glucose%2520Transporters%2520and%2520Glutaminase%2520Synergistically%2520Impairs%2520Tumor%2520Cell%2520Growth%26jtitle%3DCell.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D1214%26epage%3D1228%26doi%3D10.1016%2Fj.chembiol.2019.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sergeant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of 3-O-Methylglucose Transport in Human Erythrocytes by Forskolin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>260</i></span>,  <span class="NLM_fpage">14677</span>– <span class="NLM_lpage">14682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=2997220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADyaL2MXlvV2ku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=14677-14682&author=S.+Sergeantauthor=H.+D.+Kim&title=Inhibition+of+3-O-Methylglucose+Transport+in+Human+Erythrocytes+by+Forskolin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of 3-O-methylglucose transport in human erythrocytes by forskolin</span></div><div class="casAuthors">Sergeant, Susan; Kim, Hyun Dju</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">14677-82</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The effect of forskolin  [66575-29-9], and activator of adenylate cyclase  [9012-42-4], was investigated on glucose  [50-99-7] transport in human erythrocytes.  Forskolin was a potent inhibitor of 3-O-methylglucose (3-O-MG) influx in human erythrocytes.  The inhibition of 3-O-MG transport was instantaneous and reversible.  The inhibitor effect of forskolin was concn.-dependent, having an IC50 value of 7.5 μM.  Forskolin caused a decrease in Vmax of carrier-mediated 3-O-MG transport.  Inhibition of influx was not reversed at high concns. of 3-O-MG.  In addn., forskolin inhibited the influx of other carbohydrates including galactose  [59-23-4], ribose  [50-69-1], and fructose  [57-48-7].  In contrast, forskolin was without effect on adenosine transport.  Erythrocytes treated with 50 μM forskolin exhibited an increase in cAMP  [60-92-4] content within 10 s after forskolin exposure.  However, erythrocytes in which cAMP was allowed to accumulate in excess of 10,000 times the basal level, by means of preincubation with exogenous cAMP, displayed 3-O-MG transport indistinguishable from that of cAMP-poor control cells.  Inhibition of 3-O-MG transport appears to be mediate by a mechanism other than by stimulating adenylate cyclase activity.  Moreover, forskolin appears to directly inactivate the 3-O-MG transport system since glucose-sensitive cytochalasin B binding to erythrocyte membranes is virtually abolished by 50 μM forskolin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWeeCrLXeZerVg90H21EOLACvtfcHk0lgcG_zdTcwArQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlvV2ku7s%253D&md5=06e336a6bd9bf8bd2eca79e7e28c5155</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSergeant%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%2BD.%26atitle%3DInhibition%2520of%25203-O-Methylglucose%2520Transport%2520in%2520Human%2520Erythrocytes%2520by%2520Forskolin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D14677%26epage%3D14682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J.</span></span> <span> </span><span class="NLM_article-title">The Impact of Aromatic Ring Count on Compound Developability--Are Too Many Aromatic Rings a Liability in Drug Design?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1020</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2009.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.drudis.2009.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=19729075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1011-1020&author=T.+J.+Ritchieauthor=S.+J.+Macdonald&title=The+Impact+of+Aromatic+Ring+Count+on+Compound+Developability%2D%2DAre+Too+Many+Aromatic+Rings+a+Liability+in+Drug+Design%3F&doi=10.1016%2Fj.drudis.2009.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: Are too many aromatic rings a liability in drug design?</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">1011-1020</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of arom. ring count (the no. of arom. and heteroarom. rings) in mols. has been analyzed against various developability parameters, aq. soly., lipophilicity, serum albumin binding, CyP450 inhibition and hERG inhibition.  On the basis of this anal., it was concluded that the fewer arom. rings contained in an oral drug candidate, the more developable that candidate is probably to be; in addn., more than three arom. rings in a mol. correlates with poorer compd. developability and, thus, an increased risk of attrition in development.  Data are also presented that demonstrate that even within a defined lipophilicity range, increased arom. ring count leads to decreased aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2hOeD6TNGUbVg90H21EOLACvtfcHk0lgcG_zdTcwArQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP&md5=48454c9809e8225b4336ea76aad3f3ba</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520Impact%2520of%2520Aromatic%2520Ring%2520Count%2520on%2520Compound%2520Developability--Are%2520Too%2520Many%2520Aromatic%2520Rings%2520a%2520Liability%2520in%2520Drug%2520Design%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D1011%26epage%3D1020%26doi%3D10.1016%2Fj.drudis.2009.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lgcG_zdTcwArQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+Computational+Approaches+to+Estimate+Solubility+and+Permeability+in+Drug+Discovery+and+Development+Settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0limYjoXfpyXRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520Computational%2520Approaches%2520to%2520Estimate%2520Solubility%2520and%2520Permeability%2520in%2520Drug%2520Discovery%2520and%2520Development%2520Settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Structure-Brain Exposure Relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7559</span>– <span class="NLM_lpage">7583</span>, <span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-Brain+Exposure+Relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0limYjoXfpyXRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-Brain%2520Exposure%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving Beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (cns mpo) Approach to Enable Alignment of Druglike Properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+Beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28cns+mpo%29+Approach+to+Enable+Alignment+of+Druglike+Properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0limYjoXfpyXRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520Beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528cns%2520mpo%2529%2520Approach%2520to%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbertz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudkins, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallamo, J. P.</span></span> <span> </span><span class="NLM_article-title">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1021/cn200100h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-Based%2C+Central+Nervous+System+%28CNS%29+Lead+Selection+and+Lead+Optimization+for+CNS+Drug+Discovery&doi=10.1021%2Fcn200100h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Hudkins, Robert L.; Dorsey, Bruce D.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central nervous system (CNS) is the major area that is affected by aging.  Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment.  Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process.  On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochem. and structural differences between CNS and non-CNS drugs may assist both research areas.  Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena.  Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compds., we analyzed the physicochem. property and the chem. structural profiles of 317 CNS and 626 non-CNS oral drugs.  The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process.  A list of substructural units that may be useful for CNS drug design was also provided here.  A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs.  The combined anal. provided the following guidelines for designing high-quality CNS drugs: (i) topol. mol. polar surface area of <76 Å2 (25-60 Å2), (ii) at least one (one or two, including one aliph. amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) vol. of 740-970 Å3, (vi) solvent accessible surface area of 460-580 Å2, and (vii) pos. QikProp parameter CNS.  The ranges within parentheses may be used during lead optimization.  One violation to this proposed profile may be acceptable.  The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozqfO0vq2i5bVg90H21EOLACvtfcHk0lhdKTiHupi_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO&md5=4c20ba34c3d5397170b50242975ce25d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-Based%252C%2520Central%2520Nervous%2520System%2520%2528CNS%2529%2520Lead%2520Selection%2520and%2520Lead%2520Optimization%2520for%2520CNS%2520Drug%2520Discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D50%26epage%3D68%26doi%3D10.1021%2Fcn200100h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">Cns Physicochemical Property Space Shaped by a Diverse Set of Molecules with Experimentally Determined Exposure in the Mouse Brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5943</span>– <span class="NLM_lpage">5954</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01469</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01469" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1yqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5943-5954&author=Z.+Rankovic&title=Cns+Physicochemical+Property+Space+Shaped+by+a+Diverse+Set+of+Molecules+with+Experimentally+Determined+Exposure+in+the+Mouse+Brain&doi=10.1021%2Facs.jmedchem.6b01469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Physicochemical Property Space Shaped by a Diverse Set of Molecules with Experimentally Determined Exposure in the Mouse Brain</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5943-5954</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the "limits and boundaries" of the central nervous system (CNS) property space is a crit. aspect of modern CNS drug design.  Medicinal chemists are often guided by the physicochem. properties of marketed CNS drugs, which are heavily biased toward "traditional" aminergic targets and commonly described as small lipophilic amines.  This miniperspective describes the statistical anal. of the calcd. physicochem. properties for a diverse set of ligands for mostly "nontraditional" CNS targets and classified as either "brain penetrant" or "peripherally restricted" on the basis of the exptl. mouse brain exposure.  The results suggested that (a) the physicochem. property space conducive to brain exposure is larger than the one defined by the marketed CNS drugs and (b) the most crit. brain exposure determinants are descriptors of the mol. size and hydrogen bond capacity.  These findings led to a modified version of the CNS MPO scoring algorithm, termed CNS MPO.v2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4f3JpTCJ29rVg90H21EOLACvtfcHk0lhdKTiHupi_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1yqsbk%253D&md5=bff2a3cd68c033d6cae235a7524cc528</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01469%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCns%2520Physicochemical%2520Property%2520Space%2520Shaped%2520by%2520a%2520Diverse%2520Set%2520of%2520Molecules%2520with%2520Experimentally%2520Determined%2520Exposure%2520in%2520the%2520Mouse%2520Brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5943%26epage%3D5954%26doi%3D10.1021%2Facs.jmedchem.6b01469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ros, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasjo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">Effect of Molecular Charge on Intestinal Epithelial Drug Transport: Ph-Dependent Transport of Cationic Drugs</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2FS0014-2999%2899%2900334-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10525056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADyaK1MXntFChtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1999&pages=435-443&author=K.+Palmauthor=K.+Luthmanauthor=J.+Rosauthor=J.+Grasjoauthor=P.+Artursson&title=Effect+of+Molecular+Charge+on+Intestinal+Epithelial+Drug+Transport%3A+Ph-Dependent+Transport+of+Cationic+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs</span></div><div class="casAuthors">Palm, Katrin; Luthman, Kristina; Ros, Jenny; Grasjo, Johan; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">435-443</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The aim of this study was to investigate the effect of ionization on drug transport across the intestinal epithelium to include this effect in structure-absorption relationships.  The pH-dependent permeation of one rapidly (alfentanil) and one slowly (cimetidine) transported basic model drug across Caco-2 cell monolayers was investigated.  Both drugs had pKa values in the physiol. pH range.  The permeability coeffs. (Pc) of the model drugs were obtained at varying apical buffer pHs, thus varying the degree of drug ionization (from 5 to 95%).  The relation between Pc and the fraction of the drug in un-ionized form (fu) was analyzed to delineate the permeability coeffs. of the un-ionized (Pc,u) and ionized (Pc,i) forms of the drugs.  Theor. ests. of the pKa values were also calcd. from ionization energies for each model compd.  For both drugs, a linear increase in Pc was obsd. with increasing fu.  Transport of the un-ionized form was 150- and 30-fold more rapid than transport of the ionized form for alfentanil and cimetidine, resp.  However, when fu < 0.1, the contribution of the ionized form was significant.  Because fu is <0.1 over the entire physiol. pH range for a large no. of drugs, these results will have implications on predictions of in vivo intestinal drug absorption both from in vitro studies in cell cultures and from computed structural properties of drug mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT8-YOYJTmtrVg90H21EOLACvtfcHk0lhdKTiHupi_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFChtr8%253D&md5=c161433bb0305cb8d195107a16982bbc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2899%2900334-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252899%252900334-9%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%26aufirst%3DK.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DRos%26aufirst%3DJ.%26aulast%3DGrasjo%26aufirst%3DJ.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DEffect%2520of%2520Molecular%2520Charge%2520on%2520Intestinal%2520Epithelial%2520Drug%2520Transport%253A%2520Ph-Dependent%2520Transport%2520of%2520Cationic%2520Drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D291%26spage%3D435%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of Fluorine in Medicinal Chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+Fluorine+in+Medicinal+Chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lhdKTiHupi_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520Fluorine%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5822</span>– <span class="NLM_lpage">5880</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5822-5880&author=N.+A.+Meanwell&title=Fluorine+and+Fluorinated+Motifs+in+the+Design+and+Application+of+Bioisosteres+for+Drug+Design&doi=10.1021%2Facs.jmedchem.7b01788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5822-5880</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The electronic properties and relatively small size of fluorine endow it with considerable versatility as a bioisostere and it has found application as a substitute for lone pairs of electrons, the hydrogen atom, and the Me group while also acting as a functional mimetic of the carbonyl, carbinol, andnitrile moieties.  In this context, fluorine substitution can influence the potency, conformation, metab., membrane permeability, and P-gp recognition of a mol. and temper inhibition of the hERG channel by basic amines.  However, as a consequence of the unique properties of fluorine, it features prominently in the design of higher order structural metaphors that are more esoteric in their conception and which reflect a more sophisticated mol. construction that broadens biol. mimesis.  In this Perspective, applications of fluorine in the construction of bioisosteric elements designed to enhance the in vitro and in vivo properties of a mol. are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsoQvY950L3LVg90H21EOLACvtfcHk0lgbqf0nqIwZQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D&md5=2d0ce3326c7ff932da8d7d26972ced14</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DFluorine%2520and%2520Fluorinated%2520Motifs%2520in%2520the%2520Design%2520and%2520Application%2520of%2520Bioisosteres%2520for%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5822%26epage%3D5880%26doi%3D10.1021%2Facs.jmedchem.7b01788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerebtzoff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennernaes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senner, F.</span></span> <span> </span><span class="NLM_article-title">Coexistence of Passive and Carrier-Mediated Processes in Drug Transport</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1038/nrd3187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1038%2Fnrd3187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=20671764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=597-614&author=K.+Suganoauthor=M.+Kansyauthor=P.+Arturssonauthor=A.+Avdeefauthor=S.+Bendelsauthor=L.+Diauthor=G.+F.+Eckerauthor=B.+Fallerauthor=H.+Fischerauthor=G.+Gerebtzoffauthor=H.+Lennernaesauthor=F.+Senner&title=Coexistence+of+Passive+and+Carrier-Mediated+Processes+in+Drug+Transport&doi=10.1038%2Fnrd3187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Coexistence of passive and carrier-mediated processes in drug transport</span></div><div class="casAuthors">Sugano, Kiyohiko; Kansy, Manfred; Artursson, Per; Avdeef, Alex; Bendels, Stefanie; Di, Li; Ecker, Gerhard F.; Faller, Bernard; Fischer, Holger; Gerebtzoff, Gregori; Lennernaes, Hans; Senner, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">597-614</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The permeability of biol. membranes is one of the most important determinants of the pharmacokinetic processes of a drug.  Although it is often accepted that many drug substances are transported across biol. membranes by passive transcellular diffusion, a recent hypothesis speculated that carrier-mediated mechanisms might account for the majority of membrane drug transport processes in biol. systems.  Based on evidence of the physicochem. characteristics and of in vitro and in vivo findings for marketed drugs, as well as results from real-life discovery and development projects, the authors present the view that both passive transcellular processes and carrier-mediated processes coexist and contribute to drug transport activities across biol. membranes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppGdYhfY0-BbVg90H21EOLACvtfcHk0lgbqf0nqIwZQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCktrk%253D&md5=6e332ad6fa2c2ac8b3b1dc7940e73caf</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrd3187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3187%26sid%3Dliteratum%253Aachs%26aulast%3DSugano%26aufirst%3DK.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DGerebtzoff%26aufirst%3DG.%26aulast%3DLennernaes%26aufirst%3DH.%26aulast%3DSenner%26aufirst%3DF.%26atitle%3DCoexistence%2520of%2520Passive%2520and%2520Carrier-Mediated%2520Processes%2520in%2520Drug%2520Transport%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D597%26epage%3D614%26doi%3D10.1038%2Fnrd3187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bungay, P.</span></span> <span> </span><span class="NLM_article-title">Restricting Cns Penetration of Drugs to Minimise Adverse Events: Role of Drug Transporters</span>. <i>Drug Discovery Today: Technol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e79</span>– <span class="NLM_lpage">e85</span>, <span class="refDoi"> DOI: 10.1016/j.ddtec.2014.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.1016%2Fj.ddtec.2014.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=25027378" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=e79-e85&author=S.+Bagalauthor=P.+Bungay&title=Restricting+Cns+Penetration+of+Drugs+to+Minimise+Adverse+Events%3A+Role+of+Drug+Transporters&doi=10.1016%2Fj.ddtec.2014.03.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2014.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2014.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%26aulast%3DBungay%26aufirst%3DP.%26atitle%3DRestricting%2520Cns%2520Penetration%2520of%2520Drugs%2520to%2520Minimise%2520Adverse%2520Events%253A%2520Role%2520of%2520Drug%2520Transporters%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2014%26volume%3D12%26spage%3De79%26epage%3De85%26doi%3D10.1016%2Fj.ddtec.2014.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volpe, D. A.</span></span> <span> </span><span class="NLM_article-title">Drug-Permeability and Transporter Assays in Caco-2 and Mdck Cell Lines</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">2063</span>– <span class="NLM_lpage">2077</span>, <span class="refDoi"> DOI: 10.4155/fmc.11.149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=10.4155%2Ffmc.11.149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=22098353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVyksr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=2063-2077&author=D.+A.+Volpe&title=Drug-Permeability+and+Transporter+Assays+in+Caco-2+and+Mdck+Cell+Lines&doi=10.4155%2Ffmc.11.149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-permeability and transporter assays in Caco-2 and MDCK cell lines</span></div><div class="casAuthors">Volpe, Donna A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2063-2077</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The human colon adenocarcinoma Caco-2 and Madin-Darby canine kidney epithelial cell lines provide in vitro tools to assess a drug''s permeability and transporter interactions during discovery and development.  The cells, when cultured on semiporous filters, form confluent monolayers that model the intestinal epithelial barrier for permeability, transporter and drug-interaction assays.  The applications of these assays in pharmaceutical research include qual. prediction and ranking of absorption, detg. mechanism(s) of permeability, formulation effects on drug permeability, and the potential for transporter-mediated drug-drug interactions.  This review focuses on recent examples of Caco-2 and Madin-Darby canine kidney cells assays for drug permeability including transfected and knock-down cells, miniaturization and automation, and assay combinations to better understand and predict intestinal drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGDgJ3I35HPrVg90H21EOLACvtfcHk0lgB6Yy7z7vjzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVyksr3K&md5=3d13d17fc375ca5bd7c4cf26b8debb11</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.149%26sid%3Dliteratum%253Aachs%26aulast%3DVolpe%26aufirst%3DD.%2BA.%26atitle%3DDrug-Permeability%2520and%2520Transporter%2520Assays%2520in%2520Caco-2%2520and%2520Mdck%2520Cell%2520Lines%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D2063%26epage%3D2077%26doi%3D10.4155%2Ffmc.11.149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olszewski, K.</span>; <span class="NLM_string-name">Kim, J.-I.</span>; <span class="NLM_string-name">Poyurovsky, M.</span>; <span class="NLM_string-name">Liu, K.</span>; <span class="NLM_string-name">Barsotti, A.</span>; <span class="NLM_string-name">Morris, K.</span></span> <span> </span><span class="NLM_article-title">Preparation of Fused Pyrimidines as Glucose Uptake Inhibitors</span>. <span class="NLM_patent">WO2016210330A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+Olszewski&author=J.-I.+Kim&author=M.+Poyurovsky&author=K.+Liu&author=A.+Barsotti&author=K.+Morris&title=Preparation+of+Fused+Pyrimidines+as+Glucose+Uptake+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOlszewski%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520Fused%2520Pyrimidines%2520as%2520Glucose%2520Uptake%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02153">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_14101"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b02153?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02153</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Details of the synthetic procedures and analytical data for intermediates and final compounds <b>9a</b>–<b>m</b>, <b>10a</b>–<b>i</b>, <b>11a</b>, <b>11b</b>, <b>12a</b>–<b>p</b>, <b>13a</b>, <b>14b</b>, <b>14c</b>, <b>15a</b>, <b>15c</b>, <b>16c</b>, <b>17a</b>, <b>18a</b>, <b>19a</b>; GLUT1 IC<sub>50</sub> values (nM) in the presence of varying glucose concentrations; eurofins safety panel screen of <b>15b</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_001.pdf">jm9b02153_si_001.pdf (1.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02153/suppl_file/jm9b02153_si_002.csv">jm9b02153_si_002.csv (4.44 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02153&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02153%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-10" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02153" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679976944f073bfe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
